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Abstract
Enterococci (mainly Enterococcus faecalis and E. faecium) are the third leading
cause of hospital associated infections and have gained increased importance due to
their fast adaptation to the clinical environment. Hospital associated clonal types of
E. faecium and E. faecalis constitute subgroups within their own species that show
a tendency to spread and persist among the nosocomial setting, to acquire resist-
ance treats and may express increased pathogenicity. The high recombination rates
of enterococci are associated to the presence of several mobile elements encoding
antibiotic resistance and pathogenicity traits.
This work presents results of the analysis of two virulence-associated mobilizable
elements of Enterococcus: the putative hyaluronidase gene of E. faecium ℎ𝑦𝑙𝐸𝑓𝑚,
and the enterococcal surface protein esp-containing pathogenicity island (PAI) of
E. faecalis . The ℎ𝑦𝑙𝐸𝑓𝑚 gene, contained within a putative genomic island (GI),
is enriched among the polyclonal subpopulation of hospital associated E. faecium
strains. The ℎ𝑦𝑙𝐸𝑓𝑚 GI (17,824 bp) was found to be conserved among 39 ℎ𝑦𝑙𝐸𝑓𝑚
positive strains with variation in a specific region downstream of ℎ𝑦𝑙𝐸𝑓𝑚 (n=18)
and was located on large plasmids (150 to 350 kb) (n=37). ℎ𝑦𝑙𝐸𝑓𝑚-vanA plasmids
were horizontally transferred into three different E. faecium recipient strains but not
into E. faecalis . Sequencing of pLG1 resolved putative plasmid replication, conjug-
ation and maintenance determinants, as well as additional putative pathogenicity
factors (e.g. pilA) and antibiotic resistance genes (i.e. vanA, erm(B)). Although
the E. faecalis PAI (153 kb) is thought to be mobile, so far only internal frag-
ments of the PAI or larger chromosomal regions containing it had been mobilized.
This work presents the horizontal transfer of the entire PAI element from the chro-
mosome of E. faecalis strain UW3114 (ca. 200 kb) when selecting for transfer of
erythromycin resistance (located in plasmid pLG2). The PAI excised and circu-
larized precisely, and transferred horizontally integrating site-specifically into the
chromosome of E. faecalis (intergenic region) and E. faecium (tRNAlys). Several
phenotypic characteristics accompanied the acquisition of the PAI: Esp on the cell
surface, enhanced biofilm formation and cytolytic activity in E. faecalis , although
no differences were seen in pathogenicity using mouse bacteraemia and peritonitis
models. pLG2 is a 66 kb conjugative pheromone-responsive plasmid of mosaic struc-
ture, that transferred in parallel with the PAI, and might have promoted the PAI
1
2horizontal transfer.
These findings demonstrate the horizontal gene transfer of virulence factors and
antibiotic resistance gene clusters by a single genetic event, which might be triggered
by heavy antibiotic use, common in health care units where enterococci are increas-
ingly prevalent.
Zusammenfassung
Horizontal übertragbare Elemente von Enterococci
Enterokokken (vor allem Enterococcus faecalis und E. faecium) sind die dritthäufig-
ste Ursache von Krankenhaus Infektionen und erlangen durch ihre schnelle Anpas-
sung an die klinische Umgebung immer größere Bedeutung. Innerhalb der Spezies
E. faecium und E. faecalis existieren Krankenhaus-assoziierte klonale Komplexe,
die eine Tendenz zur Ausbreitung, den erhöhten Erwerb an Resistenzmechanismen
und eine erhöhte Pathogenitätsausprägung zeigen. Die hohen Rekombinationsraten
von Enterokokken sind mit mobilen genetischen Elementen assoziiert, die für Anti-
biotikaresistenzgene und Pathogenitätsfaktoren kodieren.
Diese Arbeit präsentiert die Ergebnisse der Analyse von zwei Virulenz-assoziierten
mobilisierbaren Elementen von Enterococcus : das putative Hyaluronidase-kodierende
Gen von E. faecium (ℎ𝑦𝑙𝐸𝑓𝑚) und die E. faecalis Pathogenitätsinsel (PAI), welche
das Oberflächenprotein esp trägt. Das ℎ𝑦𝑙𝐸𝑓𝑚 Gen, welches innerhalb einer putat-
iven genomischen Insel (GI) kodiert ist, kommt in den polyklonalen Krankenhaus-
assoziierten Subpopulationen vor. Es wurde festgestellt dass, bei der Mehrheit von
39 ℎ𝑦𝑙𝐸𝑓𝑚 positiven Stämmen, die vollständige ℎ𝑦𝑙𝐸𝑓𝑚 GI (17824 bp) auf großen Plas-
miden (150 bis 350 kb) vorliegt (n = 37). ℎ𝑦𝑙𝐸𝑓𝑚- Plasmide aus E. faecium wurden
horizontal in verschiedene E. faecium Rezipientenstämme aber nicht in E. faecalis
übertragen. Die Sequenzierung des ℎ𝑦𝑙𝐸𝑓𝑚-Plasmides PLG1 identifizierte putative
Gene für die Plasmidreplikation, -Konjugation und -Stabilität, sowie weitere pu-
tative Pathogenitätsfaktoren (zB. pilA) und Antibiotikaresistenz-Gene (zB. vanA,
erm(B)). Obwohl die E. faecalis PAI (153 kb) mobil zu sein scheint, wurden bisher
nur interne Fragmente der PAI oder größere chromosomale Regionen, welche die PAI
enthalten, mobilisiert. Diese Arbeit zeigt erstmals die horizontale Übertragung des
gesamten PAI Elements aus dem Chromosom von E. faecalis UW3114 (ca. 200 kb)
unter Erythromycin-Selektionsdruck (im Plasmid PLG2). Es konnte die Excision,
Zirkularisierung, horizontale Übertragung und Orts-spezifische Reintegration in das
Chromosom von E. faecalis (intergenisch) und E. faecium (tRNALys) gezeigt wer-
den. Mehrere phänotypische Merkmale begleiten den Erwerb der PAI in E. faecalis :
Expression von Esp auf der Zelloberfläche, verstärkte Bildung von Biofilmen und
erhöhte zytotoxische Aktivität. Es wurden jedoch keine Unterschiede in der Patho-
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4genitätsausprägung im Bakteriämie- und Peritonitis-Mausmodell beobachtet. PLG2
ist ein 66 kb großes, konjugatives Pheromon-Plasmid mit Mosaik-Struktur, das par-
allel mit der PAI übertragen wurde und könnte den horizontalen Transfer der PAI
gefördert haben.
Diese Befunde zeigen den horizontalen Gentransfer von Virulenzfaktoren und
Antibiotikaresistenzgen-Clustern in einem einzigen genetischen Ereignis. Solche
Ereignisse können besonders in klinischen Einrichtungen, wo Enterokokken in zun-
ehmendem Maße verbreitet sind, durch den erhöhten Einsatz von Antibiotika aus-
gelöst werden.
1. Introduction
1.1 Enterococci
Enterococci are ubiquitous Gram-positive cocci (Figure 1.1), living in the gastrointest-
inal tract of humans and animals and are encountered in nearly everything humans
come to contact with. Enterococci were formerly classified as group D strepto-
cocci until 1984 when genetic evidence was provided that gave them the genus
status. They are facultative anaerobes, well adapted to survive in many com-
plex niches and capable of resisting a variety of environmental stresses including
heat, acid, oxidation, hyperosmolarity and UV radiation. Enterococci can also
grow in broth containing 6.5% NaCl and 40% bile salts, can tolerate ethanol,
detergents and prolonged desiccation [reviewed in 34, 115]. In healthy humans,
enterococci are constituents of the colon flora at relatively low levels, but it ap-
pears that they are the most abundant group of bacteria in the small intestine
[54, 160]. However the role that enterococci play in the healthy human gastrointest-
inal tract is unclear. Currently 40 species in the genus enterococcus have been
described (http://www.bacterio.cict.fr/e/enterococcus.html). Enterococcus
faecalis and E. faecium are the species most commonly associated with colonization
of the human gastrointestinal tract and also cause the vast majority of enterococcal
infections.
Figure 1.1: Scanning Electron microscopy of E. faecalis strain OG1RF (Image: Dr. Norbert Bannert, Robert Koch
Institute, Berlin)
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61.1.1 Hospital associated enterococci
Although initially regarded as harmless commensals, nowadays infections caused
by members of the genus Enterococcus include urinary tract infections (UTI), bac-
teraemia, intra-abdominal and wound infections and endocarditis, often as part of
mixed species infections in immunocompromised patients. Currently, enterococci
rank as the third leading cause of nosocomial infections [123]. While E. faecium
constitutes the majority of vancomycin- and ampicillin-resistant isolates of entero-
cocci, E. faecalis accounts for the majority (60-80%) of nosocomial enterococcal
infections [reviewed in 115]. E. faecalis and E. faecium are genetically not much
related to each other, as shown by phylogenetic clustering on the basis of 16S rRNA
sequences or the sequences of the housekeeping gene encoding the 𝛼-subunit of ATP
synthase, atpA [108]. There are also a number of physiological differences between
E. faecalis and E. faecium such as the ability of E. faecalis to produce acid from
glycerol, to ferment pyruvate and the presence of cytochrome-like respiratory system
and a catalase which are absent from E. faecium [67].
1.1.2 E. faecium
Since the late 1980s a rapid increase in nosocomial E. faecium infections has been
observed [172]. The ecological switch among hospital-derived enterococci in favour of
E. faecium requires special attention because resistance against important antibiot-
ics such as ampicillin and vancomycin emerged predominantly in E. faecium and less
in E. faecalis . Early epidemiological investigations of enterococcal infections were
based on phenotypic characteristics. The introduction of various molecular tech-
niques has substantially improved the ability to discriminate enterococcal isolates
and has provided critical insights into the epidemiology of enterococcal infections
and the population biology at the species level. It has been demonstrated that
hospital-associated strains are exogenously acquired and spread by direct and indir-
ect contact among patients and intra hospital transmission and inter-hospital spread
have been documented [34]. Macrorestriction analysis using Pulse Field Gel Elec-
trophoresis (PFGE) is a highly discriminative typing method [171, 26, 191]. PFGE
can resolve the identity between strains circulating within a confined area or from
a localized outbreak. However the high genome plasticity of enterococci, leads to
extreme genome variations making PFGE less suitable for long-term epidemiological
considerations. Other typing methods as Amplified Fragment Length Polymorph-
ism (AFLP), Multiple Loci Variable number of tandem repeats (VNTR) Analysis
(MLVA) and especially Multilocus Sequence Typing (MLST) were established to cir-
cunvent limitations of PFGE and allow populational investigations. MLST analysis
initially suggested that the majority of infectious isolates of E. faecium grouped in
a distinct cluster named clonal complex 17 (CC17) [194], however it has been dis-
7puted that the e-Burst algorithm initially used to describe the population structure
of E. faecium was not appropriate as its evolution is driven by high recombination
and low mutation rates [175]. Recent analysis of the MLST database for E. faecium
using more appropriate algorithms has shown that the sequence types constituting
CC17 have evolved independently from different ancestral clones and have formed
a sub population of hospital associated clones [195]. Hospital- derived strains form
a polyclonal subpopulation of E. faecium which is linked to vancomycin, high-level
ampicillin and high level ciprofloxacin resistance [81, 189]. They are also enriched
in virulence associated factors including the Enterococcal surface protein esp gene
[193, 198, 7], the E. faecium hyaluronidase ℎ𝑦𝑙𝐸𝑓𝑚 [120], pili [59, 60] and a recently
identified gene cluster that is highly specific for hospital-derived E. faecium [57].
1.1.3 E. faecalis
E. faecalis causes the majority of human enterococcal infections and is by far more
pathogenic than E. faecium. Vancomycin resistance, seen predominantly in E. fae-
cium is an uncommon property of E. faecalis . Different MLST schemes have been
used to study the epidemiology and population structure of E. faecalis . An MLST
scheme using seven house keeping genes showed that, in contrast to E. faecium,
E. faecalis obtained from different epidemiological sources (hospitalized patients,
community and animals) frequently share identical MLST- sequence types (STs)
and group together in common complexes. Despite this alleged random dispersion
of human clinical, surveillance and animal isolates, two of the major complexes (CC2
and CC9) contain almost exclusively hospital-derived isolates, suggesting that they
are associated with the hospital environment [128].
1.2 Antibiotic resistance in enterococci
Enterococci attract increassing attention because of their increasing role in noso-
comial infections and because of their remarkable and increasing resistance to an-
timicrobial agents. Antimicrobial resistance can be divided into that which is an
inherent or intrinsic property and that which is acquired [100].
1.2.1 Intrinsic resistance
Unlike acquired resistance, intrinsic resistance is based in chromosomal genes and
is typically non-transferable. Enterococci are inherently more resistant to antimi-
crobial drugs than other clinically important Gram-positive bacteria [160]. Table
1.1 presents the intrinsic antibacterial drug resistance mechanisms in enterococci. A
characteristic feature of enterococci is the resistance to 𝛽-lactam antibiotics (partic-
ularly cephalosporins and penicillinase-stable penicillins) due to low affinity of the
8Drug Mechanism of resistance
𝛽-lactams Overproduction of low-affinity PBPs
and/or decreased affinity for binding 𝛽-
lactams
Aminoglycosides Impermeable cell wall, low uptake and
lack of an electron transport chain.
Clindamycin and lincomycin Low uptake and permeability
Fluoroquinolones Low permeability, reduced uptake and
anaerobic environment.
Trimethoprim-sulfamethoxazole Resistance in vivo due to use of exogen-
ous folates
Glycopeptides D-Ala-D-Ser ligase (VanC)
Table 1.1: Intrinsic antibacterial drug resistance in enterococci. PBP, penicillin binding protein. [Table from 160]
penicillin-binding proteins [160]. E. faecium are less susceptible to 𝛽-lactam anti-
biotics than E. faecalis because the penicillin-binding proteins of E. faecium have
markedly lower affinities for the antibiotics [196]. The first reports of strains highly
resistant to penicillin began to appear in the 1980s [12, 134]. Resistance to semi-
synthetic penicillinase-resistant penicillins is more pronounced. In addition to the
high minimmum inhibitory concentrations (MIC), enterococci are "tolerant" to all
𝛽-lactams, that is, they are not killed by concentrations higher than the MIC [100].
Another characteristic feature of enterococci is their resistance to the clinically
achievable concentrations of the lincosamide antibiotics: clindamycin and lincomy-
cin.
Low level resistance to aminoglycosides is also an inherent property of entero-
cocci and is due to low uptake of these agents. In the presence of cell wall inhibitors
such as a 𝛽-lactam or a glycopeptide, uptake of the aminoglycoside is markedly
enhanced. This results in enhanced killing, the well known synergistic effect [100].
Enterococci intrinsically resistant to vancomycin (IVRE) are infrequently recovered
(e.g. 1-2% of enterococcal isolates) and are regarded as not clinically significant. Low
level intrinsic resistance has been shown to be associated with serine-containing pep-
tidoglycan in E. gallinarum (vanC phenotype). The replacement at the C-terminus
of the peptidoglycan precursors D-Ala-D-Ala by D-Ala-D-Ser (produced by the lig-
ases Ddl and VanC1 respectively) results in lower affinity for vancomycin binding.
[160]. The vanC cluster consists of five genes, is chromosomally encoded and non-
transferable and has been detected on strains of E. gallinarum.
1.2.2 Acquired resistance
Enterococci often acquire antibiotic resistance through exchange of resistance-encoding
genes carried on conjugative transposons or broad-host-range plasmids. Multi drug
resistant (MDR) enterococci have emerged rapidly. The first high level gentamicin
resistance occurred in 1979 [65, 201], simultaneously, sporadic outbreaks of nosoco-
9mial E. faecalis and E. faecium infection appeared with penicillin resistance due to
𝛽-lactamase production [102] and finally MDR enterococci resistant to vancomycin
were reported in Europe [82, 178] and the United States [130]. The emergence of
high level ampicillin and vancomycin resistant E. faecium as a cause of nosocomial
infections has serious therapeutic consequences. Table 1.2 shows the most important
known mechanisms of acquired antibiotic resistance in enterococci. Enterococci are
intrinsically resistant to 𝛽-lactams, but high level resistance is due to overproduction
of a PBP with a natural low affinity for penicillins or to mutations that make the
PBP even less suceptible to penicillins inhibition. E. faecalis strains that produce
𝛽-lactamase are fortunately still rare [101]
1.3 Pathogenicity of enterococci
Since the first identification of a vancomycin-resistant enterococci (VRE) in 1986
[82, 178] and with the emergence of multiple drug resistant strains, the question of
enterococcal virulence has attracted increased public and clinical interest. Nowadays
they represent an increasing problem due to the evident hospital association of cer-
tain clones and the therapeutic difficulties linked to the vast array of antibiotic
resistance traits that they possess. Initially it was believed that the enterococci nat-
ive to the patients’ intestinal flora were the cause of nosocomial infections. However
it has become clear that for multiple antibiotic resistant infections, the situation
is more complex. Hospital epidemics are caused by certain circulating clones, in
contrast, enterococci from the flora of healthy patients are rarely clonal and rarely
antibiotic resistant. Moreover it is known that, within hours to days of admission,
the gastrointestinal tracts of patients become colonized with exogenously acquired
MDR strains [95, 43, 195]. Therefore, a prerequisite for multiple antibiotic resistant
enterococcal infections appears to be the asymptomatic colonization of the GI tract
of patients following hospital admission [115]. The search for factors that subvert the
commensal relationship has lead to the finding and characterization of pathogenicity
factors as traits that a) are not required for commensal existence as evidenced by
their absence from most of commensal isolates, b) are part of the accesory genome
or c) contribute to the severity of enterococcal infection in one or more models of en-
terococcal infection. Further additional factors have been described that contribute
to the fitness of enterococci at the site of infection and therefore constitute legitim-
ate therapeutic targets, but the role in the commensal existence of enterococci is less
clear because of widespread and distribution within the genus or species, including
commensal strains [41]. Table 1.3 resumes the enterococcal pathogenicity factors
known until now.
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Antibiotic resistance Mechanism
HLR to aminoglycosides 𝑎 Enzymatic (production of aminoglycoside
modifying enzymes)
Gentamicin Phosphotransferases (APH)
Kanamycin Acetyltransferases (AAC)
Streptomycin Nucleotidyltransferases (ANT)
Alteration of the target (leading to de-
creased ribosomal binding)
Resistance to glycopeptides𝑏 Alteration of the target (modification of
Vancomycin, Teicoplanin the peptidoglycan biosynthetic pathway)
Van A, Van B
Van C (VanC1, VanC2, VanC3)
Van D, Van E, Van G
Resistance to 𝛽-lactams𝑐 Alteration of the target (altered penicillin
Penicillin binding proteins (PBP), in particular
PBP5)
Ampicillin Enzymatic (production of 𝛽-lactamase)
Resistance to quinolones Target alteration (changes to the subunit A
of DNA gyrase (GyrA) and topoisomerase
Ivsubunit (ParC))
Resistance to chloramphenicol Enzymatic (production of chloramphenicol
acetyl transferase)
Active efflux
Resistance to the MLS group
Macrolides (erythromycin) Enzymatic (production of methylating en-
zymes)
Efflux protein pump (ATP-binding trans-
porter protein)
Lincosamides (clindamycin HLR) Nucleotidyltransferase (adenylation of an
hyldroxyl group in LIN and CLI)
Streptogramin B Acetyltransferases
Tetracyclin
tet(K), tet(L) Active efflux
tet(M), tet(N) tet(O), tet(S) Ribosomal protection (modification of ri-
bosomal conformation)
Oxazolidinone Alteration of the target (decreased
Linezolid ribosomal binding through 23s rRNA
mutations)
Everninomicins Alteration of the target (rRNA
methyltransferase-mediated 23s rRNA
methylation)
Table 1.2: Major patterns and mechanisms of acquired resistance to antimicrobial agents in enterococci. 𝑎HLR,
high level resistance; found in increasing frequencies in E. faecalis and E. faecium. 𝑏 VanA and VanB phenotypes
are usually found in E. faecalis and E. faecium; VanD in E. faecium and VanE in E. faecalis BM4405; VanC1
is associated with E. gallinarum, VanC2 and VanC3 with E. caseliflavus. 𝑐 Found in E. faecalis and E. faecium.
[Table modified from 34]
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1.3.1 Enterococcal surface protein, Esp
The enterococcal surface protein Esp is a cell surface-localized, 1,873 amino acid-long
protein of approximately 200 kDa that is coded by the esp gene and is expressed
on the surface of E. faecium (𝑒𝑠𝑝𝐸𝑓𝑚 gene) and E. faecalis [80, 33, 144]. While
esp is widely distributed among E. faecalis strains, it appears to be associated to
epidemic (vacomycin-resistant) E. faecium strains [80, 193]. Esp proteins contain
an N-terminal signal sequence followed by 3 to 11 very highly conserved tandem
repeats 82 amino acids in length. It possesses a transport signal sequence and a
cell wall anchor motif [144]. In E. faecalis , experimental evidence has been provided
about the role of Esp as an adhesin in colonization of the urinary tract of mice.
[142]. It has been demonstrated that although esp is capable of increasing biofilm
forming capacity in E. faecium and E. faecalis [161] [170] [180] [56], it is neither
necessary nor sufficient for biofilm formation [77] [124]. The esp gene is located on
two different pathogenicity islands (PAIs) in both E. faecalis and E. faecium.
1.3.2 Putative hyaluronidase ℎ𝑦𝑙𝐸𝑓𝑚
Recently an ORF with significant deduced amino acid identity to hyaluronidase
genes has been found in the multiresistant strain E. faecium C68 (DO) and was des-
ignated ℎ𝑦𝑙𝐸𝑓𝑚 [120]. Hyaluronidases are putative virulence factors that play a role in
adhesion or colonization [70], tissue degradation and spread [114]. So far no biochem-
ical evidence for the actual enzymatic activity of ℎ𝑦𝑙𝐸𝑓𝑚 has been reported. ℎ𝑦𝑙𝐸𝑓𝑚
might constitute a family 84 glycoside hydrolase with 𝛽-N-acetylglucosaminidase
activity as indicated by sequence similarities to such proteins [39]. Since then several
molecular and epidemiological studies have revealed the almost exclusive presence
of ℎ𝑦𝑙𝐸𝑓𝑚 among clinical strains as well as an increase in the number of CC17-E. fae-
cium carrying ℎ𝑦𝑙𝐸𝑓𝑚 in hospitals of different countries [120, 173, 195, 27, 39]. While
several studies demonstrate the epidemiological link between ℎ𝑦𝑙𝐸𝑓𝑚 and infectious
isolates, the demonstration of ℎ𝑦𝑙𝐸𝑓𝑚-associated pathogenicity remains unresolved.
A ℎ𝑦𝑙𝐸𝑓𝑚 deletion mutant of E. faecium demonstrated attenuation compared to
the wild type in a mouse peritonitis model, however complementation studies of
the ℎ𝑦𝑙𝐸𝑓𝑚 mutation were missing. In the same study pre-immunised mice with
anti-ℎ𝑦𝑙𝐸𝑓𝑚 immune rabbit antisera were challenged with a wild type E. faecium
ℎ𝑦𝑙𝐸𝑓𝑚 positive strain, demonstrating protection of infection [4]. Recent studies
have demonstrated that ℎ𝑦𝑙𝐸𝑓𝑚 is plasmid-located and that the horizontal acquis-
ition of the ℎ𝑦𝑙𝐸𝑓𝑚-containing plasmid confers strains an increased virulence in a
mouse peritonitis model; this evidenced a role in pathogenicity for ℎ𝑦𝑙𝐸𝑓𝑚 plasmids
but it could not be exclusively linked to ℎ𝑦𝑙𝐸𝑓𝑚 presence [3, 121].
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Pathophysiology/Virulence Epidemiology Reference
E. faecium
(Efm)
Enterococal
surface protein,
Esp
Biofilm formation,
Pathogenesis, Antigenic
Specifically linked to
HA Efm
56, 83
Collagen binding
adhesin of Efm,
Acm
Binding to collagen.
Pathogenesis, Antigenic
Widespread among Efm 104, 106,
105
Pili PilA PilB Not known Widespread among Efm 59, 61
Second collagen
adhesin, Scm
Binding to collagen Widespread among Efm 148
collagen binding
adhesin, EcbA
Binding to collagen and
fibrinogen
Specifically linked to
HA Efm
60, 61
hyaluronidase
(ℎ𝑦𝑙𝐸𝑓𝑚)
Putative ECM
degradation
Specifically linked to
hospital associated
clones (CC17)
120, 39, 3,
121
E. faecalis (Efs)
Agregation
substance, AS:
Asa1, Asp1,
Asc10
Bacterial aggregation,
conjugation. ECM
binding. Internalization,
pathogenesis.
Widespread among Efs 112, 184,
135, 188, 76,
158, 126,
16, 138,
182, 119, 63
Esp Biofilm formation.
Pathogenesis
Widespread among Efs 142, 161,
162, 170
Gelatinase/quorum
sensing locus fsr
Biofilm formation
Pathogenesis.
Widespread among Efs 10, 117, 152,
147, 103
Pili ebp locus Biofilm formation.
Pathogenesis, Antigenic
Widespread among Efs 107, 163,
150
bee locus Biofilm formation Among 5% of Efs 21
Adhesion to
collagen, Ace
Binding to collagen,
laminin and dentin
Widespread among Efs 122, 75, 104,
151
capsular
polysaccharide,
Cps
Antiphagocytic.
Immunologic evasion
Efs serotype C and D
strains
66, 50, 168,
169
enterococcal
polysaccharide
antigen, epa
Biofilm formation,
translocation,
Pathogenesis
Present in Efs cell wall 199, 164,
200, 149
Lipoteichoic acid,
LTA (enterococcal
group antigen )
Conjugation (binding),
Inmunogenic.
Present in enterococcal
cell wall
165, 138
Wall teichoic acid
WTA
Not known Present in enterococcal
cell wall
109
Glycolipids Biofilm formation.
Colonic cells adherence.
Pathogenesis
Present in enterococcal
cell membrane
137, 166
Cytolysin
(hemolysin/
bacteriocin)
Lysis of eukaryotic and
Gram positive cells
Widespread among Efs 16, 23, 24
Reactive oxigen
species
Extracellular superoxide,
hydrogen peroxide
Widespread among Efs.
Less frequently also
found in Efm
68, 96, 69
Table 1.3: Putative virulence factors in E. faecalis and E. faecium. UTI: urinary tract infection. HA: hospital-
associated. PMNs: polymorphonuclear leukocytes. ECM: extracellular matrix. [Table modified and completed from
reference 136].
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1.4 Horizontal gene transfer and mobile genetic ele-
ments
The horizontal gene transfer between microorganisms has a great impact on the
evolution of bacterial pathogens. The genome of bacterial pathogens is composed of
a conserved "core" genome, which contains the genetic information that is required
for essential cellular functions and an "accesory" gene pool, which encodes addi-
tional traits that might be beneficial under certain circumstances. The accesory
gene pool represents mainly mobile elements including bacteriophages, plasmids,
genomic islands (GIs), insertion sequence (IS) elements and various types of trans-
posons [31, 25, 55]. Virulence genes are frequently located on mobile or formerly
mobile, genetic elements including PAIs. The medical importance of the entero-
cocci is closely related to their propensity to participate in the horizontal transfer
of determinants for antibiotic resistance and virulence. Transfer involves primar-
ily conjugation systems which are abundant and involve plasmids and conjugative
transposons. There are no reports of natural transformation or transduction in these
organisms.
1.4.1 Enterococcal plasmids
Clinical isolates of enterococci carry up to five or six co-resident plasmids although
in most cases little is known of their classification genetic content. Determinants for
antibiotic resistance, haemolysins, bacteriocins and resistance to ultraviolet light are
frequently plasmid associated and many such plasmids encode the ability to trans-
fer or may be efficiently mobilized by a co-resident conjugative element [20] Three
classes of plasmids are known to be capable of replication in the enterococci: the
pheromone responding plasmids, the rolling circle (RCR) plasmids and the Inc18
plasmids. The RCR and Inc18 plasmids are capable of replication in a broad range
of Gram-positive bacteria and some RCR are also capable of replication in Gram-
negative species. The pheromone responding plasmids appear to be restricted to the
enterococci [186]. Large plasmids in enterococci were not described until recently
[186], however according to recent reports it seems like they are also widely dissemin-
ated [39, 179]. RCR plasmids are a rather large group of small, high-copy plasmids
that replicate via a rolling circle mechanism. The RCR process of unidirectional
nucleic acid replication can rapidly synthesize multiple copies of circular molecules
of DNA or RNA. Originally identified in Staphylococcus aureus , RCR plasmids are
found in virtually all Gram-positive bacterial species [186]. A number of cloning,
expression, transposon delivery and replicon-probe vectors derived from RCR plas-
mids have proven useful in the study of enterococci. The Inc18 plasmids are a family
of plasmids between 25 and 30 kb in size, widely distributed among the low G+C
Gram-positive bacteria. Many are self conjugative and are maintained at a relatively
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low copy number (< 5 copies/cell) The pheromone responding plasmids are char-
acterized by the ability of their hosts to form mating aggregates when mixed with
plasmid free cells (recipients) in broth. A peptide pheromone is secreted by plasmid
free recipient cells. Once a given pheromone responding- plasmid is acquired, pro-
duction of the related pheromone is shut down, however unrelated pheromones (at
least six) specific for a different family of donor plasmids, continue to be secreted.
The formation of mating aggregates relates to the induction of the protein "aggrega-
tion substance" (AS) (see also 1.3), which appears extensively over the donor surface
and binds to "enterococcal binding substance" (EBS). The prototype of pheromone
responding plasmids are pAD1 (60 kb), pCF10 (65 kb), pPD1 (56 kb) and pAM373
(36 kb). All reported pheromone responsive plasmids are from E. faecalis , with the
exception of pHKK100 which is from E. faecium [reviewed in 20].
1.4.2 The E. faecium ℎ𝑦𝑙𝐸𝑓𝑚 genomic island
As previously mentioned, ℎ𝑦𝑙𝐸𝑓𝑚 is a putative virulence gene which predominates
in E. faecium of clinical origin. ℎ𝑦𝑙𝐸𝑓𝑚 was intially described as part of a putative
pathogenicity island, ca. 20- kb, that is flanked by inverted copies of putative inser-
tion sequence IS1476 . Within the supposed GI, upstream of ℎ𝑦𝑙𝐸𝑓𝑚 exist similarities
to 2 component regulator systems and a 𝛽-galactosidase gene. Downstream of ℎ𝑦𝑙𝐸𝑓𝑚
lies an ORF with no significant homologies and an ORF encoding a putative protein
with homology to previously described guanine monophosphate (GMP) synthases
[120].
Recently, it has been described that ℎ𝑦𝑙𝐸𝑓𝑚 is contained within a 220 kb trans-
ferable plasmid in E. faecium strain C68, that can increase the virulence of strains.
The plasmid location of ℎ𝑦𝑙𝐸𝑓𝑚 was demonstrated in other strains and a physical
link to vancomycin resistance genes, high level resistance (HLR) to amynoglycos-
ides (gentamycin and streptomycin) and erythromycin was shown [3]. Analysis of
51 ℎ𝑦𝑙𝐸𝑓𝑚 positive strains showed that ℎ𝑦𝑙𝐸𝑓𝑚 is located in megaplasmids ranging
from 170 kb to 375 kb which do not contain replication proteins of the most known
Gram-positive plasmids. These plasmids showed frequent co-localization of erm(B)
but not of vanA genes [39]. Horizontal transmission of ℎ𝑦𝑙𝐸𝑓𝑚 plasmids has been
previously described both when ℎ𝑦𝑙𝐸𝑓𝑚 and van are genetically linked [3, 121] and
when they are not [39].
1.4.3 Pathogenicity islands transfer
PAIs are large genomic regions (10-200 kb) that are present in pathogenic variants
but less frequently in closely related non-pathogenic bacteria. PAIs carry one or
more virulence-associated genes, have a G+C content that differs from that of the
rest of the chromosome and are frequently integrated into tRNA genes [reviewed
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in 31]. PAIs are normally flanked by short direct repeats (DR) resembling attach-
ment sites for phage integrases (attL and attR) and carry phage related integrase
genes. This suggests that PAIs derive from integrating plasmids or phages and that
their mechanism of integration and excision corresponds to that of integrative and
conjugative elements (ICEs) [47].
For ICEs mobilization, the excisionase- mediated homologous recombination
between attL and attR produces excision and formation of circular intermediates
(carrying attB), while a recombinase (integrase) catalyzes integration by recombina-
tion between attB and a chromosomal target sequence attP generating the junction
sequences attL and attR [11]. The majority of PAIs described to date have de-
generate integrase genes or recombination sites but direct proof of integration and
excision is lacking [177]. Several PAIs have been reported to be capable of spontan-
eous excision from the chromosome and formation of circular intermediates, which
are thought to be prerequisite for the horizontal transfer. These events have been
described for the Vibrio cholerae PAIs (VPI) VPI-1, VSP-I and VSP-II [99, 118],
the Salmonella GI 1 (SGI 1), [32], the Yersinia pseudotuberculosis high pathogen-
icity island (HPI) [131], the Shigella flexneri PI (she PAI), the locus of enterocyte
effacement (LEE) of a rabbit-specific enteropathogenic Escherichia coli strain [97]
and the six PAIs of E. coli isolate 536 (PAII536 to IV536) [93, 64].
Horizontal transfer of PAIs into recipient strains facilitated by phages has been
described in VPI-1 [113] and SaPI-1 [129]. Similarly, plasmids harbouring regions
of three SaPIs, of the E. coli O26 locus of enterocyte effacement (LEE O26) and
of shePAI demonstrated PAI integration into the chromosome of recipient strains
[177, 97, 131], while SGI1 and the E. coli HPI have been shown to transfer with the
help of plasmids [32, 139]. So far, only the Y. tuberculosis HPI has been observed to
transfer spontaneously in a liquid medium without the help of a phages or plasmids
[85]. Previous attempts to transfer precisely the E. faecalis PAI have failed; only
parts of the PAI or larger chromosomal elements containing the PAI have been
observed to transfer [111, 22, 89].
Some environmental stresses that stimulate horizontal transfer of island-like ele-
ments have been identified. Mobilization of temperate phages and ICEs involves
the SOS response to mobilize themselves from the chromosome, induced by e.g. UV
irradiation or bactericidal antibiotics [9, 53, 92, 176]. The SOS system represents a
global response to DNA damage that upregulates genes involved in DNA repair re-
combination and mutagenesis [29, 28]. The SOS response has been shown to induce
the lateral transfer of antibiotic resistance encoded by the Vibrio cholerae integ-
rating conjugative element SXT (quinolone induced) [9] and of prophage-encoded
Shiga toxin in E. coli (fluoroquinolone induced) [203]. At subinhibitory concentra-
tions, quinolones have been shown to induce partial or total loss of PAIs in vitro
in uropathogenic E. coli by SOS-dependent or -independent pathways, respectively
[156]. Fluoroquinolones (ciprofloxacine) are fully effective for the mobilization of
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the staphylococcal pathogenicity islands SaPIbov1 and SaPI1 and, by implication,
of all other SOS induced SaPIs [176]. 𝛽-lactam antibiotics induce an SOS response
in S. aureus that results in replication and high-frequency transfer of the SaPIbov1
and SaPI1 [88].
The E. faecalis pathogenicity island
Genomic analysis of E. faecalis strain MMH594, which caused an outbreak in the mid
1980s and strain V583, the first vancomycin resistant isolate in the United States,
revealed the presence of a PAI of variable content. The genetic element in MMH594
is 153,571 bp large, codes for 129 open reading frames (ORFs) and possesses all
the hallmarks of a PAI. These include flanking DR, variant G+C content (32.3%
compared to the 37.38% of the whole genome) and the presence of putative genes
encoding an integrase, an excisionase, transposases, transcriptional regulators and
proteins with potential roles in virulence or adaptation and survival. The E. faecalis
PAI is inserted in a non-coding region flanked by an ORF coding for a hypothetical
protein of unknown function and a putative oxidoreductase related to the aldo-keto
reductase family, differing from most of bacterial PAIs that insert within transfer
RNA [141]. The E. faecalis PAI encodes variable traits of E. faecalis associated with
virulence, including cytolysin, aggregation substance and Esp. Additionally within
the element are genes that seem to code for a DNA-damage inducible protein, an
AraC-like transcriptional regulator, a conjugated bile acid hydrolase, components
of the phosphotransferase system and a GLS-24 like starvation inducible protein. It
appeared as if the 5’ portion of the island was derived from integration of a conjug-
ative plasmid into the chromosome, since it bears elements of pheromone responsive
plasmids pAM373 and pAD1. This plasmid-like region contains genes encoding an
aggregation substance and a TraG-like protein apparently derived from pAM373,
the cytolysin operon and a region with 87% identity to an oriT derived from pAD1
[141]. The E. faecalis PAI is widely distributed among isolates of different origins,
clonal types and complexes and its content varies greatly between different isolates
[91, 1, 90, 143]. This seems to be an speciality of the E. faecalis PAI and contrasts
the situation in Gram-negative bacteria where PAIs don’t have a modular structure
or variable gene content. Mc Bride et al. have compared among a collection of
strains from different origin, the structural variations of the PAI, using microarray
analysis, to the relatedness and chromosomal variations investigated by MLST. The
results indicated that the presence of specific PAI regions in different strains does
not correlate closely with the predicted relatedness of strains. It is supposed that
core elements of the PAI radiated outward through the species and in the process
it continues to evolve by modular gain and loss of internal gene clusters, in a more
rapid way than the core genome does [90]. The first two genes within the PAI are a
putative phage related integrase and an excisionase and a 10 bp duplicated sequence
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flanks the PAI integration site [141]. These, together with the presence of putative
plasmid-derived transfer functions, suggest that the PAI was integrated and might
be excised and transferred as a single entity [22]. Several studies have pursued the
horizontal transfer of the E. faecalis PAI. Oancea et al. showed that the esp gene
could be transferred among E. faecalis (and also among E. faecium) when selecting
for the transfer of antibiotic resistance determinants. The E. faecalis esp transferred
from chromosome to chromosome, however whether the whole or further fragments
of the E. faecalis PAI had also been transferred, could not be investigated. Coburn
et al. used a cat marker to tag the E. faecalis PAI and observed that during fil-
ter mating experiments, the chloramphenicol resistance was transferred to strain
OG1RF. A secondary transfer into strain JH2SS was also achieved. Analysis of the
transconjugants demonstrated that a 27,774 bp internal PAI segment was capable
of excision and circularization in the donor and was mobilized as a cointegrate with
a pTEF1-like plasmid. Very recently Manson et al. have reported the horizontal
transfer of the E. faecalis PAI not exclusively as a self excisable mobilizable element
but always accompanied by flanking donor chromosome sequences. The horizontal
transfer of other chromosomal regions was also observed, always accompanied by
the transfer of a pheromone responsive- plasmid (pTEF2 or pTEF3). Deletion ex-
periments showed that the transfer of regions bearing the PAI did not require the
integrase and excisionase genes encoded within the PAI, whereas deletion of plas-
mid transfer functions, including the cis-acting origin of transfer (oriT ), abolished
movement. These findings evidenced the role of plasmids in the mobilization of large
genomic elements and evolution of E. faecalis [89].
In E. faecium the 𝑒𝑠𝑝𝐸𝑓𝑚 is carried on a large PAI structure (between 64 and 104
kb) with some conserved parts and variable presence of some genetic elements. The
C+C content of the PAI is 2.3% lower than that of the entire genome, it is flanked
by an imperfect 54-bp DR and is integrated downstream of the tuf or the rpsI
gene. A 10 kb element of the 𝑒𝑠𝑝𝐸𝑓𝑚PAI is found identical in the 154 kb E. faecalis
esp-carrying PAI, suggesting a recent transfer of genetic material between these two
species or acquisition from a third source [80, 179].
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Figure 1.2: The E. faecalis PAI structucture of strain MMH594. Figure based on the available sequence
(𝑔𝑏|𝐴𝐹454824.1|), displaying all putative pathogenicity factors contained. ORFs encoding hypothetical proteins
are not shown.
2. Objectives
Horizontal transfer of the accesory genome plays a very important role in the ad-
aptation and increasing relevance of enterococci as nosocomial pathogens. However,
the transfer of pathogenicity islands among enterococci has been scarcely investig-
ated and still is not well understood. Similarly, enterococcal megaplasmids bearing
putative pathogenicity factors (as ℎ𝑦𝑙𝐸𝑓𝑚) has been just recently reported and its
biology, classification and significance remain unknown. The overall aim of this
thesis was to study the intra and inter species horizontal transfer of two elements of
the accesory genome of enterococci: the E. faecalis PAI and the plasmid encoded-
ℎ𝑦𝑙𝐸𝑓𝑚 putative genomic island.
More specifically, the following objectives were pursued:
 Investigate the horizontal transfer of the pathogenicity island of E. faecalis
intra and inter species to E. faecium, describing events associated with its
chromosomal excision, transfer and integration into recipient strains.
 Analyze the genotypic and phenotypic consequences of the aquisition of the
E. faecalis PAI in E. faecium and E. faecalis .
 Investigate the structure, distribution and transfer of the ℎ𝑦𝑙𝐸𝑓𝑚 putative ge-
nomic island among E. faecium.
 Resolve the composition of a ℎ𝑦𝑙𝐸𝑓𝑚 megaplasmid identifying those elements
that could explain its origin and its specific distribution among clinical strains.
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3. Materials and methods
3.1 Media and chemicals
The chemicals, culture media and antibiotics used in this work are listed in Tables
3.1, 3.2 and 3.3. The composition of standard solutions employed is also presented.
Chemical Producer/Manufacturer
I-CeuI New England Biolabs Inc.
SmaI New England Biolabs Inc.
Agarose Type Sigma-Aldrich GmbH
Ammonium citrate Jenapharm Laborchemie
anti-DIG-AP Roche Diagnostics GmbH
AttoPhos solution Roche Diagnostics GmbH
Blocking reagent Boehringer Ingelheim GmbH and Co.
KG
Boric acid Serva Electrophoresis GmbH
Bovine Serum Albumin (BSA) Sigma-Aldrich GmbH
Brij®58 AppliChem GmbH
Bromophenol blue Sigma-Aldrich GmbH
CDP-Star Roche Diagnostics GmbH
Chloroform Fluka Chemie AG
Chloroform CARL ROTH GmbH and Co KG
D-glucose Merck KGaA
DIG antibodies Roche Diagnostics GmbH
DIG Easy Hyb Granules Roche Diagnostics GmbH
Distilled water Sigma-Aldrich GmbH
EDTA (Ethylenediaminetetraacetic
acid)
Serva Electrophoresis GmbH
EDTA disodium (Disodium dihydrogen
ethylenediaminetetraacetate)
Serva Electrophoresis GmbH
Ethanol (98%) Merck KGaA
Ethidium Bromide (10mg/ml) CARL ROTH GmbH and Co KG
Glacial acetic acid Fluka Chemie AG
Glutaraldehyde Sigma-Aldrich GmbH
glycine CARL ROTH GmbH and C KG
goat anti-rabbit fluorescein isothiocy-
anate
Sigma-Aldrich GmbH
Gram’s Crystal violet solution Merk KgaA
hyaluronic acid salt from S. equi Sigma-Aldrich GmbH
hyaluronic acid salt from umbilical cord MP Biomedicals LLC
hyaluronidase MP Biomedicals LLC
Hydrochloric acid (37%) HCl CARL ROTH GmbH and Co KG
LMP agarose Biometra GmbH
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Lysozyme Sigma-Aldrich GmbH
Magnesium chloride MgCl2 CARL ROTH GmbH and Co KG
Magnesium chloride hexahydrate
(MgCl2 · 6H2O)
CARL ROTH GmbH and Co KG
Maleic acid CARL ROTH GmbH and Co KG
Methylcellulose 2% 25 centipoises Sigma-Aldrich GmbH
Phenol / chloroform / isoamyl alcohol
(25:24:1)
CARL ROTH GmbH and Co KG
Polyclonal anti-Esp rabbit immnune
antiserum
Eurogentech S.A.
Polyclonal anti-pilA rabbit immune an-
tiserum
Eurogentech S.A.
Polyethylene glycol 4000 (50%) Merck KGaA
Potassium acetate CH3CO2K Merck KGaA
Potassium hydroxide KOH Jenapharm Laborchemie
Protein A-gold (15 nm)
Proteinase K Sigma-Aldrich GmbH
RNaseI Sigma-Aldrich GmbH
SDS (sodium lauryl sulfate) CARL ROTH GmbH and Co KG
SI-nuclease (Takara, Bio Inc., Shiga, Japan)
Sodium acetate C2H3NaO2 Merck KGaA
Sodium azide NaN3 VEB Sprengstoffwerk
Sodium chloride NaCl CARL ROTH GmbH and Co KG
Sodium citrate NaH2C6H5O7 Jenapharm Laborchemie
Sodium deoxycholate CARL ROTH GmbH and Co KG
Sodium hydroxide NaOH CARL ROTH GmbH and Co KG
Sodium-Lauroylsarcosine Sigma-Aldrich GmbH
Tris CARL ROTH GmbH and Co KG
TrisHCl Merck KgaA
Triton X-100 Sigma-Aldrich GmbH
Tween 20 CARL ROTH GmbH and Co KG
Uranyl acetate Sigma-Aldrich GmbH
DNA Molecular Size markers
GeneRuler 100bp DNA-Ladder Plus fermentas GmbH
GeneRuler 1kb DNA-Ladder Plus fermentas GmbH
DIG III DNA-Ladder Roche Diagnostics GmbH
Table 3.1: Chemicals and materials used in this work
Medium Producer/Manufacturer
Brain Hearth Infusion (BHI) agar Difco® labs.
Brain Hearth Infusion (BHI) broth Difco® labs.
Dubelco’s Modified Eagle’s Medium (DMEM) Difco® labs.
Mueller Hinton (MH) Agar with Sheep Blood Oxoid GmbH
RPMI 1640 Cambrex Bioscience
Todd-Hewitt Broth (THB) Bacto
Tryptic Soy Agar (TSA) Difco® labs.
Tryptic Soy Broth (TSB) Difco® labs.
Table 3.2: Media used for the culture of bacteria and animal cells
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Antibiotic Soluble in Concentration Producer/manufacturer
Ampicillin H2O 8mg/L Sigma-Aldrich Chemie GmbH
Ciprofloxacine 0.1N HCl 1mg/L Fluka Chemie AG
Erythromycin Ethanol 5mg/L Abbott Laboratories
Fusidic acid H2O 20mg/L Sigma-Aldrich Chemie GmbH
Rifampicin 0.1N HCl 30mg/L Sigma-Aldrich Chemie GmbH
Spectinomycin H2O 300mg/L Sigma-Aldrich Chemie GmbH
Streptomycin H2O 500mg/L Sigma-Aldrich Chemie GmbH
Vancomycin H2O 5mg/L Sigma-Aldrich Chemie GmbH
Table 3.3: Antibiotics, used in this study, their solubility and concentrations used.
Standard Solutions:
Phosphate Buffer Saline (PBS)
Sodium chloride 137mM
Potassium chloride 2.7mM
Sodium phosphate dibasic 10mM
Potassium phosphate monobasic 2mM
pH 7.4
TES buffer
Tris-HCl pH 8.0 10mM
Bacto Trypton pH 8.0 1mM
Saline Solution
NaCl 85%
H2O
Tris-EDTA (TE) buffer
Tris-HCl 200mM
EDTA 20mM
pH 7.5
3.2 Equipment and materials
Equipment, electric devices and different materials used in this study are listed in
Table 3.4.
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Device Material Producer Manufacturer
200-mesh Formvar-carbon coated grids
aCOLyte Colony Counter Don Whitley Scientific Ltd.
Autoclave, Biomedis H+P Labortechnik
Automatic spiral plater WASP2 Don Whitley Scientific Ltd.
Bag sealer CARL ROTH GmbH and Co KG
Biodocumentation luminiscence de-
tector ChemiDocXR
Bio-Rad Laboratories
Cellulose nitrate filter, Pore size:
0.45µm, ⊘ 45 mm
CARL ROTH GmbH and Co KG
Centrifuge (Rotor 12159) Sigma Laborzentrifugen GmbH
Centrifuge tubes (15ml, 50ml) CARL ROTH GmbH and Co KG
Centrifuge, mini spin plus Eppendorf AG
Chef DR®III System Bio-Rad Laboratories
Electrophoresis chambers, Sub Cell
Mini and Mini Wide
Bio-Rad Laboratories
Electrophoresis Power suply Bio-Rad Laboratories
ELISA reader, Sunrise Tecan Group
Eppendorf tubes (0.2ml, 0.5ml, 1.5ml) Eppendorf AG
FACSCalibur flow cytometer BD Biosciences
Filter mating aparatus Sartorius GmbH
Fine Scale, Genius Sartorius GmbH
Fluorescence reader, Fluorimeter FLA-
2000
Fujifilm
Freezer -20, LIEBHERRcomfort Liebherr-holding GmbH
Glycerin culture tubes MAST Diagnostica GmbH
Hybridization oven and flasks, Techne Biostep GmbH
Incubator Shaker Sartorius Certomat NEW BRUNSWICK SCIENTIFIC, Inc
Incubator shaker SM30 Edmund Buhler GmbH
Incubator, HERAcool Heraeus Instruments
Jeol 1010 transmission electron micro-
scopy
Jeol-Europe Ltd.
Microbiological Safety Cabinet
HERAsafe
Thermo Scientific Inc.
Microwave oven, Severin CARL ROTH GmbH and Co KG
Multicanal-pipette (8 and 12 canals) Eppendorf AG
Multistep-Pipette Eppendorf AG
Nylon membranes Roche Diagnostics GmbH
Petri plates Sterilin Ltd.
pH-Metter, HANNA instruments neolab GmbH
Pipette tips (1 µl, 100 µl, 1000 µl) Eppendorf AG
Pipettes, Reference, various Eppendorf AG
Pipettes, Research, various Eppendorf AG
Plataform shaker, Heidolph Polymax
1040
neolab GmbH
Polystyrene Cell culture microplates
24-well Greiner bio-one AG
Polystyrene microtiter plates flat bot-
tomed 96-well
Greiner bio-one AG
Polystyrene microtiter plates flat bot-
tomed 96-well
Corning Life Sciences
Precision Scale, Kern 440-43N Sartorius GmbH
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Refrigerator + 4, Bosch Robert Bosch GmbH
Spectrophotometer, NovaspecII Pharmacia Biotech Inc.
Spectrophotometer, SmartSpect 3000 Bio-Rad Laboratories
Sryinges 5ml, 10ml CARL ROTH GmbH and Co KG
Thermocycler Gene Amp 9700 Applied Biosystems
Thermocycler TGradient Biometra GmbH
Thermomixer, Comfort Eppendorf AG
Thermopapier, Mitsubishi MS Laborgeräte GmbH
Thermo-Printer, Mitsubishi Bio-Rad Laboratories
Ultraviolet irraadiator, Bio-Link Cross
linker BLX 365 nm
Vilber Lourmat
Vacuum Blotter TDNA Apligene-Oncor
Vacuum centrifuge, concentrator 5301 Eppendorf AG
Variable Speed Pump Bio-Rad Laboratories
Vortex Genie 2 Scientific Industries
Water bath GFL GmbH
Water purification system SG Reinstwasser GmbH
Wattmann Paper 3MM Whatman Ltd.
Table 3.4: Instruments, devices and materials used in this study
3.3 Software and internet resources
Different software programs and other internet resources used in this study are
presented in Tables 3.5 and 3.6.
3.4 Kits
Different kits used for various molecular approaches in this work are listed in table
3.7.
3.5 Primers
All primers used in this work were purchased from Invitrogen, Life Technologies and
are listed in Tables A. 1, A. 2, A. 4 and A. 3.
3.6 Filter mating assays
Filter conjugation allowing cell-to-cell contact was used for transferring the esp-
pathogenicity island (PAI) of Enterococcus faecalis and the putative ℎ𝑦𝑙𝐸𝑓𝑚 PAI
of E. faecium by a method previously described [192]. Overnight cultures of the
recipient and donor strains at 37 in Brain Hearth Infusion (BHI) broth were
tenfold diluted in 5ml /BHI broth and growth until exponential phase (3-4h). 1ml
of the donor and 1ml of the recipient culture were mixed in one tube and applied
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Name Aplication Developer
BioNumerics 6.0 PFGE analysis, fragment
size calculation, phylogen-
etic analysis
Applied Maths
Quantity One 4.6.6 Documentation of gel im-
ages and Southern hybr.
Membranes
BioRad Labor-
atories
Dsgene Analysis of DNA se-
quences, graphics
Accelrys, Inc.
AIDA Image Analyzer3.52 Evaluation of Florometric
analysis
Raytest
Lasergene8 Seqman Evaluation of DNA se-
quences
DNAStar
Lasergene8 MegAlign DNA alignements DNAStar
Lasergene8 Seqbuilder Analysis of DNA se-
quences, graphics
DNAStar
Lasergene8 PrimerSelect confirmation of selected
primers
DNAStar
Kodon 3.61 DNA sequence aligne-
ments, comparissons, CDS
prediction, Annotation,
graphics
Applied Maths
PRISM4 Statistical analysis GraphPad
Software
Microsoft office Excel, Word, PowerPoint. Microsoft
TEXmaker 1.7 Open Source LaTeX word
processor
Pascal Brachet
Artemis12 DNA sequence edition Sanger Institut
Sequin9.00 DNA sequence anotation,
submission
NCBI
CCL Main Workbench phylogenetic analysis CCL Bio
MEGA phylogenetic analysis [159]
Table 3.5: Software programs used in this study.
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Name Aplication
Internet adress
Primer3 Primer design
http://frodo.wi.mit.edu/primer3/input.htm
PrimerBlast Primer design
http://www.ncbi.nlm.nih.gov/tools/
primer-blast/index.cgi?LINK_LOC=BlastHome
NEB Cutter V2.0 In silico restriction of DNA sequences
http://tools.neb.com/NEBcutter2/index.php
Annotation2Excel Conversion of feature tables in Excel tables
http://nbc3.biologie.uni-kl.de/
BLAST Blast search of DNA or protein sequences among all
available DNA, protein and translated protein se-
quences
http://blast.ncbi.nlm.nih.gov/Blast.cgi?
CMD=Web&PAGE_TYPE=BlastHome [203]
NCBI database Sequences Database
http://www.ncbi.nlm.nih.gov/guide/
Pubmed bibliography database
http://www.ncbi.nlm.nih.gov/pubmed/
ExPASy Proteom-
ics Server
Identification of protein domains, families and func-
tional sites as well as associated patterns and profiles
http://expasy.org/prosite/
Table 3.6: Internet resources used in this study
Aplication Kit-Name Producer/ manufac-
turer
DNA isolation DNAeasy Blood and
Tissue kit
QIAGEN GmbH
DNA quantifica-
tion
Quant-it PicoGreen®-
DNA-Quantitation Kit
Invitrogen®
Molecular Probes
Gel extraction
Genomic walking
sequencing
DNA Walking Speedup
 Premix kit
Seegene
PCR puRe Taq Ready-To-Go
Beads
GE Healthcare GmbH
PCR PCR Master Mix fermentas GmbH
PCR large amlic-
ons
Expand Long Template
PCR
Roche Diagnostics
PCR product
purification / gel
extraction
GFX PCR DNA and
Gel Band Purification
Kit
QIAGEN GmbH
Plasmid prepara-
tion
Plasmid Mini Kit, Midi
kit
QIAGEN GmbH
Probe labeling
(Southern Hybr)
DIG High-Prime Roche Diagnostics
Sequencing of
PCR products
Cycle Sequencing Kit
V3.1 (Big Dye)
Applied Biosystems
Table 3.7: Kits used for different molecular approaches in this work
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through a nitrocellulose filter mounted on a filter matting apparatus (Sartious).
The cell concentration of the recipient culture was determined by plating 100 µl
of serial dilutions (10−4, 10−6, 10−8) on BHI agar overnight at 37. Mating was
allowed by overnight incubation of the filter at 37 with the bacterial cells top up
on a BHI agar plate. Cells were harvested from the filter by adding 1ml of saline
solution and re-suspending the bacteria with help of a glass tool. Re-suspended
cells were collected on a 1.5ml tube and centrifuged at 8,000 rpm for 5min at 4.
Pellets were washed once with 500 µl of saline solution, and re-suspended in 500µl
of saline solution. Serial dilutions (10−1; 10−2, 10−3, 10−4) of the transconjugant
suspensions were prepared and 100 µl of each were plated by duplicate on selective
plates, and incubated overnight at 37. Antibiotics can induce SOS responses
that trigger horizontal gene transfer [176, 9, 88, 156]. Antibiotic-SOS induction was
used in some cases by exposing the donor strain to sub inhibitory concentrations
of ciprofloxacin (1mg/L) and ampicillin (8ml/L) during 3 h previous to the filter
mating. Transconjugants were selected on BHI agar containing the selective marker
for the donor and those for the recipient (Tables 3.9 and 3.8)
3.7 Bacterial strains
The bacterial strains used are grouped into four categories as they were used for:
(a) filter mating -transfer of the E. faecalis PAI, (b) filter mating -transfer of the
ℎ𝑦𝑙𝐸𝑓𝑚 genomic island (GI) of E. faecium, (c) investigation of the structure and
distribution of the E. faecium ℎ𝑦𝑙𝐸𝑓𝑚 GI, or (d) other purposes. E. faecalis strains
carrying the esp gene were used as donor, and others lacking this marker were used
as recipient (Table 3.9). ℎ𝑦𝑙𝐸𝑓𝑚 is only found in E. faecium. Transfer of ℎ𝑦𝑙𝐸𝑓𝑚
was intended using ℎ𝑦𝑙𝐸𝑓𝑚 positive E. faecium strains as donor and ℎ𝑦𝑙𝐸𝑓𝑚 negative
E. faecium and E. faecalis strains as seen in Table 3.8. The "nosocomial infections"
unit of the Robert Koch Institute, Wernigerode branch, serves as a focal laboratory
for enterococci in Germany. In general enterococcal isolates sent to the unit are
pre-selected for being vancomycin and muti-resistant or with the suspicion of clonal
spread (outbreak). For investigation of the ℎ𝑦𝑙𝐸𝑓𝑚GI and its environment, a subset
39 ℎ𝑦𝑙𝐸𝑓𝑚-positive E. faecium clinical isolates (15 VRE and 24 VSE) was selected
originating from 11 federal states (between 1998-2007) and from different clinical
laboratories or university medical centres, with different sequence type (MLST) and
MLVA type to exclude copy isolates (listed in Table 3.10). ℎ𝑦𝑙𝐸𝑓𝑚GI structure, as
well as the plasmid content of all strains and localization of ℎ𝑦𝑙𝐸𝑓𝑚 and vanA markers
were evaluated as described below in this chapter. Other strains used are listed in
Table 3.11.
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Strain MLST Resistance plasmid content ( kb)𝑎
Donors
UW2774 ST18 VAN/ERY 281, 75
UW2460 ST17 VAN/ERY 264, 235, 213, 45, 33, 10
UW5904 ST203 VAN 188, 68
UW5905 ST192 VAN 188, 68
UW3308 ST65 VAN/AMP 206, 156, 101, 76, 44
UW6715 ST192 ERY 314, 165, 272, 73, 40
UW6717 ST317 ERY 384, 187, 270, 187, 88, 40
Recipients
E. faecium
64/3 ST21 FUS/RAM None
BM4105RF ST172 FUS/RAM None
GE-1 ST-515 FUS/RAM None
64SS ST21 STR/SPECT None
E. faecalis
OG1RF ST1 FUS/RAM None
JH2-2 ST8 FUS/RAM None
UV202 ST8 FUS/RAM None
Transconjugant
64/3xUW2774 T-1 𝑏 - VAN/ERY/FUS/RAM 281
64/3xUW2774 T-2 to 5 VAN/ERY/FUS/RAM variable 𝑐
64/3xUW2460 T-1 to 5 - VAN/ERY/FUS/RAM variable 𝑐
64SSxT2 - VAN/STR/SPECT not pursued
Table 3.8: Strains used in filter mating experiments for ℎ𝑦𝑙𝐸𝑓𝑚 transfer. ST, Sequence type; FUS, fusidic acid;
RAM, rifampicin VAN, vancomycin; ERY, erythromycin; GEN, gentamycin (high level); PEN, penicillin; OTE,
oxitetracycline, STR, streptomycin, SPE, spectinomycin. Only antibiotic resistances relevant for the transconjugants
selection are presented. 𝑎Approximate plasmid size resolved by S1-nuclease Pulse field gel electrophoresis (PFGE)
analysis. 𝑏Strain also used as donor and for plasmid (pLG1) sequencing. 𝑐 For detailed plasmid content of each
strain see Table 4.2. Plasmids in bold face are ℎ𝑦𝑙𝐸𝑓𝑚- plasmids.
Strain MLST Resistance esp present
Donor
E. faecalis
UW3114 ST4 ERY/OTE/STR Yes
Recipients
E. faecium
64/3 ST21 RAM/FUS No
E. faecalis
OG1RF ST1 RAM/FUS No
Transconjugants
OG1RFxUW3114 T-12 𝑎 RAM/FUS/ERY Yes
OG1RFxUW3114 T-1𝑏 RAM/FUS/ERY No
64/3xUW3114 T-10 RAM/FUS/ERY Yes
64/3xUW3114 T-1𝑏 RAM/FUS/ERY No
Table 3.9: Strains used in filter mating experiments for esp transfer. ST, Sequence type; FUS, fusidic acid; RAM,
rifampicin VAN, vancomycin; ERY, erythromycin; STR, streptomycin. Only antibiotic resistances relevant for this
study are presented. 𝑎Strain OG1RFxUW3114 T-12 was used for plasmid (pLG2) sequencing. 𝑏 Strains that
acquired a 66 kb erm(B)-plasmid but did not acquire the esp PAI.
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Strain Year MLST MLVA van
DO 1991 18
UW1952 1998 18 1 vanA
UW2774 1999 18 281 vanA
UW2460 1999 17 1 vanA
UW2457 1999 80 1 vanA
UW3056 2000 65 5 0
UW3488 2001 18 1 vanA
UW3183 2001 18 1 vanA
UW3308 2001 65 - vanA
UW5905 2004 192 159 vanA
UW5352 2004 17 7 vanB
UW5275 2004 376 1 vanB
U0317 2005 78
UW6379 2005 18 1 vanA
UW6352 2005 18 1 vanA
UW6151 2005 17 1 vanA
UW6112 2005 378 5 0
UW6993 2006 192 159 0
UW6990 2006 18 7 0
UW6985 2006 81 7 0
UW6982 2006 192 159 0
UW6951 2006 192 159 0
UW6947 2006 17 7 0
UW6943 2006 192 159 0
UW6941 2006 192 12 0
UW6929 2006 192 159 0
UW6893 2006 192 159 0
UW6883 2006 378 new 0
UW6882 2006 117 282 0
UW6717 2006 317 - 0
UW6715 2006 192 159 0
UW6711 2006 192 159 0
UW6498 2006 18 7 vanA
UW6923 2007 202 1 0
UW6920 2007 117 282 0
UW6919 2007 192 159 0
UW6918 2007 17 7 vanB
UW6917 2007 17 1 0
UW6916 2007 378 new 0
Table 3.10: Strains used for investigation of ℎ𝑦𝑙𝐸𝑓𝑚 GI structure, ℎ𝑦𝑙𝐸𝑓𝑚 genomic location and distribution. vanco-
mycin resistance type is shown for vancomycin resistant strains.
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Strain Description Reference
Staphylococcus aureus
NCTC8325
Size marker in PFGE
Streptococcus equi Hyaluronidase activity assay
Escherichia coli EHEC Positive control in adherence to epi-
thelial cells.
Escherichia coli DH5-𝛼 Negative control in adherence to epi-
thelial cells
E. faecium U0317 Bears ℎ𝑦𝑙𝐸𝑓𝑚 GI [179]
E. faecium DO Bears ℎ𝑦𝑙𝐸𝑓𝑚 GI [120]
E. faecium E1165 Bears the complete E. faecium esp
PAI
[79]
E. faecalis MMH594 Bears the complete E. faecalis PAI [141]
plasmids
pLG1 ℎ𝑦𝑙𝐸𝑓𝑚 vanA ca. 281.02 kb from
strain 64/3xUW2774 T-1
this study
pLG2 erm(B) ca. 66 kb from strain
OG1RFxUW3114 T-12
this study
Table 3.11: Strains (other than for conjugation experiments) and plasmids used in this study.
3.8 Isolation of whole cell DNA
Genomic DNA was isolated using DNAeasy Blood and Tissue kit (QIAGEN, Hilden,
Germany) following the instructions of the manufacturer, with addition of an ini-
tial lysis step for better breakage of the cell wall. 1ml of an overnight culture in
BHI broth at 37, was centrifuged and re-suspended in 180µl Gram positive cells-
lysis buffer (not included in the kit) and incubated at 37 for 60min. Then 25 µl
ProteinaseK and 200 µl Buffer AL were added, and further incubated at 70 for
60min. 200µl ethanol 98% were added, mixed and the whole content added into
the DNAeasy spin mini column. Columns were centrifuged at 8,000 rpm for 1min,
200µl buffer AW1 were added to the columns and then centrifuged again. 200µl
buffer AW2 were added and centrifuged again at 14,000 rpm for 3 minutes. DNA
was eluted from the column incubating two times for 1min with 15 µl buffer AE at
room temperature and centrifuging again at 8,000 rpm for 1min. DNA was stored
at -20 avoiding thaw and freezing.
Gram positive cells-lysis buffer
Tris, pH 8.0 20mM
EDTA 2mM
Triton X-100 1.2%
Lysozym 20mg/ml (added before use)
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Tube Amount DNA Amount Conc.
TE µl DNA ( µ𝑔/ml)
1 5 µl lambda DNA 95 5.0
2 50 µl from 1 50 2.5
A1 40µl from 2 60 1.0
A2 50µl from A1 50 0.5
A3 40µl from A2 60 0.25
A4 50µl from A3 50 0.1
A5 40µl from A4 60 0.05
A6 50µl from A5 50 0.025
A7 40µl from A6 60 0.01
A8 - 100 0.0
B1 1 µl probe 99 unknown
B2 10 µl from B1 90 unknown
Table 3.12: Scheme for PicoGreen DNA quantification. Standard curve preparation (A) and investigated sample
(B) dilutions are indicated.
3.9 DNA concentration determination
DNA average concentration was determined using a SmartSpect spectrophotometer
(Biorad) at default meassurement conditions for dsDNA quantification (A260nm,
conversion factor: 1.0=50.0 µ𝑔/ml). For more specific quantification and for plas-
mid samples DNA concentration was determined using Quant-iT PicoGreen®, an
ultra-sensitive fluorescent nucleic acid stain for quantification of double-stranded
DNA (dsDNA) in solution. A standard curve using the provided lambda DNA was
prepared for every measurement, as well as appropriate dilutions of the samples as
shown in Table 3.12.
A solution 1:200 of PicoGreen in TE was prepared and 50µl of this solution was
added into each flat-bottomed well of polystyrene black microtiter plates. 50 µl of
each dilution A1 until A8 and B1 until Bx were diluted into the 50 µl of PicoGreen
solution into the wells. The microtiter plates were scanned on a florescence reader
at 480-520 nm.
3.10 PCR
3.10.1 Regular PCR
The PCR reactions were performed using PuReTaq Ready-To-Go PCR Beads (GE
Healthcare Europe GmbH) which are dried beads containing Taq Polymerase, nucle-
otides and buffer. Water, primers and template were added to final volume of 25µl
which contained1.5 U Taq DNA polymerase, 200µM each dNTP, 0,1µl template
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MM 1: Final conc.: MM2: Amount:
dNTP each 500µM PCR Buffer 10x 5µl
Primer each 400 n𝑀 Expand long
Template DNA 300 n𝑔 Enzyme mix 0,75 µl
Water up to 25 µl Water up to 25 µl
Table 3.13: Long PCR reaction setting.
DNA. Cycling conditions were variated according to the annealing temperature of
the used primers and expected amplicon size, but in general were as follows: after
a denaturing step, 35 cycles were run for 30 s at 94, 30 s at 50 and 30 s at 72
followed by a final step of 5min at 72. The PCR products were resolved in 1.0%
agarose gels, these were stained with ethidium bromide for 15min, rinsed for other
15min and visualized in UV light.
3.10.2 Long template PCR
Long template PCR was performed using an Expand long template PCR (Roche)
under the conditions recommended by the manufacturer as follows: two master
mixes (MM) were prepared separately and then mixed to a 50 µl final volume as
presented in Table 3.13.
Cycling conditions included increased extension times to ensure a higher yield of
amplification product. After an initial denaturation step at 92 for 2min, 10 cycles
were run for 10 s at 92, 30 s at 50-65, 10-20min (elongation) at 68. Additional
20 cycles were run for 15 s at 92, 30 s at 50-65, 10-20min (elongation) at 68
plus 20 s cycle elongation for each successive cycle. The final elongation cycle was
for 7min at 68. The elongation time used was 10min for PCR products between
5 and 10 kb and 15min for larger expected products.
3.10.3 Determination of E. faecalis PAI and putative ℎ𝑦𝑙𝐸𝑓𝑚
GI presence and structure
The GI containing ℎ𝑦𝑙𝐸𝑓𝑚 previously suggested by Rice et al. [120] was searched
among the available E. faecium genome sequences of strain DO (NZ_AAAK00000000)
and U0317 (NZ_ABSW00000000) and the different sequences found were com-
pared by BlastN and re-annotated into one sequence with the help of DSgene and
Kodon software. The E. faecalis PAI structure described by Shankar et al. [141]
𝑔𝑏|𝐴𝐹454824.1|, was used as a reference for the investigation of PAI structure.
Transconjugants were tested for co-transfer of esp gene by PCR using the primers
esp1 and esp2 and for co-transfer of the ℎ𝑦𝑙𝐸𝑓𝑚 gene using the primers hyl1 and hyl2
(Table A. 1). For the screening of esp positive transconjugants, pools of genomic
DNA of 20 colonies were analyzed in each PCR reaction, and if positive, single
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colonies were investigated in detail. (see table A. 1).
Presence of the whole E. faecalis esp PAI was tested by amplification of over-
lapping regions of ca. 10 kb by long template PCR (PAI regions 1 to 9). Re-
gions yielding unexpected size or no product were further investigated by regular
PCR of each predicted ORF present into that region. Primers used are listed in
table A. 1. Presence of the whole ℎ𝑦𝑙𝐸𝑓𝑚 GI was tested by amplification of three
overlapping regions (hylGI1, hylGI2 and hylGI3) of ca. 5.5 kb by long template
PCR. Region hylGI3 was analysed by amplification of smaller regions (hylGI3a,
hylGI3b, hylGI3c, hylGI3d) for further detailed analysis. Presence of replication,
mobilization and maintenance genes of the ℎ𝑦𝑙𝐸𝑓𝑚 plasmid pLG1 was investigated
by regular PCR using the primers listed in Table A. 1 (rep-, MobC-, rel-, repB-,
MazE-pUW2774). All the primers used for ℎ𝑦𝑙𝐸𝑓𝑚 genomic environment are listed
in Table A. 1. Specificity of the PCR products was confirmed by HindIII diges-
tion. The digestion reaction was set with 1 µl of each PCR product, 40 units of the
enzyme (2µl), 1.0µl of NEBuffer2, and 6 µl H2O, and was incubated overnight at
37. Prediction of the digestion fragment sizes was done using NEBcutter V2.0
(http://tools.neb.com/NEBcutter2/index.php).
3.10.4 Detection of excision, circularization and integration
of the E. faecalis PAI
Primers binding outside of the integration site of the esp PAI PAI164 / PAI167
and PAI164Efm / PAI167Efm were used to amplify the intact integration site in the
E. faecalis and E. faecium strains respectively. Primers EF2 and ER1 binding inside
the PAI (reading outwards the PAI) were used in different combinations with primers
binding outside of the PAI to demonstrate the integration site in the transconjugants.
Excision of the E. faecalis PAI from the chromosome of E. faecalis was tested by two
stage nested PCR with primers amplifying the integration site of the PAI, under the
following conditions: after a denaturing step, 35 cycles were run for 30 s at 94,
60 s at 55 and 60 s at 72 followed by a final step of 5min at 72. For the
first round the primers PAI164 and PAI167 were used, and for the second round 1µl
of PCR product was used for amplification of an inner region thereof using primers
PAI164nes and PAI167nes (Table A. 1, Figure 3.2). Circularization of the E. faecalis
PAI were tested by two-stage nested PCR with primers binding in the E. faecalis
PAI ends which are supposed to join during circularization, and reading outwards
the PAI under the following conditions: after a denaturing step, 35 cycles were run
for 30 s at 94, 30 s at 55 and 60 s at 72 followed by a final step of 5min
at 72. For the first PCR the primers TSP2 5’ and TSP2 3’ were used, and for
the nested PCR 1µl of PCR product was used for amplification of an inner region
thereof using primers TSP3 3’ and TSP3 5’. (Table A. 1, Figure 3.2). All PCR
products were sequenced.
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3.11 Genomic walking
The DNA Walking Speedup  Premix kit (Seegene) was used for investigation of
the unknown regions adjacent to a known DNA region. This genomic walking tech-
nique employs Annealing control primers (ACP) which enhances specificity of short
oligomers making DNA walking experiments more simple and cost-effective. The
kit is composed of a PCR master mix and unique DNA Walking-Annealing Con-
trol primers (DW-ACP) that are designed to capture unknown targets with high
specificity. The optimized PCR conditions (referred to as DW ACP-PCR techno-
logy) allow unknown flanking regions of up to 3 kb long to be obtained. One of the
four ACP primers and the target specific primer 1 (TSP 1) were used to amplify
the target region from the template in the first PCR. The first PCR product was
purified using a QiaQuick PCR purification kit. The second PCR (the first nested
PCR) used the DW-ACPN primer and the TSP 2 primer to amplify the target from
the first PCR product. The third PCR (the second nested PCR) used Universal
primer and TSP 3 and the second PCR product as a template (see figure 3.1). The
Specific primers used were designed according to the specifications of the manu-
facturer. For investigation of the genomic region flanking the E. faecalis PAI in
E. faecium, following primers were used TSP1 5’, TSP2 5’ and TSP3 5’, tagging the
5’end of the PAI and TSP1 3’TSP2 3’, TSP3 3’ tagging the 3’ end of the PAI (see
table A. 1). To investigate the flanking regions of the ℎ𝑦𝑙𝐸𝑓𝑚 GI primers TSP1hylGI
3’, TSP2hylGI3’ and TSP3hylGI 3’, tagging the 3’ end and primers TSP1hylGI 5’,
TSP2hylGI 5’, TSP3hylGI 5’ tagging the 5’ end were used. The PCR products
obtained were visualized on 1% agarose gels, bands were extracted and sequenced
directly using both the universal primer and the corresponding TSP3 primer. The
PCR conditions were s shown in Table 3.14.
3.12 Sequencing
PCR products were completely or partially sequenced according to the manufacturer
recommendations for cycle sequencing of PCR products (Applied Biosystems). A
sequencing reaction was set as shown in Table 3.15. The cycling conditions were as
follows: after a 2-minutes denaturing step at 96, 25 cycles were run for 10 s at
96, 5 s at 45 to 60 and 4min at 60.
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First PCR
Reagents Cycling conditions
Genomic DNA 50-100 ŋ 94 5min 1 cycle
2.5 µM each DW-ACP 42 1min
(DW-ACP 1, 2, 3, 4) 4µl 72 2min
10 µM TSP1 1 µl 94 40 s 25 cycles
2x SeeAmp ACP 55 40 s
Master Mix II 25 µl 72 90 s
H2O x 72 7min 1cycle
Total 50 µl 4 ∞
Second PCR
Reagents Cycling conditions
Purified first PCR
product 3 µl
10 µM DW-ACPN 1 µl 94 5min 1 cycle
10 µM TSP2 1 µl 94 40 s 30 cycles
2x SeeAmp ACP 60 40 s
Master Mix II 10 µl 72 90 s
H2O 5µl 72 7min 1cycle
Total 20 µl 4 ∞
Third PCR
Reagents Cycling conditions
second PCR
product 1 µl
2.5 µM Universal Primer 1µl 94 5min 1 cycle
10 µM TSP3 1 µl 94 40 s 30 cycles
2x SeeAmp ACP 60 40 s
Master Mix II 10 µl 72 90 s
H2O 7µl 72 7min 1cycle
Total 20 µl 4 ∞
Table 3.14: DNA-Walking PCR setting scheme (Seegene)
Reagent Final conc.:
PCR-Product (200-500 bp) 3-10 n𝑔 or
PCR-Product (500-1 kb) 10-20 n𝑔
Primer 5 pmol
BigDye 3.1 1µl
H2O up to 10 µl
Table 3.15: Sequencing reaction setting
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Unknown sequence 
Known sequence 
DW-ACP1 DW-ACP2 DW-ACP3 DW-ACP4     .    .    .    .   . 
1st PCR Template DNA 
DW-ACP2
DW- ACPN
TSP1 
TSP2 
TSP3 
Universal Primer 
1st PCR product
2nd PCR product 
3rd PCR product 
Direct sequencing or Cloning 
2nd PCR 
3rd PCR 
Figure 3.1: The general strategy of DNA walking ACP PCR technology. DW-ACP (DNA Walking Annealing
Control Primer); TSP (Target Specific Primer). Source: Seegene, Inc SpeedUp 𝑇𝑀 User’s manual
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Figure 3.2: Representation of the E. faecalis PAI showing the primers used in this study for esp detection and
investigation of PAI excision, circularization and integration (not to scale). Black arrowheads represent the primers.
Solid black region represents chromosomal DNA, grey region represents the PAI. The junction- nucleotide sequences
after PAI integration in the chromosome of E. faecalis are shown in detail; the direct repeats (DR) appear in
underlined bold text. Dashed lines indicate joining of PAI regions during formation of circular intermediates; A
and B indicate two different events of excision and circularization of the PAI that were confirmed in this study (see
Results and Discussion sections).
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3.13 Pulse field gel electrophoresis (PFGE) and south-
ern hybridization
The Pulse field gel electrophoresis (PFGE) can resolve macrorestriction fragments
of DNAs and can be used to type microorganisms at the molecular level. PFGE
involves embedding of the organisms in agarose, lysing the organisms in situ and
treating with enzymes and detergents to remove all cellular components from the
DNA. Finally the total DNA is digested with restriction endonucleases that cleave
the DNA infrequently (SmaI for enterococci). The restriction fragments (10 to 20
for enterococci with sizes varying between 5 and 400 kb for E. faecium, 600 kb for
E. faecalis) are separated in an agarose gel by alternating the electric field between
spatially distinct pairs of electrodes arranged in a hexagonal contour. The varying
electric field allow the separation of DNA fragments ranging in size from a few kb
to some megabases. Preparation of samples and subsequent macrorestriction was
done as previously described [197, 192] For DNA -preparation, cells were grown
in 5ml of triptic soy broth (TSB) overnight at 37. Cells were harvested from
1.0ml of this culture and suspended in PIV buffer. The cells were transferred to an
Eppendorf tube, centrifuged and resuspended in 1ml of ice-cold PIV. 50µl of this
suspension were mixed with 50 µl of 1.2% LMP agarose and immediately pipetted
into the sample mold (BIO-RAD) and allowed to solidify. For lysis each plug was
placed in 1ml of lysis buffer and incubated overnight at 37 under gentle shaking.
The plugs were washed twice with 1ml ES-buffer and incubated in 1ml ESP-buffer
overnight at 50. The plugs were washed three times for at least 30 minutes at
room temperature with 14ml of TE-buffer. For digestion with SmaI the agarose
plugs were first given 1ml 1x SmaI-buffer for 30min to equilibrate, and then freshly
prepared 1x SmaI buffer with 40 U SmaI enzyme per plug. using a CHEF-DR III
apparatus (Biorad). The sizes of the restriction fragments were predicted according
to an external size standard (SmaI digested Staphylococcus aureus NCTC8325) and
calculations using software BioNumerics v. 5.1 (Applied Maths) [98].
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Lysis-buffer
Tris-HCl pH 7.6 6mM
Sodium chloride 1 M
Disodium EDTA pH7.6 100mM
Brij 58 0.5%
Sodium deoxycholate 0.2%
Sodium lauroylsarcosine 0.5%
pH 7.6
Add before use:
RNAase 60 µ𝑔/ml
Lysozyme 1mg/ml
ES-buffer
Disodium EDTA pH 9.0 5.0M
Lauroylsarcosine 1%
pH 9.0
PIV-buffer
Tris-HCl pH 8.0 10mM
Sodium chloride 1M
pH 7.6
LMP-agarose
1.2% agarose in PIV-buffer
ESP-buffer
Proteinase K 1mg/ml in ES-Buffer
TE-buffer
Tris-HCl 10mM
Disodium EDTA 1mM
pH 7.5
3.13.1 Southern blot
Southern-blot is a method for transferring DNA fragments from agarose gels to
solid supports (nylon membranes or nitrocellulose filters). The nylon membranes
are positively charged for a more efficient binding of the negatively charged DNA to
the membrane. The methods used for southern hybridization were capillary transfer
and vacuum transfer of DNA to positively charged nylon membranes according to
the methods described by Sambrook et al. [132]. Capillary transfer involved the
transfer of DNA from the gel on the surface of nylon membranes, carried on a flow
of liquid which is drawn through the gel by capillary action established by a stack
of dry absorbent paper towels. Capillary transfer was used for transfer of DNA
from macrorestriction analysis resolved in pulse field gels. Prior to the transfer the
gels were washed in different buffers in order to render the DNA in smaller single-
stranded fragments, which are then more efficiently eluted from the gel. The gel was
washed as follows: once for 10min in Blot-buffer 1, 2 times 15min in Blot-buffer 2,
and 2 times 15min in Blot-buffer 3. A dish was filled with the transfer buffer and
the blot was built as follows: the inverted gel was placed on wet 3MM Whatman
paper whose ends were immersed in the transfer buffer; over the gel the membrane
(1 mm larger than the gel in both dimensions) was placed and on the membrane
two pieces of 3MM Whatman paper and a stack of dry paper towels cut of the same
size of the membrane. The transfer was allowed to proceed for 12 - 18h. To fix the
DNA to the membrane the side of the membrane carrying the DNA was crossed
linked by ultraviolet irradiation exposure (150 mJoule, 30 s). The membrane could
then be used for hybridization experiments.
Vacuum transfer was used for rapid transfer of DNA from gels to nylon mem-
40
branes, and was used for the transfer of DNA from plasmid preparation, PCR and
S1 nuclease gels. The transfer method was performed according to the instructions
accompanying the Vacuum Blotter device (Apligene). The blot was constructed pla-
cing the membrane on the blot surface under the gel. The transfer was performed
at 50 mbar. The buffers were poured on the gel covering it completely. The gel was
washed as follows: Blot-buffer 1 for 30min, Blot-buffer 2 for 30min, vacuum-Blot-
buffer 3 for 30min. Finally the transfer buffer was given for 120min on the gel. The
wet membrane was crossed linked by ultraviolet irradiation exposure (150 mJoule,
30 s).
Blot buffer 1
HCl 0.25M
Blot buffer 2
NaOH 0.5M
NaCl 1.5M
Blot buffer 3
Tris 0.5M
NaOH 20mM
Transfer buffer
NaCl 3M
Sodium citrate 0.3M
Vacuum blot buffer 3
Tris 1M
NaCl 2M
3.13.2 Probe labelling
Digoxigenin (DIG)-11-dUTP alkali-labile was used to label DNA probes using PCR
DIG-High Prime system (Roche), according to the random primer labelling tech-
nique. 1 µ𝑔 of DNA to be labelled (i.e. PCR products) were diluted in 16 µl of H2O.
The DNA was denaturised for 10min at 96 and immediately cooled in ice. 4 µl of
High-Prime solution were added and incubated for 2 h at 37. The reaction was
stopped by heating at 65 for 10min. esp probes were generated using primers
esp1 and esp2; erm(B) probes, using primers ermB1 and ermB2; ℎ𝑦𝑙𝐸𝑓𝑚 probes,
using primers hyl1 and hyl2; vanA probes using primers vanA1 and vanA2, pilA
probes using primers piliF and piliR. Other probes were produced using the primers
listed in table A. 3.
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3.13.3 Southern hybridization
Southern hybridization was done using DIG system kits following the manufac-
turer’s recommendations (Roche). The Southern blot membranes loaded with single-
stranded DNA were hybridized with a DIG-labelled DNA probe. The nylon mem-
branes were pre-hybridized with 20ml hybridization buffer at 37 for 2 h. The
solution was replaced with 12ml hybridization buffer containing 5 µl freshly dena-
turised probe DNA and was incubated for 12 h at 37. The membrane was then
washed twice with SSC-buffer 1 for 5min and twice with SSC-buffer 2 for 15min.
After this the membrane could be used for immunological detection.
20 x SSC buffer
NaCl 3 M
NaCitrat (pH7) 0.3 M
Hybridization-buffer 1
SSC 5 x
Blocking reagent 1 x
N-lauroylsarcosine 0.1%
SDS 0.02 %
SSC-buffer 1
SSC 2 x
SDS 0.1 %
SSC-buffer2
SSC 0.1x
SDS 0.1 %
Blocking reagent (Stock solution)
Blocking reagent (Roche) 10%
in Hybridization-buffer 1
3.13.4 Immunological detection
Immunological detection was performed using the DIG nucleic acid detection kit
(Roche). DIG-labelled DNA was detected after hybridization to target nucleic
acids, using an antibody-conjugate (anti-DIG alkaline phosphatase conjugate, anti-
DIG-AP) which binds selectively to the DIG-labelled d-UTP (probe). The complex
formed is then visualized with CDP-Star (Roche), a chemi luminescent substrate for
alkaline phosphatase. The membranes were washed briefly in Detection-buffer 1 +
0,3%Tween® 20, then incubated for 30min with 100ml Detection buffer 2. Then the
membranes were incubated for 30min with 50ml of diluted antibody conjugate solu-
tion 1:10,000 in Detection-buffer 2. The unbound antibody conjugate was removed
by washing twice for 15min with 100ml of Detection-buffer 1 and the Membrane was
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equilibrated for 2 to 5min with 20ml of Detection-buffer 3. The membrane was then
placed into a hybridization bag where 7µl CDP-Star in 1ml Detection-buffer 3 were
given and left for 5min to react protected from the light. The CDP star solution was
removed. Visualization of hybridized fragments was done using a Biodocumentation
luminescence detector ChemiDoc X R (Biorad) by extended exposure of at least 1 h.
Detection-buffer 1
Maleic acid 0.1M
NaCl 0.15M
pH 7.5
Detection-buffer 2
blocking reagent (Roche) 1x
Detection-buffer 1 9x
Detection-buffer 3
Tris-HCl 0.1M
NaCl 0.1M
MgCl2 50mM
pH 9.5
3.13.5 I-CeuI PFGE
Chromosomal location was analyzed by southern hybridization of I-CeuI macrorestric-
tion analysis as previously described [110]. I-CeuI is an intron-encoded endonuclease,
used to cut a 26 bp site in the rRNA genes, coding for the 23S large subunit rRNA
The agarose blocks containing total bacterial DNA were prepared for restriction as
previously described [192]. Previous to restriction, the blocks were equilibrated in
100 µl of a 20mM Tris pH 8.0 5mM EDTA solution for 30 minutes at room tem-
perature. This solution was replaced for 100 µl of a second equilibration solution
containing 1µ𝑔 BSA, 20 µl 10x enzyme buffer NEB4 and 79µl water, and were in-
cubated for 30min at 4. Finally the blocks were incubated overnight in a lysis
solution containing 4 U of I-I-CeuI, 1µ𝑔 BSA 10µl NEB4, and 88,2 µl water. The
ramped pulse field times were as follows:5.0-30.0 s for 23 h at 14. SmaI digested
S. aureus NCTC8325 was used as the size indicator.
3.13.6 S1-nuclease PFGE
Plasmid content analysis and possible plasmid localization was evaluated by south-
ern hybridization of S1-nuclease macrorestriction analysis by the method described
by Barton et al. S1-nuclease is a unique enzyme in that it is effective on any super
coiled plasmid, has a self limiting action and makes few cleavages in chromosomal
DNA. These features are consequences of its specificity for unpaired nucleic acids.
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In negatively super helical plasmids, transiently denaturated regions sensitive to
S1 action occur as a result of torsional stress in the molecule. After one strand is
cut, S1 can cleave the intact strand opposite the initial break due to "breathing"
of ends at the nick where the cooperativity of base pairing is diminished. Under
this conditions, the enzyme has little subsequent activity on linear, double stranded
DNA. S1 probably cuts supercoiled domains in genomic DNA but the cleavages are
sufficiently infrequent to produce relatively few fragments. Consequently, linearised,
single-copy plasmids are detectable after electrophoresis as bands in a faint genomic
background [8]. The agarose blocks containing total bacterial DNA were prepared
for restriction as previously described [192]. The agarose blocks were equilibrated
in 100 µl tris-HCl, 10mM pH 8, then incubated for 15min at 37 in 100 µl of
enzymatic solution containing 14 Units S1-nuclease (Takara) and 10µl of 10x S1-
nuclease buffer. Finally the enzymatic solution was carefully removed and blocks
were equilibrated for 1 h in 100µl TE buffer. The ramped pulse field times were as
follows:5.0-35.0 s for 22 h at 14. SmaI digested S. aureus NCTC8325 was used as
the size indicator.
3.14 Plasmid isolation
Plasmids were isolated after modification of the method from Woodford et al. as
follows: Cells were grown on BHI agar plate at 37, re-suspended in 1ml TES buffer,
pH 8.0 and centrifuged at 8,000 rpm for 5 minutes. Pellets were re-suspended and
incubated during 60min at 37 in 200 µl TES buffer containing 10 mg/ml lysozyme
and 5 µ𝑔/ml RNAase. 400µl 0,2N NaOH / 1% SDS were added, the tube was mixed
gently and further incubated at 56 for 60min. 300µl 3M potassium acetate, pH8,4
were added and the tube was kept on ice for 20 minutes, following centrifugation
at 15,000 rpm for 15min. The supernatant was carefully transferred into a new
tube. then the supernatants were washed 3 times by adding 3 volumes of Phenol /
chloroform / isoamyl alcohol (25:24:1), inverting it ca. .30 times and centrifuging it at
12,000 rpm for 10 minutes and collecting the upper, aqueous phase. One extraction
using only Chlorophorm followed. After this the DNA was precipitated overnight
at -20 with 2 vol. ethanol 98%, following a final centrifugation at 15,000 rpm for
30min at 4. The pellets were washed with 500µl 70% ethanol and centrifuged,
then dried at 37 during 30min and dissolved in 20µl water for 20min at room
temperature. The final DNA concentration was determined using PicoGreen and
the plasmid preparation was visualized by electrophoresis in 1% agarose gel.
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3.15 454-sequencing
454 Sequencing is a large-scale parallel pyrosequencing system capable of sequencing
approximately 100 megabases of DNA per 10-hour run on the Genome Sequencer
FLX with GS FLX Standard series reagents. The technology is known for its un-
biased sample preparation and long, accurate sequence reads ( 250 base pairs in
length), including paired reads.
Two plasmids were sequenced by means of 454 technology at GATC Biothech
(Konstanz, Germany):
(a) pLG1: transferable megaplasmid (ca. 281.02 kb) bearing ℎ𝑦𝑙𝐸𝑓𝑚 and vanA from
transconjugant strain 64/3xUW2774 T-1.
(b) pLG2: transferable plasmid (ca. 66 kb) from transconjugant OG1RFxUW3114
T-12, strain that acquired the esp pathogenicity island. The plasmid sequencing at
GATC Biotech was done according to standard procedures for sequencing on the
Genome Sequencing (GS) FLX system (Roche).
For preparation of the single read libraries the double stranded DNA (dsDNA)
was column purified and sheared on a Covers ATA to fragments in a size of ca. 700 bp.
The A and B adapters for sequencing of the Roche technology were ligated to the
ends of the sheared DNA fragments. The samples were run on a 2% agarose gel and
the band in a size range of 700 to 900 bp was excised and column-purified. After
concentration measurement the resulting library was immobilized onto DNA capture
beads and the amplicon-beads obtained were amplified through emPCR according
to the manufacturer’s recommendations. Following amplification the emulsion was
chemically broken and the beads carrying the amplified DNA library were recovered
and washed by filtration. The samples were sequenced on a GS FLX Pico-Titer
plate device.
3.16 Sequence analysis and annotation
All sequences were analysed using DNAStar software SeqMan Engine and DS Gene
software packages, as well as BlastX and BlastN. After 454 plasmid sequencing, pre-
assembled contigs were obtained. Southern hybridization allowed confirmation of
plasmid localization of contigs that contained chromosomal-like sequences in pLG1.
The primers used for probe synthesis are listed in Table A. 3. Gap closure was done
when possible in pLG1 sequences by PCR, long PCR, primer walking and cycle
sequencing. The primer pairs used for gap closure are listed in Table A. 4. putative
coding sequences (CDS) were predicted and annotated using Kodon® and with the
help of BLAST programs. Open reading frames equal or greater than 100 bp with
initiation codon were searched, deleting smaller features with an overlap larger than
50% with a feature size less than 50% of the bigger feature size. Feature annotation
of CDS was accepted with an identification score over 70%. Identification of origin
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of replication, origin of vegetation, and other conserved motifs was done with the
help of BlastX, BlastN and visual inspection. Phylogenetic analysis of the replicase
and relaxase genes of pLG1 was done according to Weaver et al. and Garcillan-
Barcia et al.. The RepA homologs, retrieved from the NCBI database by a standard
BLAST search using pAD1 RepA as query, were analyzed together with repA-pLG1.
The un-rooted phylogenetic tree was drawn using the CLC Combined Workbench
sequence analysis software at default settings [185]. The relaxase homologs retrieved
from the databases using PSI-BLAST and iterative BLAST searches were analyzed
together with the rel-pLG1. The phylogenies were constructed with MEGA version
3.1. A phylogenetic tree was built using neighbour-joining (NJ) analysis, tested with
bootstrap values (1000 replicates) [40].
3.17 Hyaluronidase activity
Two different tests for evaluation of hyaluronidase activity were used. For the estab-
lishment of the tests S. aureus NCTC8325 and NCTC8325-1 were used as positive
controls and E. faecium strain 64/3 was used as a negative control. The first is a
simple method used for routine-detection of hyaluronidase activity in pneumococci
(van der Linden, M. and Nicklas, W. personal communication). A strain of Strepto-
coccus equi which produces an external capsule made mainly of hyaluronic acid and
does not produce hyaluronidase, was used. Each test strain (PCR ℎ𝑦𝑙𝐸𝑓𝑚 positive
strains) was inoculated onto agar plates together with the S. equi strain in crossed
streaks and was incubated for 24 or 48 hours at 37 and 40. Degradation of
the mucous capsule produced by S. equi was observed in the region where a hy-
aluronidase positive strain had grown. The second is a plate method using BHI
agar, supplemented with Bovine serum albumin (BSA) (1% w/v) and hyaluronic
acid sodium salt from S. equi (0.04% w/v) [154, 35]. Cells were inoculated onto
hyaluronic acid agar plates and were incubated during 24 and 48 hours at 37 and
40. Undegraded hyaluronate precipitated around grown bacteria as a conjugate
with albumin in the presence of 2M acetic acid for 15 minutes. Hyaluronate lyase
activity was observed as a clear zone against a background precipitate.
3.18 Transmission immunoelectron microscopy
Transmission immunoelectron microscopy was used to visualize the Esp protein and
pilA pili expressed on the bacterial surface as previously described [180, 59] Bacteria
were grown on Mueller Hinton (MH) blood agar plates at 37 and re-suspended in
PBS (1×109 CFU/ml. A drop of re-suspended bacteria was placed on Parafilm, and
a 200-mesh Formvar-carbon-coated copper grid was floated on the surface for 10 min.
Grids were washed three times by floatation for 5 min on drops of 0.02 M glycine
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in PBS and blocked by floatation for 15 min on drops of 1% bovine serum albumin
in PBS. Esp was labelled by floating the grids for 1 h on drops containing a 1/100
dilution of anti-Esp rabbit immune serum in PBS. Grids were washed four times by
floating them for 2min on drops of 0.1% bovine serum albumin in PBS. Antibodies
were labelled by floating the grids for 20min on drops of protein A-Gold (15 nm) in
PBS. Grids were washed by floatation four times for 2min on drops of PBS, fixed
by floatation on drops of 1% glutaraldehyde, and washed again by floatation eight
times for 2min on drops of H2O. Bacteria were stained by floating the grids for 5min
on drops containing 1.8% methylcellulose (25 centipoises) and 0.4% uranyl acetate
( pH 4) and subsequently air dried for 10 min. Grids were examined by using a Jeol
1010 transmission electron microscope.
3.18.1 Flow cytometry
Flow cytometry was used for quantitative detection of Esp on the bacterial surface
as previously described [180]. For flow cytometry assays bacteria were grown over
night on MH blood agar plates, and re-suspended in RPMI 1640 containing 0.05%
human serum albumin (HSA) to an OD660 of 1.0 ( 1 × 109 CFU/ml). 100µl of
each sample were pelleted by centrifugation (1min×8000 rpm), and re-suspended
in 50 µl RPMI 1640-HSA containing 1:100 anti esp-rabbit immune serum. Bacteria
were incubated 30min on ice and then washed with 1ml cold RPMI 1640-HSA.
Cells were centrifuged (1min×8000 rpm) and re-suspended in 50 µl RPMI 1640-HSA
containing 1:50 goat anti-rabbit flourescein isothiocyanate. Samples were left for
30min on ice, then 1ml cold RPMI 1640-HSA was added and cells were centrifuged
(1min × 8000 rpm). Bacteria were re-suspended in 50 µl RPMI 1640-HSA. Before
analyses in a FACSCalibur flow cytometer, bacteria were re-suspended in 300µl
RPMI 1640-HSA. All measurements were performed with the same machine using
the same parameters. The data were normalized for bacterial size, and experiments
were performed three times. The mean fluorescence (mean fluorescence channel 1)
was used as a measure for cell surface-associated Esp. Each sample was incubated
without anti-Esp rabbit immune serum and was used as negative controls. The
specificity of the anti-Esp rabbit immune serum had been previously demonstrated
by blocking the binding of serum to Esp on the bacterial cell surface after pre-
incubating 1/300-diluted anti-Esp serum in RPMI 1640-HSA with serial dilutions
of rN-Esp, starting with 100µ𝑔/ml, for 15min prior to incubation with the bacteria
[180]
3.19 Biofilm formation
In vitro biofilm formation was evaluated on polystyrene microtiter plates follow-
ing the methodology previously described [56] with slight modifications. Briefly,
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bacteria were grown on MH blood agar plates and re-suspended in TS broth sup-
plemented with 0.25% glucose to a concentration of 5 × 108 CFU/ml.A 100 µl
aliquote of bacterial suspension was added in triplicate per well, using Flat bot-
tomed 96-well polystyrene microtiter plates (Greiner Bio One and Corning) After
incubation at 37 during 24 hours, the bacteria were removed and the wells were
washed with 200µl of PBS. The plates were dried for 1h at 60 and stained with
100µl of 0.2% Gram’s crystal violet solution (Merk, Darmstadt, Germany) during
15 minutes at room temperature. The dye was removed and the wells washed again
with 200µl PBS three times. The plates were dried 10 minutes at 60. The dye
was re-suspended for 30 minutes by adding 100ml of ethanol 98% into each well.
Absorbance at 595 nm was measured with a Sunrise ELISA reader.
3.20 Cytolysin/haemolysin
The haemolytic activity of the strains was detected using MH blood agar plates, as
elsewhere described [155]. Strains were streaked onto agar plates containing BHI
agar with 5% (w/v) defibrinated human erythrocytes, 1% (w/v) glucose and 0.03%
(w/v) L-arginine.
3.21 Growth
Differential growth of the strains was tested by measuring the turbidity as optical
density (OD-600), produced by cells grown in BHI broth in agitation at 37. A
Novaspec spectrophotometer was used. An inoculum of each strain was prepared
inoculating a colony in 4ml of BHI broth, growing it overnight and freezing it at
-20. Later a 50 µl aliquot (108 cells/ µl) of the inoculum was added to 2,45ml of
BHI broth and OD-600 was measured every 60 minutes until the stationary phase
was reached. Each experiment was repeated three times. The OD at every time
point of each recipient and its corresponding transconjugant strain were compared
using an unpaired two-tailed t-test.
3.22 Animal experiments
The pathogenic potential of strains was evaluated in mouse bacteraemia and peri-
tonitis models as described previously [66, 166]. The animal studies described in
the present study were reviewed and approved by the Institutional Animal Care
and Use Committee at Harvard University. For preparation of the inocula bacteria
were grown in 1L Todd-Hewitt broth (THB) (Bacto) overnight, centrifuged, and
re-suspended in sterile saline. Aliquots were shock-frozen and stored at -80. The
concentration of the stock was verified by dilutions and viable counts on Triptic Soy
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Agar (TSA), and these numbers were used to calculate the appropriate dilutions
for the desired inoculum. For the experiments, aliquots were thawed and diluted in
sterile saline solution; the actual diluted inoculum was once more verified by viable
counts. Eight female 6-8-week-old BALB/c mice were inoculated intravenously in
the tail vein (bacteraemia model) or intraperitoneally (peritonitis model) with 8 or
5 x 108 CFU respectively of each strain. 24 h after infection, the mice were sacri-
ficed and exsanguinated, and bacterial counts in the blood and in the kidneys were
done by serial dilutions. Multiple comparisons were done using one way ANOVA
(PRISM4, GraphPad software).
3.23 Adherence to epithelial cells
The ability of enterococci as a gut commensal to adhere to colonic epithelium is
involved in the establishment of infections since it is supposed be the first step for
biofilm formation and for translocation across the intestinal barrier. Adherence of
bacteria to human epithelial colorectal adenocarcinoma cells (Caco-2) was investig-
ated. C2Bbe1 (Caco-2 Brush Border Expressing (clone) 1), ATCC CRL-2102 cells
were cultivated in Dubelco’s Modified Eagle’s Medium (DMEM) without supple-
ments and grown in a 5% CO2 atmosphere. All the experiments were performed
on cells between 15th to 25th passage. Cells were incubated into 24-well plates
(Greiner Bio One) to a cell density of 1 − 1.2 × 105 cells/well. An overnight cul-
ture of the bacterial strains to be tested was prepared. To make a mid log phase
culture 150µl of the overnight culture were inoculated into 3ml of BHI broth, and
were incubated for 3 hours at 37 at 50rpm. Bacterial density was determined by
measuring absorbance at 595nm in an Eppendorf Biophotometer. The Caco-2 cells
were incubated for 2 h at 37 5% CO2 with bacterial suspensions in DMEM with
a cell: bacteria ratio of 1:100 (1× 107 bacteria/well). The bacterial inoculums were
quantified by plating serial dilutions on BHI agar. After infection, epithelial cells
were washed 4 times with PBS to remove non adherent bacteria, and were lysed with
500 µl 0.25% Triton-X at 37 for 5 min. Total attached and internalized bacteria
were quantified by cultivation of serial dilutions of the cell-culture lysates. Bacterial
quantification was done with the help of an automated spiral plater (WASP2) and
a colony counter (aCOLyte). The percentages of adherent bacteria were calculated
and corrected to a partial derivated error. Differences among strains were compared
using an unpaired two-tailed t-test.
3.24 Statistical analysis
Data from in vitro growth and biofilm forming capacity of the recipient strains
Vs. their corresponding PAI positive strains were compared using one way ANOVA
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followed by Tukey’s multiple comparison test. Results from FACS were analyzed
using two way ANOVA to compare statistical significance of temperature on esp ex-
pression; One way ANOVA and Tukey’s post test were applied to compare the esp
expression of the different strains at 37∘C. Data from animal experiments were ana-
lyzed applying Kruskal-Wallis test followed by multiple comparissons using Dunn’s
post-test. All statistical analysis were done using GraphPad Prism5 software.
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4. Results
4.1 Transfer of ℎ𝑦𝑙𝐸𝑓𝑚 plasmids
The in vitro transfer of large-sized plasmids containing ℎ𝑦𝑙𝐸𝑓𝑚 genomic island (GI)
was achieved by filter mating conjugation using seven Enterococcus faecium donor
and seven recipient strains, four of which were E. faecium and three E. faecalis .
Filter mating conjugation experiments showed different transfer rates of ℎ𝑦𝑙𝐸𝑓𝑚 plas-
mids and different mating rates among the mating pairs tested. Transfer of ℎ𝑦𝑙𝐸𝑓𝑚
plasmids occurred at a higher frequency when vanA and ℎ𝑦𝑙𝐸𝑓𝑚 were located onto the
same plasmid (Table 4.1). Strain UW5905 yielded no transconjugants. S1-nuclease
digestion and Southern hybridization analysis of some of the transconjugants showed
sporadic changes in the plasmid size and in the presence of ℎ𝑦𝑙𝐸𝑓𝑚 or vanA genes in
the acquired plasmids after horizontal transfer (Table 4.2, Figure 4.2 and Figure 4.1)
Conjugation experiments yielded the transconjugant strain 64/3xUW3114 bearing
only pLG1. Further transfer of pLG1 from this transconjugant into the recipient
strain 64SS was also confirmed (Table 4.1). Transfer of ℎ𝑦𝑙𝐸𝑓𝑚 plasmid without
transfer of other plasmids, suggests that ℎ𝑦𝑙𝐸𝑓𝑚 plasmids are self transferable. Later
sequence analysis confirmed this observation (see below). I-CeuI macrorestriction
analysis of the transconjugants showed that no chromosomal integration of ℎ𝑦𝑙𝐸𝑓𝑚
had occurred (Figure 4.3 and Figure 4.4)
4.2 ℎ𝑦𝑙𝐸𝑓𝑚 Genomic environment
4.2.1 ℎ𝑦𝑙𝐸𝑓𝑚 Genomic island structure
Search of the ℎ𝑦𝑙𝐸𝑓𝑚 GI in the databases and comparison of the sequences resul-
ted in re-annotation of the ℎ𝑦𝑙𝐸𝑓𝑚 GI into a 17,817 bp structure by joining frag-
ments of contig 547 (5948:23 bp) (AAAK03000114.1) and contig 625 (1374:12729
bp) (AAAK03000042.1) of DO whole genome shotgun sequences (Figure 4.5). PCR
reaction using primersctg625DOdelF / ctg625DOdelR and HylPAIgapF / HylPAI-
gapR confirmed the joint of these two contigs. The ℎ𝑦𝑙𝐸𝑓𝑚GI structure was also found
identical (by microbial BlastN) in 6 other E. faecium microbial genomic contigs
(ACIY01000535.1, ACOB01000003.1, ACJQ01000003.1, ACAX01000152.1, ACBA-
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Donor strain Recipient
strain
Selection (mg/L) ℎ𝑦𝑙𝐸𝑓𝑚 -
vanA co-
localization
Mating rate𝑎 ℎ𝑦𝑙𝐸𝑓𝑚
positive
T
E. faecium
UW2460 64/3 VAN5-RAM30-FUS20 no 4.75𝑥10−8 5/20
UW5904 64/3 VAN5-RAM30-FUS20 no < 1.25𝑥10−9 -
UW5905 64/3 VAN5-RAM30-FUS20 no < 1.25𝑥10−9 -
UW3308 64/3 VAN5-RAM30-FUS20 no 6.43𝑥10−6 0/22
UW2774 64/3 VAN5-RAM30-FUS20 yes 2.8𝑥10−6 23/24
UW6715𝑏 64/3 ERY5-FUS20-RAM30 van𝑠 7.14𝑥10−6 0/20
UW6717𝑏 64/3 ERY5-FUS20-RAM30 van𝑠 7.14𝑥10−6 2/20
UW2774 BM4105RF VAN5-RAM30-FUS20 yes 5.54𝑥10−5 n-t
UW2774 GE-1 VAN5-RAM30-FUS20 yes 7.48𝑥10−05 n-t
64/3xUW2774 64SS VAN4-STR500-SPE300 yes 4.4𝑥10−02 3/4
E. faecalis
UW2774 OG1RF VAN5-RAM30-FUS20 yes < 5, 05𝑥10−07 -
UW2774 JH2-2 VAN5-RAM30-FUS20 yes < 3, 72𝑥10−06 -
UW2774 UV202 VAN5-RAM30-FUS20 yes < 2, 89𝑥10−06 -
Table 4.1: Conjugative transfer of plasmids containing the ℎ𝑦𝑙𝐸𝑓𝑚 GI by filter mating. Notice that no transfer into
E. faecalis could be achieved. 𝑎Expressed as number of transconjugants (T), VAN or ERY resistant, per recipient
cell. van𝑠, vancomycin sensitive; FUS, fusidic acid; RAM, rifampicin VAN, vancomycin; ERY, erythromycin; STR,
streptomycin, SPE, spectinomycin, n-t, not tested.
Strain plasmids present (calculated size in Kb)
UW2774 281 (h,v) 75
64/3x UW2774 T-1 281 (h,v)
T-2 226(h) 180,75 (h) 168,09 (h)
T-3 286 (h)
T-4 275 93,35 (v)
T-5 310 85 (v)
UW2460 250,13 213,57 (h) 75,87 33 (v) 9,87
64/3x UW2460 T-1 86,63
T-2 247,75 213,71 (h) 29,1(v) 9,95
T-3 248,79 30,04 (v) 9,94
T-4 213,17 (h) 31,7 (v)
T-5 254,78 214,68 (h) 33,89 (v) 9,89
Table 4.2: Plasmid content of selected transconjugants, calculated based on S1-nuclease PFGE analysis. Presence
of ℎ𝑦𝑙𝐸𝑓𝑚 (h) and/or vanA (v) onto the plasmid are indicated. T, transconjugant
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Figure 4.1: S1-nuclease analysis resolving plasmid content of donor strain UW2460, recipient strain 64/3 and its
corresponding transconjugants. Notice variations in ℎ𝑦𝑙𝐸𝑓𝑚 vanA plasmid sizes after transfer. Southern hybridiz-
ation membranes using ℎ𝑦𝑙𝐸𝑓𝑚 and vanA probes are also shown. T-1, T-2, T-3, T-4 and T-5 are 64/3xUW2460
transconjugants. T-1 is ℎ𝑦𝑙𝐸𝑓𝑚 negative. The uppermost bands visible are the pockets. The bands migrating at an
apparent size of ca. 674 kb visible in all lanes and hybridizing to ℎ𝑦𝑙𝐸𝑓𝑚 probe correspond to undigested chromosomal
and plasmid DNA.
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Figure 4.2: S1-nuclease analysis resolving plasmid content of donor strain UW2774, recipient strain 64/3 and its
corresponding transconjugants. Notice variations in ℎ𝑦𝑙𝐸𝑓𝑚 vanA plasmid sizes after transfer. Southern hybridization
membranes using ℎ𝑦𝑙𝐸𝑓𝑚 and vanA probes are also shown. 64/3xUW2774 T-1, transconjugant used for plasmid
pLG1 sequencing, T-2, T-3, T-4, T-5, additional 64/3 x UW2774 transconjugants. T-5 is ℎ𝑦𝑙𝐸𝑓𝑚 negative. The
uppermost bands visible are the pockets. The bands migrating at an apparent size of ca. 674 kb visible in all lanes
and hybridizing to ℎ𝑦𝑙𝐸𝑓𝑚 probe correspond to undigested chromosomal and plasmid DNA.
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Figure 4.3: I-CeuI macrorestriction analysis resolving only chromosomal bands of donor strain UW2460, recipient
strain 64/3 and its corresponding transconjugants. Southern hybridization membranes using ℎ𝑦𝑙𝐸𝑓𝑚 and vanA
probes are also shown. T-1, T-2, T-3, T-4 and T-5 are 64/3xUW2460 transconjugants. T-1 is ℎ𝑦𝑙𝐸𝑓𝑚 negative. The
last lane shows the SmaI restriction pattern of the donor strain. The uppermost bands visible are the pockets.
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Figure 4.4: I-CeuI macrorestriction analysis resolving only chromosomal bands of donor strain UW2774, recipient
strain 64/3 and its corresponding transconjugants. Southern hybridization membranes using ℎ𝑦𝑙𝐸𝑓𝑚 and vanA
probes are also shown. 64/3xUW2774 T-1, transconjugant used for plasmid pLG1 sequencing, T-2, T-3, T-4, T-5,
additional 64/3 x UW2774 transconjugants. T-5 is ℎ𝑦𝑙𝐸𝑓𝑚 negative. The last lane shows the SmaI restriction
pattern of the donor strain. The uppermost bands visible are the pockets.
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01000164.1 and ACAS01000191.1). For investigation of the ℎ𝑦𝑙𝐸𝑓𝑚 GI structure,
long template PCRs amplifying overlapping regions of ca. 5.5 kb (hylGI1, hylGI2
and hylGI3) were done (Figure 4.5). Later sequencing of ℎ𝑦𝑙𝐸𝑓𝑚 plasmid pLG1
allowed confirmation of the re-annotated ℎ𝑦𝑙𝐸𝑓𝑚 genomic region (HM565216) and
Table 4.4). The putative ℎ𝑦𝑙𝐸𝑓𝑚 GI structure was then investigated in 39 clinical
E. faecium isolates revealing a conserved structure. Twenty of the investigated isol-
ates yielded no product in region hylGI3c (Table 4.3). No association could be
established between the negative PCR in region 3c and a certain MLST type, the
plasmid size, the presence of vanA or the year of isolation. Presence of an inser-
tion into region hylGI3c was resolved in pLG1 amplifying region hylGI3c by long
template PCR and sequencing using a series of primers hylPAI3 seq (see Table A.
1). The ℎ𝑦𝑙𝐸𝑓𝑚GI has a 2,344 bp insertion downstream of ℎ𝑦𝑙𝐸𝑓𝑚 in the intergenic
region between the GMP synthase (pLG-0216) and a conserved hypothetical pro-
tein (pLG-0213) putative genes (Table 4.4, Figure 4.5). The integration of IS66
was not investigated in all strains. This insertion is an incomplete copy of IS66
and bears two ORFs (pLG-214, IS66 Orf2 like and pLG-215, Transposase IS66) and
25 bp inverted repeats (GTAAGCGCCCCATAGAACAGTACCT) at coordinates
14851:14875 bp and 17171:17195 bp (in contig 65). The 8 bp DR at the insertion
site were not present. The identified IS66 of pLG1 contains two transposases which
have a conserved Integrase core domain of the rve superfamily (cl01316). The IS66
element of pLG1 lacked of significant similarity (blastN) to the classical IS66 , IS679
of Escherichia coli (NC_002695, NC_002142). This insertion is absent from the
ℎ𝑦𝑙𝐸𝑓𝑚 GI of strain DO and from the 6 E. faecium genomic contigs where the ℎ𝑦𝑙𝐸𝑓𝑚
genomic region is conserved (see above).
The putative GI is flanked by two incomplete inverted copies of the E. faecium
IS1476 (U63997) putative transposase gene. Presence of the complete two flanking
IS was not confirmed. The transposase IS1476 gene is 1500 bp and only confirm
presence of a 501 bp und 753 bp fragments up and downstream of the island could
be confirmed. The regions flanking the putative GI outside of IS1476 could not be
determined neither by primer walking (Seegene, Seoul, Korea) nor by 454 sequencing
and data assembly. In the DO contig 625 which was initially used for annotation
of the ℎ𝑦𝑙𝐸𝑓𝑚 GI, the sequence extends downstream of the 3’ flanking IS1476 . PCR
using primers Hyl PAI-4F/Hyl PAI-4R, enzymatic digestion and sequencing of the
amplified products showed that this region downstream of ℎ𝑦𝑙𝐸𝑓𝑚 GI is specific for
strain DO but not for the other strains tested: U0317, UW2460 and UW2774. The
presence of the IS1476 at the ends of they GI prevented the resolution of the GI
flanking regions by genomic walking Speedup ®, since amplicons large enough to
provide the sequences of the ℎ𝑦𝑙𝐸𝑓𝑚 GI flanking regions are out of the limits of
detection of the method. The reannotated first two genes of the putative ℎ𝑦𝑙𝐸𝑓𝑚 GI
are predicted to encode a two component system transcription regulation operon
consisting of a sensor histidine kinase (pLG-0203) and a response regulator (pLG-
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0204). A frame shift in strain DO contig 547 (AAAK03000114.1), absent in pLG1,
caused a premature stop codon in the response regulator gene located downstream
of the 5’ flanking IS.
hypothetical protein
sugar-binding lipoprotein
IS1476 putative transposase
sensor histidine kinase, putative
response regulator receiver
Binding-protein-dependent transport systems
beta galactosidase subunit smaII
glycoside hydrolase Hyaluronidase eukariotic/prokariotic
IS1476 putative transposase
2K 4K 6K 8K 10K 12K 14K 16K 18K
hylGI3hylGI1 hylGI2
Conserved hypothetical protein
Transposase IS66
20K
Binding-protein-dependent transport systems
a b 
c d 
hyl
IS66 ORF2 like
GMP synthase
Figure 4.5: Structure of the genomic environment of ℎ𝑦𝑙𝐸𝑓𝑚 in pLG11. Solid bars show fragments amplified by
PCR. hylGI1, hylGI2 and hylGI3 correspond to the regions amplified by long template PCR, (hylGI3-) a, b, c, d
and hyl are regions amplified by regular PCR.
4.2.2 ℎ𝑦𝑙𝐸𝑓𝑚 Localization in E. faecium isolates
The ℎ𝑦𝑙𝐸𝑓𝑚 gene was localized on megaplasmids ranging from 150 kb to 350 kb in 37
of 39 clonally different E. faecium strains analyzed (Figure 4.6). Among the vanA
positive strains (n=12) vanA and ℎ𝑦𝑙𝐸𝑓𝑚 were localized on the same plasmid in four
isolates (including pLG1) while eight carry these genes on different plasmids (Figure
4.7, Table 4.3). We did not see hybridization of ℎ𝑦𝑙𝐸𝑓𝑚 to any of the plasmid bands
of strains DO and UW6379 (Figure 4.6). Instead, Southern hybridization of I-CeuI
PFGE showed hybridization to a chromosomal band (data not shown) suggesting
that in these two strains ℎ𝑦𝑙𝐸𝑓𝑚 is integrated in the chromosome.
4.3 Hyaluronidase activity
Two different methods to evaluate hyaluronidase activity were established. None of
the 39 enterococcal strains tested were able to lyse hyaluronic acid despite being
designated as ℎ𝑦𝑙𝐸𝑓𝑚 positive. The predicted ℎ𝑦𝑙𝐸𝑓𝑚 protein sequence was searched
for protein domains and functional sites stored in Prosite database (http://expasy.
org/prosite/) aiming to predict an alternative function, no motifs were found.
Figure 4.8 shows an example of positive and negative reactions observed in both
tests used.
4.4 ℎ𝑦𝑙𝐸𝑓𝑚-megaplasmid (pLG1) sequencing
Sequencing of ℎ𝑦𝑙𝐸𝑓𝑚 vanA megaplasmid pLG1 lead to findings regarding the back-
bone and classification of this plasmid, as well as possible contribution to metabol-
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Figure 4.6: S1-nuclease PFGE of 39 ℎ𝑦𝑙𝐸𝑓𝑚 positive isolates is shown (top) and corresponding Southern hybridization
membranes using ℎ𝑦𝑙𝐸𝑓𝑚 probe (bottom). Characteristics of the strains and the calculated ℎ𝑦𝑙𝐸𝑓𝑚 plasmid sizes are
described in Table 4.3. Linearized plasmids are resolved in the gel on a background of degraded chromosomal DNA.
The upper bands (migrating at an apparent size of ca. 674 kb) visible in all lanes and hybridizing to ℎ𝑦𝑙𝐸𝑓𝑚 probe
correspond to undigested chromosomal and plasmid DNA.
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Figure 4.7: S1-nuclease PFGE of 12 strains ℎ𝑦𝑙𝐸𝑓𝑚 and vanA positive and the corresponding Southern hybridization
membranes using ℎ𝑦𝑙𝐸𝑓𝑚 and vanA probes. Transconjugant strain 64/3xUW2774 (T-1) is also included. Arrows
point at the hybridization signal of the vanA probe. Linearized plasmids are resolved in the gel on a background of
degraded chromosomal DNA. Characteristics of the strains and the calculated ℎ𝑦𝑙𝐸𝑓𝑚 plasmid sizes are described
in Table 4.3. The upper band (migrating at ca. 674 kb) visible in all lanes correspond to undigested chromosomal
and plasmid DNA.
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(a) (b)
Figure 4.8: (a) Positive hyaluronidase activity expressed by Staphylococcus aureus 8325-4 on S. equi hyaluronic
acid-capsule degradation test. (b) Plate test using hyaluronic acid media, shows in the upper right quarter of the
plate the positive control S. aureus and clockwise, E. faecium strains UW2460, UW2774 and 64/3xUW2774, with
no hyaluronidase activity. None of 39 ℎ𝑦𝑙𝐸𝑓𝑚 PCR positive strains tested showed a hyaluronidase activity
ism, pathogenicity and resistance, of determinants that are encoded on this con-
jugative element. The E. faecium plasmid pLG1 sequences have been deposited at
GenBank under accession numbers HM565168 to HM565236. The assembly statist-
ics after 454-sequencing of ℎ𝑦𝑙𝐸𝑓𝑚 vanA megaplasmid pLG1 were the following:
 total of contigs: 99
 total number of aligned bases: 2,853,150 bp
 contigs lager than 500 bp: 64
 number of bases in contigs larger than 500 bp: 256.16 kb
 average contig size: 4,002 bp
 largest contig: 40,663 bp
 N50 contig size 7,757 bp
Of the 35 contigs smaller than 500 bp, 13 did not contain any predicted CDS and
were excluded from the analysis. Given the calculated plasmid size of 281.02 kb and
the total number of aligned bases of 2,853,150 bp, the covering was about 10.1 reads
per bp. Difficulties in the assembly were due to the presence of several insertion
sequences, transposons and other repetitive sequences. Southern hybridization was
positive for all the 32 probes tested (including ℎ𝑦𝑙𝐸𝑓𝑚) confirming location of the
tested contigs onto the sequenced plasmid and not in the chromosome. Primers
used for probe synthesis and putative function of the investigated CDSs are listed
in Table A. 3. Eighteen PCR reactions were performed intending to close 17 gaps in
the draft assembly. Fourteen of these PCR reactions yielded products, these were
sequenced and its sequences were re-aligned with the pLG1 sequencing contigs. In
this way a total of 17 gaps could be closed. This resulted in a final total of 69
sequencing contigs of pLG1. Primers used for closing gaps are listed in Table A. 4.
The identified homologies of predicted open reading frames (ORF) can be grouped
into: replication, mobilization/conjugation, resistance and metabolism as presented
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below. An overview of the identified ORF and their predicted functions is presented
in Table 4.4. Some of the ORFs putatively involved in replication, maintenance
and mobilization found in pLG1 were investigated by PCR in the set of 39 ℎ𝑦𝑙𝐸𝑓𝑚
positive strains and some ℎ𝑦𝑙𝐸𝑓𝑚 negative strains that carry large sized- plasmids.
The results are presented in Table 4.5.
4.4.1 Replication and mobilization
A 1,038 bp ORF was identified as a putative replicase gene (repA-pLG1 pLG-0001)
based on similarity at the protein level to the RepA of pAD1 (gb|AAB00503.1) and
is expected to encode a replication initiator protein, originally from E. faecalis . The
overall similarity at the protein level between RepA_pAD1 and RepA_pLG1 is on
average 54% (189/347 identities), but similarity differed in the N-terminal and the
C-terminal regions (79% and 30% respectively). A putative oriV was also identi-
fied within the conserved C-terminal sequence of repA-pLG1 by similarity at the
nucleotide level to the 170 bp oriV region of repA-pAD1. The direct and inver-
ted repeats which are essential in RepA binding to oriV, as described by Francia
et al., were also highly conserved in repA-pLG1 [37]. Francia et al. have previ-
ously reported the conservation of Y41, D58, L90, L95 and Y116, in the N-terminal
domain of 38 RepA homologues [37]. This motif was also found to be conserved
in RepA_pLG1. The identified RepA_pLG1 consists of 436 amino acids (AA),
remarkably larger than RepA_pAD1 (336 AA) and other annotated enterococcal
RepA (326 to 346 AA). Phylogenetic analysis of repA_N homologues as described
by Weaver et al. [185] was performed including the RepA_pLG1. This demon-
strated that pLG1 bears a RepA_N family replicon and revealed that it fits squarely
among the enterococcal sequences but constituting a single branch (Figure 4.9). An
ORF (pLG-0236) with 100% similarity to the replication associated gene repB of
pTEF3 (ref|ZP_00602517.1|) was also found in pLG1. This ORF has homology to
proteins related to CDS1_ pRE25. No genetical link of repB and the identified
repA could be established. A putative relaxase gene rel -pLG1 (pLG-0177) having
98% identity (525/535) to conserved hypothetical protein sequences of enterococci
and 27% identity (136/487) to a putative relaxase of Streptococcus macedonicus
(𝑔𝑏|𝐴𝐵𝐼30222.1|) was also identified. Analysis of the translated sequence of this
ORF showed that the relaxase domain was contained in the first 150 amino acids
of the N-terminus. Phylogenetic analysis of relaxase genes according to Garcillán-
Barcia et al. [40] was applied to Rel_pLG1 and it was seen that it belongs to the
MobP family, MobP7 subfamily (Figure 4.10) and it clusters among lactococcal and
E. faecalis relaxases. Further replication and segregation related genes present in
pLG1 are presented in Table 4.4. The presence of the replicase gene of pLG1 was
investigated for the set of 39 ℎ𝑦𝑙𝐸𝑓𝑚 positive strains by PCR and sequencing of a
135 bp fragment of the variable N-terminal region. This showed that repA-pLG1
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Strain Year MLST MLVA ℎ𝑦𝑙𝐸𝑓𝑚-pl. van vanA-pl. hylGI
𝑎 regions
1 2 3
a b c d
DO 1991 18 C + + + + + +
UW1952 1998 18 1 252.11 vanA 58.59 + + + + - +
UW2774 1999 18 281 281.02 vanA 281.02 + + + + - +
UW2460 1999 17 1 213.57 vanA 27.81 + + + + + +
UW2457 1999 80 1 205.00 vanA 205.00 + + + + + +
UW3056 2000 65 5 228.20 0 +𝑏 + + + + +
UW3488 2001 18 1 205.43 vanA 205.43/50.0 + + + + + +
UW3183 2001 18 1 214.46 vanA 104.20 +𝑏 + + + + +
UW3308 2001 65 - 206.05 vanA 44.02 +𝑏 + + + + +
UW5905 2004 192 159 188.12 vanA 68.43 + + + + - +
UW5352 2004 17 7 296.07 vanB + + + + + +
UW5275 2004 376 1 179.73 vanB + + + + + +
U0317 2005 78 195.06 + + + + + +
UW6379 2005 18 1 C vanA 101.45 + + + + - -
UW6352 2005 18 1 316.39 vanA 316.39 + + + + + +
UW6151 2005 17 1 262.60 vanA 98.38 + + + + + +
UW6112 2005 378 5 216.19 0 + + + + + +
UW6993 2006 192 159 187.53 0 + + + + - +
UW6990 2006 18 7 215.97 0 + + + + + +
UW6985 2006 81 7 222.85 0 + + + + - +
UW6982 2006 192 159 184.69 0 + + + + - +
UW6951 2006 192 159 189.90 0 + + + + - +
UW6947 2006 17 7 187.24 0 + + + + - +
UW6943 2006 192 159 189.27 0 + + + + - +
UW6941 2006 192 12 163.64 0 + + + + - +
UW6929 2006 192 159 265.66 0 + + + + - +
UW6893 2006 192 159 169.07 0 + + + + - +
UW6883 2006 378 new 216.94 0 + + + + - +
UW6882 2006 117 282 255.15 0 + + + + + +
UW6717 2006 317 - 186.93 0 + + + + - +
UW6715 2006 192 159 165.5 0 + + + + - +𝑏
UW6711 2006 192 159 190.41 0 + + + + - +
UW6498 2006 18 7 222.63 vanA 101.04 + + + + + +
UW6923 2007 202 1 167.78 0 + + + + - +
UW6920 2007 117 282 250.52 0 + + + + + +
UW6919 2007 192 159 167.98 0 + + + + - +
UW6918 2007 17 7 187.07 vanB + + + + - +
UW6917 2007 17 1 168.20 0 + + + + - +
UW6916 2007 378 new 216.98 0 + + + + + +
Table 4.3: ℎ𝑦𝑙𝐸𝑓𝑚 location and ℎ𝑦𝑙𝐸𝑓𝑚 GI structure in 39 E. faecium ℎ𝑦𝑙𝐸𝑓𝑚 positive clinical strains. Aproximate
ℎ𝑦𝑙𝐸𝑓𝑚 and vanA plasmid (pl) sizes are given in kb and were calculated by S1-nuclease PFGE analysis.
𝑎 hyl
genomic island (hylGI) presence was determined by PCR (see Figure 4.5). 𝑏 Product larger than expected. C: the
results indicate chromosomal localization.
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Locus Tag Contig Accession
number
Coordenates Product
ℎ𝑦𝑙𝐸𝑓𝑚 genomic island
pLG1-0203 65 HM565216 347:1075 response regulator receiver [E. faecium
1,230,933]
pLG1-0204 65 1053:2639 sensor histidine kinase, putative [E. faecium
U0317]
pLG1-0205 65 2836:3792 Binding-protein-dependent transport systems
[E. faecium DO]
pLG1-0206 65 3804:4715 Binding-protein-dependent transport systems
[E. faecium DO]
pLG1-0207 65 4739:6211 sugar-binding lipoprotein [E. faecium DO]
pLG1-0208 65 6262:6873 hypothetical protein EfaeDRAFT_1158 [E.
faecium DO]
pLG1-0209 65 6852:8816 glycoside hydrolase [E. faecium 1,230,933]
pLG1-0210 65 9093:11924 beta galactosidase subunit small [E. faecium
1,230,933]
pLG1-0211 65 11921:13582 Hyaluronidase eukaryotic/prokaryotic [E. fae-
cium DO]
pLG1-0212 65 13622:14554 conserved hypothetical protein [E. faecium
DO]
pLG1-0213 65 14885:15127 hypothetical protein EfaeDRAFT_2591 [E.
faecium DO]
pLG1-0214 65 15117:15470 IS66 Orf2 like [E. faecium DO]
pLG1-0215 65 15572:17119 Transposase IS66 [E. faecium DO]
pLG1-0216 65 17267:18832 GMP synthase [E. faecium U0317]
Replication and mobilization
pLG1-0001 21 HM565183 40769:41809 replication-associated protein RepA [E. fae-
cium 1,230,933]
pLG1-0015 21 3411:3896 Single-strand binding protein [E. faecium DO]
pLG1-0019 21 5746:5997 topoisomerase [E. faecium DO]
pLG1-0020 21 6023:7747 DNA topoisomerase [E. faecium DO]
pLG1-0054 21 39614:39946 positive regulator for conjugation [E. faecium
DO]
pLG1-0055 1 HM565168 458:4825 type III restriction endonuclease [E. faecium
1,230,933]
pLG1-0056 1 5756:6199 putative DNA repair protein RadC [E. faecalis
PC1.1]
pLG1-0059 1 7169:7792 Resolvase, N-terminal:helix-turn-helix region
[E. faecium DO]
pLG1-0146 17 HM565181 394:1017 MobC filamentation induced by cAMP- Fic [E.
faecium 1,231,410]
pLG1-0162 26 HM565186 236:871 Resolvase, N-terminal: helix-turn-helix region
[E. faecium DO]
pLG1-0165 29 HM565187 1168:1782 site-specific recombinase, resolvase family [E.
faecium E1071]
pLG1-0237 78 HM565222 1084:1875 hypothetical protein EfaeDRAFT_2626 [E.
faecium DO]
pLG1-0277 94 HM565234 3880:4443 resolvase [E. faecium 1,230,933]
pLG1-0250 86 HM565227 9139:9693 resolvase [S. pneumoniae CGSP14]
pLG1-0177 35 HM565192 2109:3716 putative relaxase
Maintenance
pLG1-0164 29 HM565187 14:1117 abortive infection bacteriophage resistance
protein [E. faecium E1071]
pLG1-0004 21 HM565183 44100:44354 transcriptional regulator/antitoxin, MazE
[Mesorhizobium sp. BNC1]
pLG1-0005 21 44355:44672 plasmid stabilization system protein [E. fae-
cium 1,141,733]
pLG1-0006 21 2:145 PemI family protein [E. faecalis V583]
pLG1-0017 21 4814:5407 abortive infection protein AbiGI [E. faecium
1,230,933]
pLG1-0163 26 HM565186 895:1245 PemK family protein [E. faecium DO]
pLG1-0110 12 HM565176 7743:8012 Plasmid stabilization system [E. faecium DO]
T4SS-like components
pLG1-0034 21 HM565183 18203:19408 (VirB1-like) peptidase M23B [E. faecium
D344SRF]
pLG1-0035 21 19408:21438 (VirB4-like) ATPase [E. faecium 1,231,410]
pLG1-0040 21 25576:28188 (VirD4-like) conjugation protein [E. faecium
1,230,933]
pilin gene cluster
pLG1-0044 21 HM565183 31362:33452 pilF conserved hypothetical protein
pLG1-0045 21 33449:33709 conserved hypothetical protein [E. faecium
1,231,501]
pLG1-0046 21 33722:34483 pilE conserved hypothetical protein
pLG1-0047 21 34499:35251 sortase family protein [E. faecium E1071]
pLG1-0048 21 35266:37242 PilA [E. faecium ]
pLG1-0049 21 37295:37993 sortase [E. faecium 1,141,733]
Resistance
heavy metal
pLG1-0167 32 HM565189 11:424 integral membrane protein [E. faecium
1,231,501]
pLG1-0168 32 771:3239 copper-translocating P-type ATPase [E. fae-
cium E1071]
pLG1-0221 70 HM565218 3201:3434 putative copper chaperone [E. faecium E1071]
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pLG1-0222 70 3587:5536 cadmium-translocating P-type ATPase [E.
faecium E1071]
pLG1-0259 91 HM565231 827:1282 copper transport repressor, CopY/TcrY family
[E. faecium E1071]
pLG1-0260 91 1295:3760 TcrA [E. faecium ]
pLG1-0261 91 3845:4051 TcrZ [E. faecium ]
pLG1-0262 91 4190:6352 TcrB [E. faecium ]
pLG1-0263 92 HM565232 112:1077 CtpA [Listeria monocytogenes ]
pLG1-0090 6 HM565172 990:1319 cadmium efflux system accessory protein [E.
faecium 1,230,933]
antibiotic
pLG1-0091 6 HM565172 1606:2091 teicoplanin resistance protein [E. faecium ]
pLG1-0092 6 2244:3161 VanY protein [E. faecium ]
pLG1-0093 6 3338:4633 transposase [E. gallinarum EG2]
pLG1-0094 6 5106:5714 D-ala-D-ala dipeptidase [E. faecium 1,230,933]
pLG1-0095 6 5720:6799 vancomycin/teicoplanin A-type resistance pro-
tein VanA [S. aureus ]
pLG1-0096 6 6744:7724 vancomycin resistance protein VanH [S. aureus
]
pLG1-0097 6 7927:9081 sensor histidine kinase VanS [E. faecium
E1071]
pLG1-0061 2 HM565169 605:1342 ErmB [Lactobacillus plantarum ]
Carbohydrate transport and metabolism
pLG1-0063 3 HM565170 3013:4488 Sulfatase [E. faecium DO]
pLG1-0064 3 4789:5610 PTS system mannose/fructose/sorbose family
IID [E. faecium DO]
pLG1-0067 3 7423:7902 PTS system sorbose subfamily IIB component
[E. faecium DO]
pLG1-0068 3 7906:9684 Beta-galactosidase [E. faecium DO]
pLG1-0070 3 10565:11701 Radical SAM [E. faecium DO]
pLG1-0080 4 HM565171 4564:5424 oxidoreductase domain protein [E. faecalis
TX0104]
pLG1-0081 4 5436:6263 3-methyl-2-oxobutanoate hydroxymethyl-
transferase [E. faecalis V583]
pLG1-0082 4 6278:7126 Pantoate-beta-alanine ligase [E. faecium DO]
pLG1-0083 4 7136:7531 Aspartate decarboxylase [E. faecium DO]
pLG1-0087 4 11004:11654 ABC transporter related protein [E. faecium
DO]
pLG10101 8 HM565173 123:1373 PTS lactose/cellobiose IIC component [E. fae-
cium DO]
pLG1-0105 12 HM565176 1641:2942 PTS lactose/cellobiose IIC component [E. fae-
cium DO]
pLG1-0108 12 5395:6087 sugar isomerase [E. faecium 1,141,733]
pLG1-0119 12 15704:16579 Metallophosphoesterase [E. faecium DO]
pLG1-0120 12 16751:17698 Aldo/keto reductase [E. faecium DO]
pLG1-0122 12 18485:19738 extracellular solute-binding protein, family 1
[E. faecium DO]
pLG1-0123 12 19821:20744 Binding-protein-dependent transport systems
[E. faecium DO]
pLG1-0126 12 22897:24585 Phosphoenolpyruvate-dependent sugar phos-
photransferase system, EIIA 2 [E. faecium
DO]
pLG1-0127 12 24740:25885 Phosphoenolpyruvate-dependent sugar phos-
photransferase system, EIIA 2 [E. faecium
DO]
pLG1-0128 12 25990:26283 Phosphotransferase system PTS,
lactose/cellobiose-specific IIA subunit [E.
faecium DO]
pLG1-0129 12 26285:26596 Phosphotransferase system, EIIC [E. faecium
DO]
pLG1-0132 12 28886:29839 Alpha-mannosidase [E. faecium DO]
pLG1-0133 12 32931:34307 Bleomycin hydrolase [E. faecium DO]
pLG1-0134 12 34382:35200 Myo-inositol catabolism IolB [E. faecium DO]
pLG1-0135 12 35250:36227 Carbohydrate kinase, PfkB [E. faecium DO]
pLG1-0136 12 36178:38136 Pyruvate decarboxylase [E. faecium DO]
pLG1-0137 12 38158:39312 Iron-containing alcohol dehydrogenase [E. fae-
cium DO]
pLG1-0138 12 39335:39766 GCN5-related N-acetyltransferase [E. faecium
DO]
pLG1-0149 17 HM565181 2754:3806 membrane protein, putative [E. faecium DO]
pLG1-0150 17 3819:4757 Ketopantoate reductase ApbA/PanE [E. fae-
cium DO]
pLG1-0151 18 HM565182 85:561 Sugar-specific permease, EIIA 1 domain [E.
faecium DO]
pLG1-0152 18 574:2076 PTS, EIIB: EIIC [E. faecium DO]
pLG1-0153 18 2090:2779 N-acylglucosamine-6-phosphate 2-epimerase
[E. faecium 1,231,502]
pLG1-0154 18 2939:3757 Helix-turn-helix protein RpiR:Sugar isomerase
(SIS) [E. faecium DO]
pLG1-0157 18 4710:5519 ROK [E. faecium DO]
pLG1-0187 49 HM565202 1:174 hydrolase, HAD superfamily [E. faecium
E1071]
pLG1-0193 55 HM565208 1:177 binding-protein-dependent transport system
[E. faecium 1,231,502]
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pLG1-0199 63 HM565214 21:248 glucose-6-phosphate isomerase [E. faecium
TX1330]
pLG1-0200 64 HM565215 3:236 NAD-dependent epimerase/dehydratase [E.
faecium E1071]
pLG1-0225 73 HM565219 2569:2796 ABC transporter, ATP-binding protein [E.
faecalis V583]
pLG1-0253 87 HM565228 2860:4029 Sugar isomerase (SIS) [E. faecium DO]
pLG1-0254 87 4045:5040 DeoC/LacD family aldolase [E. faecium
1,230,933]
phage related
pLG1-0181 42 HM565196 87:248 head-tail joining protein [E. phage EFAP-1]
pLG1-0184 45 HM565199 2:331 bacteriophage terminase large subunit [Lacto-
bacillus phage phiPYB5]
pLG1-0186 47 HM565201 84:194 prophage pi3 protein 45 [E. faecium 1,230,933]
pLG1-0142 13 HM565177 322:939 phage integrase [E. faecium 1,231,502]
pLG1-0062 3 HM565170 55:1149 Phage integrase:Phage integrase, N-terminal
SAM-like [E. faecium DO]
pLG1-0164 29 HM565187 14:1117 abortive infection bacteriophage resistance
protein [E. faecium E1071]
Table 4.4: Annotation of some of the identified pLG1 ORFs. Contig where the ORF is found and exact location
are given. repA-pLG1 was arbitrarily taken as pLG-001. All contig sequences are available under accession numbers
HM565168 to HM565236
is present in all ℎ𝑦𝑙𝐸𝑓𝑚 positive strains investigated, with slight differences in the
nucleotide sequences (mainly 2 non-synonymous nucleotide substitutions) (Table
4.5). Three ℎ𝑦𝑙𝐸𝑓𝑚 negative strains carrying large sized plasmids were also positive.
Analysis of the presence of res-pLG1, mobC -pLG1 and rel -pLG1 showed variable
presence along the ℎ𝑦𝑙𝐸𝑓𝑚 positive strains.
4.4.2 Pili and conjugation
A copy of the entire pilin gene cluster (PGC) -1 (EU909697) is present in pLG1
(99% identity on the DNA level) (from pLG-0044 to pLG-0049). PGC-1 contains
the genes encoding the two minor pilin proteins PilF (pLG-0044) and PilE (pLG-
0046), a gene of unknown function (pLG-0045), a class C (pLG-0047) and class
A (pLG-0049) sortase genes and the major pilin subunit pilA (pLG-0048). All the
conserved motifs of the described pilin subunits [59] were found intact in pLG1. The
consensus pilin motif with a conserved HLYPK motif, is present in pLG1 pilA; the
sequence YSLEETKAPENY resembling the consensus Ebox motif was also found
intact in pilA-pLG1 as well as the N-terminal signal sequence; finally, the VPMTG
sortase substrate motif was also found. Transmission immuno-electron microscopy
(TEM) imaging using anti-PilA immunogold particles, showed that the donor strain
UW2774 expressed PilA pili (Figure 4.11). This phenotype could not be confirmed
in any of the transconjugants that acquired pLG1 due to the low adherence of the
strains to the carbon coated copper grids used to perform the TEM.
In pLG1 a set of genes are arranged in an operon like way are co-located upstream
the previously described pilin gene cluster resembling a complete set of transfer genes
related to Type IV secretion system (T4SS) (Table 4.4). In pLG1 the following genes
related to T4SS were found:
 a VirD4 homolog conjugation protein (coupling protein with conservedWalkerA
and WalkerB NTP binding motifs)
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Figure 4.9: Phylogenetic alignment of Gram-positive plasmid RepA protein sequences including RepA-pLG1. The
arrow points at RepA-pLG1.
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Figure 4.10: Phylogenetic alignment of MobP-family relaxase protein sequences including Rel-pLG1. The arrow
points at Rel-pLG1.
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 a VirB4-like ATPase (putatively coding for a 77,472.6 Da protein matching
to the usual size of these ATPases (larger than 70-80 kDa, being the largest
element of the putative T4SS clusters)
 a peptidase (lysozyme)
 the entire pilin gene cluster PGC-1.
Figure 4.11: pilA pilin expression in strain UW2774 shown by transmission immunoelectron microscopy of cells
negatively stained and labeled with immunogold (15µm) using anti-PilA antiserum
4.4.3 Maintenance
The plasmid pLG1 has several putative coding sequences that potentially contrib-
ute to its segregational stability as listed in Table 4.4). Among them pLG-0004 and
pLG-0005 seem to constitute a complete plasmid stabilization module. The pre-
dicted proteins have small sizes (9.3 kDa and 12.2 kDa respectively) and show an
overlapping organization. Despite homology (37% identity) of pLG-002 to a MazE
component, search of the complete mazEF region of E. coli among pLG1 sequences
did not retrieve matches that indicated the presence of the entire mazEF system.
Functionality tests of these and other putative plasmid maintenance systems should
be performed in order to determine the genes that are responsible for the stability
of ℎ𝑦𝑙𝐸𝑓𝑚 and van plasmids among the enterococcal population.
4.4.4 Resistance
Several genes encoding heavy metal resistance were found on pLG1 (Table 4.4)
including a complete tcrYAZB operon encoding for copper resistance. A complete
67
vanA operon was identified in pLG1 (Table 4.4). An insertion between vanY and
vanX was detected. Presence of a transposase (IS204/IS1001/IS1096/IS1165 ) was
partially resolved, with similarity at the nucleotide level to ISEfa5 . This vanA
cluster might then constitute one subtype of Tn1546 -like elements. erm(B) which
encodes resistance to macrolides, lincosamides and streptogramin B antibiotics was
also identified on pLG1. The acquired antibiotic resistance determinants observed
by plasmid sequencing was congruent with the observed antibiotic resistance of the
transconjugants, which acquired besides the selection marker vancomycin resistance,
also macrolide resistance conferred by erm(B).
4.4.5 Metabolism
As previously mentioned the genes neighboring the putative ℎ𝑦𝑙𝐸𝑓𝑚 gene seem to
be involved in carbohydrate metabolism. In the same way several of the identified
ORFs in pLG1 are putative metabolic genes that might be involved in uptake and
utilization of different carbohydrates. Several of the identified ORFs show homology
to phosphotransferase systems (PTS). Neighboring all the identified PTS compon-
ents identified putative CDSs related to sugar carbon metabolism were also found,
including those of the ℎ𝑦𝑙𝐸𝑓𝑚 GI (Table 4.4).
4.5 Transfer of the E. faecalis PAI
Transfer of the esp gene by selecting for the transfer of antibiotic resistance determ-
inants was pursued by filter mating. The esp gene of E. faecalis was transfered
from donor strain UW3114 into E. faecalis and E. faecium recipients along with the
transfer of plasmid-encoded erythromycin resistance. One conjugation experiment
using E. faecium strain 64/3 as recipient yielded one esp positive transconjugant
(strain 64/3xUW3114 T-10) among 14 transconjugants tested. In contrast, five con-
jugation experiments using E. faecalis strain OG1RF as recipient, resulted in no esp
positive transconjugants among 600 transconjugants screened. The stimulating in-
fluence of SOS response in the transfer of genetic elements was assessed by exposing
the donor strain UW3114 to subinhibitory concentrations of ampicillin and cipro-
floxacin. When ciprofloxacin challenge was used, one transconjugant carrying esp
was identified (strain OG1RFxUW3114 T-12) among 100 transconjugants screened
(Table 4.6).
PCR analysis of overlapping regions covering the entire PAI (153.57 kb as in
reference strain MMH594) demonstrated that the transferred PAI of donor strain
UW3114 differed from the PAI in the reference strain MMH594. However, no dif-
ference was observed between the donor and the transconjugants, indicating that
the PAI did not undergo any changes during horizontal transfer (Figure 4.12, Table
4.7). Approximately 90.6 kb of the reference PAI -MMH594 were present in the
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Strain repA-
pLG1
res-
pLG1
mobC-
pLG1
rel-
pLG1
DO + + - -
UW1952 + + - -
UW2774 + + + +
UW2460 + - + -
UW2457 + - + -
UW3056 + - + -
UW3488 + - - -
UW3183 + - - -
UW3308 + + + +
UW5905 + + - -
UW5352 + - + -
UW5275 + - - -
U0317 + - - -
UW6379 + - - -
UW6352 + - + -
UW6151 + - + -
UW6112 + - + -
UW6993 + + - 𝑎 -
UW6990 + - + -
UW6985 + + - 𝑎 -
UW6982 + + - 𝑎 -
UW6951 + + - 𝑎 -
UW6947 + + - 𝑎 -
UW6943 + + - -
UW6941 + + - -
UW6929 + + - -
UW6893 + + - -
UW6883 + - - -
UW6882 + - - -
UW6717 + + - -
UW6715 + + - -
UW6711 + + - -
UW6498 + - - -
UW6923 + + - 𝑎 -
UW6920 + - - 𝑎 -
UW6919 + + - -
UW6918 + + - -
UW6917 + - - -
UW6916 + - - -
ℎ𝑦𝑙𝐸𝑓𝑚 negative strains:
UW6470 + - - -
UW5868 + - - -
UW6463 + - - -
64/3 - - - -
Table 4.5: Replicase, resolvase, mobC and relaxase of pLF1 investigated in 39 E. faecium ℎ𝑦𝑙𝐸𝑓𝑚 positive clinical
strains. Aproximate ℎ𝑦𝑙𝐸𝑓𝑚 and vanA plasmid (pl) sizes, given in kb are also shown.
𝑎 faint PCR amplicon with
the expected size was observed. C: chromosomal localization.
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Donor strain Recipient
strain
Selection (mg/L) Mating rate𝑎 esp positive
transconjug-
ants
E. faecalis E. faecalis
UW3114 OG1-RF OTE5-RAM30-FUS20 5.8𝑥10−6 0/200
UW3114 OG1-RF ERY10-RAM30-FUS20 4.7𝑥10−6 0/300
UW3114 OG1-RF STR500-RAM30-FUS20 1.4𝑥10−5 0/100
UW3114𝑎 OG1-RF ERY10-RAM30-FUS20 1, 3𝑥10−7 1/100
UW3114𝑏 OG1-RF ERY10-RAM30-FUS20 1, 3𝑥10−8 0/100
E. faecalis E. faecium
UW3114 64/3 ERY10-RAM30 2.5𝑥10−8 1/14
Table 4.6: Conjugative transfer of esp by filter mating. Notice that the esp gene of E. faecalis was transferred
into E. faecalis and E. faecium. Donors grown in subinhibitory concentrations of 𝑎 ampicillin or 𝑏 ciprofloxacin to
induce stress and SOS response.
PAI of UW3114 including the aggregation substance gene, the complete cytolysin
operon and the entire esp gene. Long PCR bridging the gaps of the putative absent
regions confirmed deletions located in regions: 2b-2c, 4b-5a and 9. No regular or
long PCR amplification was possible that closed the gaps in regions 6a-6b and 7b-8b,
suggesting that elements too large to be amplified were present (Figure 4.12, Table
4.7). The size of the transferred PAI element and its chromosomal integration were
determined by PFGE and Southern hybridization. SmaI-PFGE analysis revealed
that a single restriction fragment in each transconjugant strain was enlarged and
hybridized to the esp probe (Figure 4.13). The fragment size shift appeared to be
ca. 200 kb (calculated sizes were 206 kb in E. faecalis and 193 kb in E. faecium) and
corresponded to the total size of the PAI transferred element. Precise integration
(presence of 3’ and 5’ ends) of the whole PAI was confirmed (see below Sect. 4.5.1).
Given that only 90.6 kb of the reference PAI were confirmed to be present and that
additional DNA seemed to be integrated within certain regions (see above), it is
likely that additional ca. 119.4 kb DNA were inserted within the PAI (Figure 4.12).
S1-nuclease analysis demonstrated that the E. faecalis and E. faecium transconjug-
ants acquired a ca. 66 kb plasmid (pLG2) (Figure 4.13), which did not hybridize to
the esp probe, but to the selection marker erm(B). I-CeuI macrorestriction analysis
confirmed localization of esp on a chromosomal band in both transconjugant strains
(Figure 4.14).
4.5.1 Integration site
The integration site of the E. faecalis PAI in the chromosome of E. faecalis strain
OG1RF (𝑁𝑍_𝐴𝐵𝑃𝐼01000001.1) is at coordinates 374617:374626. This integration
site was found by comparing the OG1RF genome to the chromosomal region span-
ning the E. faecalis PAI in the genome of E. faecalis strain V583 (𝑔𝑏|𝐴𝐸016830.1| )
(PAI coordinates, 445126:583433). PCR amplification of the integration site of the
PAI prior to its insertion confirmed that it is intact in the recipient strain OG1RF
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Figure 4.12: The E. faecalis PAI of strain UW3114 that was horizontally transfered. The structure was investigated
based on the E. faecalis PAI of strain MMH594 (𝑔𝑏|𝐴𝐹454824.1|), by long template PCR, regular PCR, sequencing
and Southern hybridizations. The long template PCR regions are indicated by horizontal lines (1 to 9) (Table A.
2). Regions present are shown in dark blue and sum up to ca. 90.6 kb. White regions are absent. Light blue regions
are absent and hold additional insertions. Only representative ORFs from the regions present are shown.
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Figure 4.13: A. S1-nuclease analysis showing transfer of a ca. 66 kb conjugative plasmid into both transconjugants.
None of the plasmid bands hybridized to an esp probe (not shown). B. SmaI restriction analysis and corres-
ponding Southern hybridization using an esp probe. M, Marker Staphylococcus aureus 8325 SmaI-digested; D,
Donor UW3114; 64/3, E. faecium recipient; 64/3 T-10, E. faecium transconjugant 64/3xUW3114 T-10; OG1-RF,
E. faecalis recipient; OG1-RF T-12, E. faecalis transconjugant OG1RFxUW3114 T-12. White arrows indicate the
fragment size shift due to PAI acquisition in E. faecalis (ca. 206 kb larger) and E. faecium (ca. 193 kb larger).
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Figure 4.14: CeuI restriction analysis of the mating strains after E. faecalis PAI transfer. M, Marker Staphylococcus
aureus 8325 SmaI-digested; D, Donor UW3114; 64/3, E. faecium recipient; 64/3 T-10, E. faecium transconjugant
64/3xUW3114 T-10; OG1-RF, E. faecalis recipient; OG1-RF T-12, E. faecalis transconjugant OG1RFxUW3114
T-12. White arrows indicate the fragment size shift due to PAI acquisition in the transconjugants.
and occupied by the PAI in the transconjugant OG1RFxUW3114 T-12. The re-
gion where the PAI integrated into the E. faecium transconjugant 64/3xUW3114
T-10 genome was identified to be a tRNAlys gene, which is located in the E. fae-
cium U0317 contig00182 (𝑔𝑏|𝐴𝐵𝑆𝑊01000168.1|) at coordinates 47388:47460 (Fig-
ure 4.15). PCR amplification confirmed that the identified integration site tRNAlys
was intact in the recipient strain 64/3 and occupied by the E. faecalis PAI in
the transconjugant 64/3xUW3114 T-1(Figure 3.2). BLAST comparisons of the
E. faecalis and the E. faecium regions where the E. faecalis PAI integrated revealed
that they share 85% similarity at the nucleotide level along a 94 and 93 bp region
respectively. A 10 bp (AATTCTCAGT) sequence (resembling attB) was found to
be present at the PAI integration site of the E. faecium and E. faecalis recipient
strains. PCR and sequencing of the flanking ends of the PAI and chromosomal re-
gions spanning it demonstrated the exact integration of the PAI and confirmed the
presence of the two 10 bp direct repeats (DR) (resembling attl and attR).
The region where the 𝑒𝑠𝑝𝐸𝑓𝑚 PAI is located in E. faecium (E. faecium U0317
Contig 00248 (𝑔𝑏|𝐴𝐵𝑆𝑊01000226.1|) [179]) was amplified by PCR and confirmed
to be free in the recipient (64/3) and transconjugant (64/3xUW3114 T-10) strains,
indicating that neither the E. faecium nor the E. faecalis PAI are integrated in this
chromosomal region in the E. faecium donor and transconjugant strains.
4.5.2 PAI excision and circularization
Presence of a circular intermediate formed from the precisely excised PAI element
could be detected by nested PCR in the donor strain UW3114. Sequencing of these
amplicons confirmed that the PAI can precisely excise at its flanking ends and that
these ends join together, resulting in circularization of the PAI element (See Fig.
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Conserved hypothetical protein
Hypothetical protein
Conserved hypothetical proteinDegV family protein
Integration site E. faecalis PAI
Enterococcus faecium U0317 ctg00182
46K  46,5 K  47 K  47.5 K  48 K  48.5 K  49K   
( …TAGAGCAGCTGACTCTTAATCAGCGGGT…)
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feoB
Hypothetical protein
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374K 374.5K 375K 375.5K 376K
Recognition sequence esp PAI
Enterococcus faecalis OG1RF, whole genome
(…GAGAGCATCTGACTCTTAATCAGAGGGT…)
Figure 4.15: Chromosomal region where the E. faecalis PAI integrated in E. faecium as in strain U0317
𝑔𝑏|𝐴𝐵𝑆𝑊01000168.1| (top) and E. faecalis OG1RF 𝑟𝑒𝑓 |𝑁𝑍𝐴𝐵𝑃𝐼00000000| (bottom). The vertical white arrow
points at the integration site of the E. faecalis PAI. The detailed nucleotide sequence shows the 10 bp region of
recognition and integration of the PAI as underlined bold text.
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Long
PCR-
region
MMH594 UW3114 64/3
T-10
OG1RF
T-12
Regular
PCR -
ORF
MMH594 UW3114 64/3
T-10
OG1RF
T-12
1 + + - + EF0001 + + + +
2a + + + + EF0005 + + + +
2b 𝑑 + - - - EF0009 + + + +
EF0011 + + + +
EF0012 + - - -
2c + + * + * + * EF0013 + + + +
EF0014 + + + +
EF0015 + + + +
EF0016 + + + +
EF0017 + + + +
EF0019 + + + +
EF0020 + + + +
EF0021 + + + +
3a + + + +
3b + + + +
4a + + + + EF0046 + + + +
4b 𝑑 + - + * + * EF0055 + + + +
EF0056 + + + +
EF0057 + - - -
EF0058 + - - -
EF0059 + - - -
EF0060 + - - -
5a + - - - EF0061 + - - -
EF0062 + - - -
EF0065 + - - -
EF0066 + - - -
EF0067 + - - -
EF0068 + - - -
EF0069 + - - -
EF0070 + - - -
EF0072 + + + +
EF0073 + + + +
5b + + + + EF0074 + + + +
EF0076 + + + +
EF0077 + + + +
EF0078 + + + +
EF0079 + + + +
EF0080 + + + +
EF0081 + + + +
EF0082 + + + +
6a 𝑖 + - - - EF0083 + + + +
EF0084 + - - -
6b + - - - EF0087 + - - -
EF0089 + - - -
EF0091 + - - -
7a + - - - EF0092 + - -
EF0093 + + + +
EF0094 + + + +
EF0095 + + + +
7b + + * + * + * EF0101 + + + +
EF0102 + + + +
EF0108 + + + +
8a 𝑖 + - - - EF0109 + - - -
EF0111 + - - -
EF0115 + - - -
8b + - - - EF0117 + - - -
EF0119 + - - -
EF0122 + - - -
EF0123 + - - -
9 𝑑 + +* - +* EF0124 + + + +
EF0125 + + + +
EF0126 + + + +
EF0126 + + + +
EF0128 + + + +
EF0128-
129
+ - - -
EF0129 + - - -
TSP2 3´-
9PAIR
+ + - +
Table 4.7: Results of Long template PCRs and regular PCRs screening for presence of the entire E. faecalis PAI (as
in reference strain MMH594 [141]). PAI overlapping regions are described in A. 2 and Figure 4.12. Recipient strains
were negative for all PCRs. * A product of unexpected size was amplified. 𝑖, an insertion within this region(s) is
suspected. 𝑑, a deletion within this region(s) was confirmed.
3.2). The precisely excised circular intermediate carried the specific 10 bp sequence
(AATTCTCAGT) resembling attP. Accordingly, excision of the PAI from the chro-
mosome could be confirmed by amplification of the free chromosomal region that
contained the PAI in the E. faecalis donor strain UW3114. Excision from the chro-
74
mosome could also be detected only after two rounds of nested PCR. In addition
to precise excision and circularization of the PAI (only detected in donor UW3114),
imprecise PAI excision and circularization was also observed. PCR and sequencing
demonstrated that different fragments of the PAI can remain in the chromosome
after excision, or chromosomal fragments can be excised together with the PAI. The
following two scenarios of imprecise excision were the most frequently observed (as
they were more frequently amplified in different PCR attemps): (a) the fragment
1:223 bp of PAI remains in the chromosome after PAI excision and (b) the frag-
ment 1:1,704 bp of PAI remains in the chromosome after PAI excision (Figure 3.2).
Case (a) was detected in donor strain UW3114, while case (b) was seen in reference
strain MMH594, donor strain UW3114 and transconjugants 64/3xUW3114 T-10
and OG1RFxUW3114 T-12. An internal region of the PAI (coordinates 1704:1764-
1784 bp) shares similarity to the chromosomal region flanking the PAI downstream,
in strains MMH594 and UW3114 (50/61 identities (81%) ) and OG1RF (identit-
ies=68/82, 82%). In E. faecium strain 64/3 this homology extends along a larger
region (identities=316/393, 80%). These similarities between internal regions of the
PAI and the chromosomal region flanking it downstream could trigger the imprecise
excision of the PAI.
4.6 Phenotypic changes after PAI acquisition
PAI acquisition altered the phenotype of the E. faecium and E. faecalis strains.
Presence of Esp on the cell surface, biofilm formation, cytolytic activity, adherence to
epithelial cells and growth in vitro were assessed. Pathogenicity and in vivo survival
of the E. faecalis strains were compared using mouse bacteraemia and peritonitis
models.
4.6.1 Cell surface esp expression
Transmission immunoelectron microscopy displayed the Esp protein associated with
the cell wall of the donor and transconjugant strains but not on the surfaces of
the recipients (Figure 4.17). FACS analysis revealed a high level of expression
of esp in the donor strain UW3114 as well as in the E. faecalis transconjugant
strain OG1RFxUW3114 T-12 as compared to the reference strain MMH594. E. fae-
cium transconjugant 64/3xUW3114 T-10 showed a lower esp expression than the
E. faecalis strains (Figure 4.16). In all strains less Esp was expressed at lower levels
at 21 in comparison to 37 (Figure 4.16).
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Figure 4.16: Differential expression of cell wall-associated Esp at 37 and 21 measured by flow cytometry (FACS)
of anti-Esp labelled cells. Strains UW3114 (donor) and MMH594 (reference) are shown for comparison. Strains
64/3 T-10 (64/3xUW3114 T-10) and OG1RF T-12 (OG1RFxUW3114 T-12) are the transconjugants that acquired
the E. faecalis PAI from strain UW3114 (See also Table 3.9). Control is a conjugate control. The mean values from
two different experiments are shown, error bars denote standard deviations.
4.6.2 Biofilm formation
The E. faecalis transconjugant strain OG1RFxUW3114 T-12 showed a 2-fold in-
crease in biofilm forming capacity compared to its homologous strain, the recipient
OG1RF. In the E. faecium strains both the recipient and the transconjugants showed
very low biofilm formation (Figure 4.18).
4.6.3 Cytolysin/haemolysin
Both the reference (MMH594) and the donor (UW3114) strains showed haemo-
lytic activity while none of the recipient strains were haemolytic. The E. faecalis
transconjugant developed a strong beta-haemolysis after PAI acquisition, while
the pathogenicity island (PAI) positive E. faecium transconjugant remained non-
haemolytic. Since the cytolysin operon can also be plasmid-encoded, haemolysis
was also tested in transconjugants carrying the erm(B) plasmid pLG2 but lacking
the PAI and were non-haemolytic. Furthermore, sequencing of pLG2 did not reveal
the presence of any haemolysin or cytolysin genes (see below). Consequently the ac-
quired haemolytic activity of E. faecalis transconjugants could be linked exclusively
to the cytolysin operon present within the PAI.
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(a) MMH594 (b) UW3114
(c) 64/3 (d) 64/3xUW3114 T-10
(e) OG1RF (f) OG1RFxUW3114 T-12
Figure 4.17: Esp expression shown by transmission electron microscopy of cells negatively stained and labeled with
immunogold (15µm) using anti-Esp antiserum. Strains (a) MMH594 (reference) and (b)UW3114 (donor) are shown
for comparison. Strains (d)64/3xUW3114 T-10 and (f)OG1RFxUW3114 T-12 are the transconjugants that acquired
the plasmid pLG2 and the E. faecalis PAI from strain UW3114 (See also Table 3.9). Bar length= 200 nm
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Figure 4.18: Comparison of in vitro biofilm formation of the transconjugants. Strains UW3114 (donor) and MMH594
(reference) are shown for comparison. Strains 64/3 T-10 (64/3xUW3114 T-10) and OG1RF T-12 (OG1RFxUW3114
T-12) are the transconjugants that acquired the plasmid pLG2 and E. faecalis PAI from strain UW3114 (See also
Table 3.9). The mean values of three different experiments are shown. Error bars denote standard deviation.
(a) (b) (c)
Figure 4.19: haemolytic activity tested on human blood agar plates. (a) top, non-haemolytic recipient strain
OG1RF; bottom, haemolytic donor strain UW3114. (b) Non-haemolytic E. faecium transconjugant strains: top,
64/3xUW3114 T-10 bearing PAI, bottom, 64/3xUW3114 T-1 PAI free. (c) E. faecalis transconjugant strains: top,
haemolytic OG1RFxUW3114 T-12 bearing PAI, bottom non haemolytic OG1RFxUW3114 T-1 PAI free.
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4.6.4 Animal experiments
Mouse bacteraemia and peritonitis models were used to compare the pathogenic
potential of E. faecalis isogenic strains differing only by presence of the PAI. The
bacterial loads in blood and kidneys after 24 h of infection were compared. The
differences between the PAI-positive and PAI negative transconjugant strains were
not statistically significant. However, the PAI-positive strain yielded lower bacterial
counts than its isogenic strain lacking the PAI although the bacterial counts in blood
in the bacteraemia model were higher. (Figure 4.20). The mouse bacteraemia model
was used to compare the pathogenicity of the E. faecium isogenic strains carrying
and lacking the PAI. Although not significant, the E. faecium transconjugant strain
bearing the PAI 64/3xUW3114 T-10 appeared to yield lower bacterial counts than
its corresponding recipient and PAI negative isogenic strain (64/3xUW3114 T-1)
(Figure 4.20). However the inoculum of the PAI positive E. faecium strain was ca.
1 log lower, not allowing any possible conclusions.
4.6.5 in vitro Growth
Growth of the recipient strains and the transconjugant strains lacking and carrying
the PAI was compared in order to determine differences in growth as a consequence
of the altered genome size (ca. 266 kb larger genome in PAI-positive strains). There
was no significant difference for the E. faecium recipient vs. transconjugant strains
(p>0,05). In E. faecalis a significant delay of growth was observed in the PAI-
carrying transconjugant compared to the recipient from the beginning of the log
phase (p<0,05) (Figure 4.21).
4.6.6 Adherence to epithelial cells
Differential adherence to epithelial cells in vitro of the transconjugant strains lacking
and carrying the PAI was compared using CACO cells. The differences observed did
not reach statistical significance, although both E. faecalis and E. faecium transcon-
jugant strains carrying the PAI were slightly more adherent than those lacking the
PAI (Figure 4.22)
4.7 Plasmid pLG2 sequencing
The plasmid pLG2 (calculated size 66 kb) was sequenced in order to investigate
the presence of gene clusters that might be involved in conjugation and could have
supported the horizontal transfer of the E. faecalis PAI. The sequences of pLG2 can
be found in GenBank under the accession numbers HQ426650 to HQ426665. Only
contigs larger than 400 bp and with identified ORFs were submitted (52 kb). The
assembly statistics after 454-sequencing of pLG2 were the following:
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Figure 4.20: Bacterial counts in the blood (left) and kidneys (right) 24 h after A, intraperitoneal, or B, intravenous,
injection of 6-8-week-old female BALB/c mice with E. faecalis. C, shows results after intravenous injection with
E. faecium strains. Data represent the individual bacterial counts and the media. The inocula used for the
bacteraemia model were 64/3: 9.6x108, 64/3xUW3114 T-1: 1.26x109, 64/3xUW3114 T-12: 2.8x108, OG1RF:
8.5x108, OG1RFxUW3114 T-1: 5.5x108, OG1RFxUW3114 T-12: 5.2x108. The inocula used for the peritonitis
model were OG1RF: 4.4x108, OG1RFxUW3114 T-1: 5.3x108, OG1RFxUW3114 T-12: 5.7x108.
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Figure 4.21: Comparative in vitro growth of E. faecium (left) and E. faecalis (right) recipient and transconjugant
strains. Strains 64/3 T-10 (64/3xUW3114 T-10) and OG1RF T-12 (OG1RFxUW3114 T-12) are the transconjugants
that acquired pLG2 and the E. faecalis PAI from strain UW3114 (See also Table 3.9). Error bars denote standard
deviation.
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Figure 4.22: Comparison of in vitro adherence of the transconjugants to CACO-2 cells. Strains UW3114 (donor)
and MMH594 (reference) are shown for comparison. Strains 64/3 T-10 (64/3xUW3114 T-10) and OG1RF T-12
(OG1RFxUW3114 T-12) are the transconjugants that acquired the plasmid pLG2 and E. faecalis PAI from strain
UW3114. The mean values of three replicates are shown. Error bars denote standard deviation.
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 total of contigs: 46
 total number of aligned bases: 62.6 kb
 contigs lager than 500 bp: 17
 number of bases in contigs larger than 500 bp: 53.2 kb.
 average contig size: 1362 bp
 largest contig: 33,447 bp
Analysis of the plasmid sequences showed that pLG2 does not correspond entirely to
any previously described enterococcal plasmid. Similarities to fragments of different
enterococcal plasmids (pAD1, pTEF1, pTEF2, pAM373, pVEF1, pVEF2, pEF1,
pIP816, pRE25) were discovered, especially to putative genes encoding replication
and mobilization functions suggesting that pLG2 has a modular structure. Complete
replication and mobilization modules including an oriT suggest that pLG2 is a
conjugative plasmid, theoretically capable of triggering the transfer of the E. faecalis
PAI. The finding of a pheromone binding protein and the structure of the replication
module suggested that pLG2 is a pheromone responding plasmid. Determinants
encoding antibiotic resistance to erythromycin, streptomycin and streptothricin were
also located within the plasmid sequence (Table 4.8).
We identified a replicase gene, repR-pLG2 (pLG2-0001) that shared 100% iden-
tity at the nucleotide level to the replicase genes of E. faecium plasmids p5753cB
(GQ900487.1), pIP816 (AM932524.1), pVEF1-3 (AM296544.1, AM410096.1, AM93
1300.1), pEF1 (DQ198088.1) and E. faecalis plasmid pRE25 (X92945.2) represent-
ing replicases of Inc18-type plasmids. Similarity extended to a 5.3 kb region span-
ning the replicase (contig 13 coordinates 1:5374). The region spanning the replicase
gene was 99% identical to the 3.7 kb replication region of pEF1, which is virtually
identical to a homologous region described in pRE25. This region contains a pu-
tative replication origin oriR, up to five DnaA boxes and several inverted repeats
[127]. With regard to the segregation machinery, we identified a putative PrgP-PrgO
partitioning system, upstream and inverted to the replicase gene.
The region between coordinates 2783:1091 of contig 8 shared 98% similarity at
the nucleotide level along 1.6 kb of the 4.8 kb mobilization region of pEF1 (e=0.0). A
resolvase (pLG2-0012) and a "Filamentation induced by cAMP protein-Fic" (pLG2-
0013), homologous to pEF1 MobC are encoded in this region. Within the same
contig, an origin of transfer (oriT ) was identified based on the 99% similarity (ex-
pect=0.0) to the mobilization region of pAD1 where an oriT has been previously
identified between ORF53 and ORF57 (AF343837) [38]. No ORF that exhibits ho-
mology to a relaxase could be identified. All the elements necessary for plasmid
mobilization in Gram-positives were identified in pLG2 as can be seen in Table 4.8.
Other mobilization related genes of pLG2 include a putative single strand binding
protein gene (pLG2-0026) that could act as a coupling protein that binds the DNA
for substrate presentation during transfer, two peptidase putative genes (pLG2-0058
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and pLG2-0059), which might degrade the bacterial cell wall for the formation of a
transfer canal and two putative resolvase genes (pLG2-0012 and 38) that could be
involved in plasmid segregation by resolving plasmid dimers.
Locus Tag Contig Accession
number
Coordinates Product
Replication and mobilization
pLG2-0001 13 HQ426650 1975 3468 similar to plasmid replication protein [E. faecium
DO]
pLG2-0003 13 HQ426650 4068 5033 PrgP [E. faecium]
pLG2-0004 13 HQ426650 5005 5280 PrgO protein [E. faecalis TX1322]
pLG2-0063 25 HQ426655 2 373 SPOUT methyltransferase superfamily protein [E.
faecalis ATCC 29200]
pLG2-0065 27 HQ426657 3 506 Nucleotidyltransferase/DNA polymerase involved
in DNA repair Enterococcus sp. 7L76]
pLG2-0012 8 HQ426665 1489 2061 resolvase [E. faecalis TX0104]
pLG2-0013 8 HQ426665 2077 2682 Filamentation induced by cAMP protein Fic [E.
faecium DO]
pLG2-0019 8 HQ426665 7519 8400 DNA nuclease [E. faecalis TX0104]
pLG2-0026 8 HQ426665 11240 11716 single-strand binding protein [E. faecalis V583]
pLG2-0027 8 HQ426665 11856 13190 PcfJ [E. faecalis JH1]
pLG2-0038 8 HQ426665 24043 24597 resolvase [S. pneumoniae CGSP14]
pLG2-0047 8 HQ426665 30710 32254 DNA recombinase, putative [Streptococcus suis
05ZYH33]
pLG2-0048 8 HQ426665 32274 32690 recombinase [Streptococcus suis 05ZYH33]
pLG2-0049 8 HQ426665 32691 33017 possible DNA recombinase [E. faecalis TX0104]
pLG2-0050 8 HQ426665 33021 33188 DNA recombinase, putative [Streptococcus suis
05ZYH33]
pLG2-0058 17 HQ426652 2 133 peptidase [E. faecalis T1]
pLG2-0059 17 HQ426652 126 461 peptidase M16 [E. faecalis T1]
pLG2-0067 30 HQ426659 3 338 cell wall surface anchor family protein [E. faecalis
TX0104]
pLG2-0068 30 HQ426659 447 677 cell surface protein [E. faecalis T2]
pLG2-0072 38 HQ426663 14 481 pheromone binding protein [E. faecalis TUSoD
Ef11]
pLG2-0069 31 HQ426660 3 578 phage infection protein [E. faecalis HIP11704]
Antibiotic resistance
pLG2-0039 8 HQ426665 24952 25689 erythromycin resistance transferase [E. faecium]
pLG2-0040 8 HQ426665 25790 26155 predicted protein [E. faecalis T2]
pLG2-0041 8 HQ426665 26439 27233 aminoglycoside 3’-phosphotransferase [Staphylo-
coccus epidermidis RP62A]
pLG2-0042 8 HQ426665 27326 27481 streptothricine-acetyl-transferase Campylobacter
coli]
pLG2-0043 8 HQ426665 27552 27794 possible streptothricin acetyltransferase [E.
faecalis TX0104]
pLG2-0044 8 HQ426665 27803 28711 streptomycin aminoglycoside 6-adenyltransferase
[E. faecium]
pLG2-0056 14 HQ426651 1664 3604 tetracycline resistance protein [Lactococcus gar-
vieae]
others
pLG2-0060 20 HQ426653 15 503 FeS assembly protein sufD [E. faecalis T11]
pLG2-0061 24 HQ426654 10 288 regulator of sorbitol operon [E. faecalis TX1322]
pLG2-0062 24 HQ426654 340 588 transcriptional regulator SrlR [E. faecalis V583]
pLG2-0064 26 HQ426656 2 502 aspartate kinase [E. faecalis E1Sol]
pLG2-0066 29 HQ426658 2 481 GTP-binding protein [E. faecalis T3]
pLG2-0073 43 HQ426664 2 169 RinA family transcriptional regulator [E. faecalis
V583]
Table 4.8: Annotation of complete identified ORF in the sequencing contigs of pLG2. Contigs where the ORF is
found and exact location within them are given.
5. Discussion
5.1 ℎ𝑦𝑙𝐸𝑓𝑚 Genomic environment
The putative ℎ𝑦𝑙𝐸𝑓𝑚 genomic island (GI) was reannotated as a 17,817 bp structure
highly conserved among ℎ𝑦𝑙𝐸𝑓𝑚 positive Enterococcus faecium. This high conser-
vation was seen when analyzing nucleotide databases and by investigating a set of
39 diverse clinical ℎ𝑦𝑙𝐸𝑓𝑚 positive strains. 20 of these strains appeared to have an
insertion downstream of ℎ𝑦𝑙𝐸𝑓𝑚 at a specific region (hylGI3c) (Table 4.3). The pre-
valence of this event among the strains analyzed can be biased by over representation
of ℎ𝑦𝑙𝐸𝑓𝑚 positive isolates recovered during 2006 and the prevalence of this insertion
among ℎ𝑦𝑙𝐸𝑓𝑚 positive strains worldwide remains unclear. In pLG1 this insertion
was resolved as a 2,344 bp, constituting a relic of IS66 (Table 4.4, Figure 4.5).
Recently Gourbeyre et al. have described that IS66 is a family of ISs largely limited
to the Proteobacteria, which normally include three ORFs (orfA, orfB and orfC ),
well conserved terminal inverted repeats of about 20-30 bp and are flanked by an
8 bp direct repeat [44]. IS66 of pLG1 consists of the transposase (orfC) and what
seems to be the orfA component. pLG1 bears the 25 bp inverted repeats with
highly conserved sequence described by Gourbeyre et al. (GTAAGCGNCCNYN)
but the 8 bp direct repeats at the insertion site are not present. IS66 family ISs
are largely limited to the proteobacteria, but include two well-defined clades, one
limited to the Bacteriodetes/Chlorobi (green sulfur bacteria) and the other one to
the Firmicutes [44]. Whether the IS66 transposase of pLG1 is functional, cannot
be told. Functionality of IS66 transposase has been confirmed only for IS679 by
Han et al. [49], however pLG1’s IS66 has no significant similarity to IS679 , but to
other regions annotated as IS66 from enterococci and lactobacillae. ℎ𝑦𝑙𝐸𝑓𝑚 GI en-
codes a two component system transcription regulation operon that could regulate
the expression of the ℎ𝑦𝑙𝐸𝑓𝑚 GI-genes. Two component systems are commonly used
by pathogenic bacteria to control the expression of virulence factors required for
infectivity [157].
ℎ𝑦𝑙𝐸𝑓𝑚 was found to be plasmid located in 37 (n=39) E. faecium strains (plasmid
sizes 150 to 350 kb). vanA was co-localized in the ℎ𝑦𝑙𝐸𝑓𝑚 plasmid in 4 isolates
(n=12). The co-localization of vanA and ℎ𝑦𝑙𝐸𝑓𝑚 onto the same plasmid has also
been reported by Arias et al. and Rice et al. [3, 121]. Freitas et al. analysed a set
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of 51 ℎ𝑦𝑙𝐸𝑓𝑚 positive isolates from a worldwide collection of vancomycin-resistant
and vancomycin-susceptible enterococci belonging to the clonal complex (CC) of
hospital associated strains (CC17). They found that ℎ𝑦𝑙𝐸𝑓𝑚 was located on plasmids
ranging from 170 kb to 375 kb and in contrast to the results presented here, vanA
and ℎ𝑦𝑙𝐸𝑓𝑚 genes were never identified on the same plasmids [39]. The different sizes
of the ℎ𝑦𝑙𝐸𝑓𝑚 megaplasmids suggests different structures and compositions, however
further differences or similarities were not investigated. Among the strains analyzed
the isolates of the year 2006 representing ST-192 (MLVA-159) isolates might be
over represented more likely due to a clonal spread than to an increase in ℎ𝑦𝑙𝐸𝑓𝑚
positive strains during that period [also discussed in 191]. ℎ𝑦𝑙𝐸𝑓𝑚 appeared to be
chromosomally located in strains DO and UW6379, although in previous studies it
has been reported that ℎ𝑦𝑙𝐸𝑓𝑚 is located on a plasmid in strain DO [3, 121]. Probably
propagation, several passages and manipulation of this strain in different laboratories
over years, turned it into a descendent of the original strain DO in which ℎ𝑦𝑙𝐸𝑓𝑚 is
now integrated in the chromosome. It is worth mentioning that strain UW6379 was
the only strain where the region downstream of ℎ𝑦𝑙𝐸𝑓𝑚 the putative GI structure
was completely absent (Table 4.3).
None of the 39 strains tested in this study showed any hyaluronidase activity.
Original annotation of ℎ𝑦𝑙𝐸𝑓𝑚 was based on translated nucleotide similarity (BlastX)
to a hyaluronidase from Streptococcus pyogenes known as Spy1600 (Accession num-
bers 𝑁𝑃_269657 and 𝑁𝑃_607664) and to a hyaluronidase from Clostridium per-
fringens [120]. A recent report demonstrates that Spy1600 despite its original an-
notation as a hyaluronidase does not have detectable hyaluronidase activity but does
remove ß-O-linked N-acetylglucosamine from mammalian glycoproteins [146]. This
might also be the case of ℎ𝑦𝑙𝐸𝑓𝑚, however no biochemical evidence for the actual
enzymatic activity of ℎ𝑦𝑙𝐸𝑓𝑚 has been reported so far. The predicted ℎ𝑦𝑙𝐸𝑓𝑚 pro-
tein sequence did not reveal any protein domains or functional sites that allowed
prediction of an alternative function. ORFs adjacent to spy1600, as those adjacent
to ℎ𝑦𝑙𝐸𝑓𝑚, encode a transcriptional regulator, other glycosidases and sugar binding
proteins supporting the idea that these genes are involved in carbohydrate metabol-
ism although a role in deglycosylation of human O-glcNAc proteins cannot be ruled
out [146]. Blast comparison of the ℎ𝑦𝑙𝐸𝑓𝑚 GI and a 20 kb region spanning spy1600
showed no similarity between these two regions except for the ℎ𝑦𝑙𝐸𝑓𝑚 gene and the
region encoding two binding protein dependent transport systems (pLG-037 and
pLG-038) (64% identities). However the genomic region spanning spy1600, similar
to ℎ𝑦𝑙𝐸𝑓𝑚 GI, bears genes related to transcription regulation, carbon metabolism and
sugar transport systems (Figure 4.5, Table 4.4). Specific metabolic activities have
been reported as plasmid-encoded, e.g. Zhang et al. reported recently the link of
alpha-galactosidase to conjugative megaplasmids in E. faecium [202]. It is possible
that the exclusive association of ℎ𝑦𝑙𝐸𝑓𝑚 to hospital associated strains is due to the
antibiotic selective pressure imposed in the clinical settings that favors the spread
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and maintenance of ℎ𝑦𝑙𝐸𝑓𝑚 multiresistance plasmids on the population.
5.2 ℎ𝑦𝑙𝐸𝑓𝑚-Megaplasmid (pLG1)
Large plasmids have not been previously described in enterococci [186], however
according to recent reports it seems like they are widely disseminated [39, 179]. The
sequence of plasmid pLG1 is the first reported sequence of a megaplasmid in E. fae-
cium. Several molecular and epidemiological studies have revealed the exclusive
prevalences of ℎ𝑦𝑙𝐸𝑓𝑚 among clinical strains [120, 173]. In this study, however, the in
vitro transfer of ℎ𝑦𝑙𝐸𝑓𝑚 plasmids was demonstrated from various clinical E. faecium
strains into clinical and non-clinical E. faecium recipient strains of different MLST
types (Table 3.8). The fact that ℎ𝑦𝑙𝐸𝑓𝑚 plasmids were easily transferable into non-
hospital recipient strains of different MLST types means that a narrow host range
of the ℎ𝑦𝑙𝐸𝑓𝑚-plasmids can not be responsible for the exclusive presence of ℎ𝑦𝑙𝐸𝑓𝑚
among clinical strains. The transfer of ℎ𝑦𝑙𝐸𝑓𝑚 plasmids into E. faecalis could not be
achieved, which is in accordance to the fact that this marker is exclusively found
among E. faecium [120] suggesting a limited host range of the ℎ𝑦𝑙𝐸𝑓𝑚 megaplasmids
as a reason for this exclusive distribution. Horizontal transmission of ℎ𝑦𝑙𝐸𝑓𝑚 plas-
mids has been previously described both when ℎ𝑦𝑙𝐸𝑓𝑚 and van are genetically linked
[3, 121] and when they are not [39]. It is known that plasmids are dynamic structures
that change by gain and loss of genomic fragments influenced by the changing envir-
onment in which they reside [71]. Differences observed among the transconjugants
can be due to rearrangements and duplications of genomic fragments or incomplete
transfer during plasmid conjugation as has been also observed by others in various
plasmid conjugation experiments (Freitas, A und Coque, T. personal communica-
tion). At the beginning of this study ℎ𝑦𝑙𝐸𝑓𝑚 had only been described as a genomic
marker and no plasmid location had been suggested [120]. After the first conjug-
ation experiments were performed and high transfer rate of ℎ𝑦𝑙𝐸𝑓𝑚 was observed,
the genomic location of ℎ𝑦𝑙𝐸𝑓𝑚 was investigated and it was found that ℎ𝑦𝑙𝐸𝑓𝑚 was
encoded within large plasmids. Shortly after, the plasmid location of ℎ𝑦𝑙𝐸𝑓𝑚 was
reported [3, 121]. Other enterococcal virulence factors are also present into plas-
mids. These are the E. faecalis agregation substances ASA1 and Asc10 (adherence
and internalization to human cells) [112, 16, 119, 182, 158], the ebp locus (biofilm,
endocarditis and UTI- associated pili of E. faecalis) [107, 150] and the cytolysin
(increased mortality in endocarditis model) [16].
The presence of several insertions sequences, transposases and other repetitive
elements along plasmid pLG1 complicated the assembly of the 454-generated se-
quences but at the same time, together with the presence of phage-related genes
and recombinases, supported the current model that plasmids in E. faecium are
mosaic-like elements.
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A putative replicase gene repA-pLG1 was identified with a conserved oriV, based
on the similarity to the RepA of the E. faecalis plasmid pAD1. Francia et al. have
demonstrated that the replication initiator protein of pAD1, RepA, is necessary and
sufficient for initiation of plasmid DNA replication at an oriV located within its
own coding sequence, based on its ability to support replication when RepA was
supplied in trans [37]. RepA of pAD1 functions as the replication initiator protein
[185]. The C-terminal sequence of RepA-pLG1 has a low similarity (30%) to that
of RepA_pAD1, while the N-terminal sequence had high similarity (79%). The C-
terminal sequence of RepA_N homologs is highly variable and provides variability
and the host specificity [185]. The specificity provided by the C-terminal sequence
of RepA-pLG1 could explain why ℎ𝑦𝑙𝐸𝑓𝑚 is never found among E. faecalis as well as
the negative results in ℎ𝑦𝑙𝐸𝑓𝑚 plasmids transfer into E. faecalis . The N-terminal se-
quence similarity between RepA-pLG1 and RepA_pAD1 matches to the observation
that most sequence conservation among RepA homologs is found at the N-terminal
region (first 100 amino acids of each protein), which constitutes the RepA_N con-
served domain [185]. Most members of the RepA-pAD1 related family are similar
in size [37]. However RepA-pLG1 is larger than other enterococcal RepA. Weaver et
al. constructed an un-rooted phylogenetic tree of 43 RepA homologs associated to
mobile genetic elements to demonstrate the broad distribution and narrow host range
of RepA_N plasmids [185]. This phylogenetic analysis applied to the RepA-pLG1
confirmed that it is a RepA_N family replicon. The RepA_N replicons represent an
ancient group of plasmids that have co-evolved with the low G + C Gram-positive
bacteria. The replication, partition and conjugative transfer components of the
RepA_N plasmids have not evolved as a single unit but rather as separate modules
that have been shuffled among various plasmids native to these organisms [185]. A
putative repB was identified in pLG1. RepB proteins are ATPases that, together
with a DNA binding protein and a centromere-like site, comprise an "active partition
locus" which facilitate plasmid distribution at cell division [185]. Different to RepA,
RepB family of proteins are not associated with the RepA_N family of replicons
and its comparison fail to segregate by host genus as do the RepA_N proteins [185].
The putative repB -pLG1 has homology to proteins related to CDS1_pRE25 which
do not belong to RepA_N family of replication initiators, indicating that replication
and maintenance are two different plasmid modules. This matches to the observation
that RepA_N plasmids show an independent evolution for replication and mainten-
ance modules. Within Enterococcus, RepB homologs of several Gram-positives are
interspread evidencing the modular evolution of these plasmids [185]. A putative
relaxase gene was identified. Relaxases are the proteins that initiate and terminate
conjugative DNA processing and are the only essential protein of the mobilization
(MOB) machinery of mobilizable plasmids [40]. Garcillán-Barcia and collaborators
have described a classification scheme of conjugative transfer systems based on the
comparison of the sequences and properties of the relaxase proteins contained in
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gene sequence databases [40]. This analysis applied to Rel-pLG1 showed that it be-
longs to the MobP7 subfamily of the largest relaxase family MobP. MobP7 relaxases
have been found encoded by RepA_N plasmids before (e.g. pCF10); pAD1, instead,
encodes a MobC relaxase [40]. PCR investigation of backbone genes of pLG1 in the
39 ℎ𝑦𝑙𝐸𝑓𝑚 positive strains indicated that the repA-pLG1 was always present, while
the relaxase, resolvase and mobC, were variably present. However, ℎ𝑦𝑙𝐸𝑓𝑚 negat-
ive strains carrying large sized plasmids also carry repA-pLG1, suggesting that this
replicase is widely distributed (Table 4.5) and not exclusively associated to ℎ𝑦𝑙𝐸𝑓𝑚
presence. Although not confirmed by Southern hybridization it is feasible that the
repA-pLG1 is the replicase of ℎ𝑦𝑙𝐸𝑓𝑚- megaplasmids, considering that in a previous
study, none of the until then known Gram-positive replicase genes could be found
in ℎ𝑦𝑙𝐸𝑓𝑚- megaplasmids (n=51) [39].
Hendrickx et al. have previously described 4 different pilin gene clusters (PGC)
in E. faecium [58]. Pili are supposed to be implicated in adhesion to multiple
types of human cells and in biofilm formation [reviewed in 136]. In E. faecalis pili
are reported to be associated with biofilm formation playing a role in endocarditis
and urinary tract infections [150, 149]. A complete copy of PGC-1 with all the
conserved motifs of the described pilin subunits was found in pLG1. The major
pilin subunit of E. faecium PilA has very conserved pilin (LxxIHLYPKNxx) and E
box (YxxxETxAPExY) motifs, as well as an N-terminal signal peptide sequence and
an LPXTG-like sortase substrate motif at the C-terminus [59]. Meanwhile the minor
pilin subunit PilF contains a variant pilin motif, an N-terminal peptide but not a
cell wall anchor and PilE contains only an N-terminal signal sequence and a putative
cell wall anchor motif [58]. Originally the genomic localization of these PGC was
not studied in detail [59]. A recent study demonstrated the plasmid co-localization
of pilA (fms21 ) and ℎ𝑦𝑙𝐸𝑓𝑚 in 3 of 7 clinical E. faecium isolates [73]. speculated
that ancestral E. faecium isolates carried the pilA gene cluster and subsequently
acquired antibiotic and virulence determinants.
Conjugation systems appear to be a subgroup of T4SS that have evolved the
additional capacity to translocate DNA-protein complexes [17]. In Gram-positive
plasmids, proteins homologous to most of the protein families involved in DNA trans-
fer and in Gram-negative bacterial plasmid transfer have been described [reviewed
in 46]. These should provide:
 substrate presentation (coupling proteins or VirD4): coupling proteins that are
thought to link the DNA transfer intermediate and perhaps guide it through
the mating channel,
 necessary energy for the translocation process (ATPases or VirB4, VirB11
homologs): mainly ATPases that might act as chaperones involved in translo-
cation of transfer components across the membranous system and
 formation of the mating channel (lytic transglycosylases or VirB1 homologs
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and transmembrane proteins or VirB6 homologs): homologs to the family of
lytic transglycosilases that might open the peptidoglycan and aid the DNA
and proteins to cross the cell envelope- lysozyme.
In Gram-positive bacteria the close contact between donor and recipient cells
preceding conjugative transfer is thought to be established without the help of pili
[2] and is supposed to involve the role of adhesins, aggregation substance or pro-
teins with cell wall anchor motifs. No association between pili and DNA/protein
secretion or transfer has been assessed in Gram-positive bacteria. Nevertheless Type
IV pilin-like protein genes have been demonstrated to be involved in genetic trans-
formation of Gram-positive bacteria [reviewed in 5] and genes coding for secretion
channel-like proteins have been described for several Gram-positive conjugative plas-
mids [reviewed in 15]. Hence participation of pilus-like structures in the conjugative
transfer processes of Gram-positive bacteria cannot be excluded [2]. Presence of
genes required for mobilization as well as a T4SS allowing assembly and function-
ality of the mating channel are hallmarks of self-transmissible plasmids [40]. In the
vicinity of this region, an ORF (pLG-0015) with similarity to a single stranded DNA
(ssDNA) binding protein (SSBP) was found which is normally encoded in the con-
jugation regions of some sex pheromone plasmids such as pAD1. SSBPs are believed
to coat the ssDNA in order to protect it from the action of nucleases in the recipient
cell. In pLG1 a set of genes were found that resemble a T4SS operon.
Plasmids possess a number of systems that, by virtue of their ability to kill cells
which have lost a specific plasmid element, stabilize the plasmid in a growing pop-
ulation of cells. There are two types of stabilization systems that kill plasmid-free
cells. In one case, both toxin and antitoxin proteins are specified by the plasmid
but the toxin protein is more stable, or less susceptible to degradation than is the
antitoxin protein (TA systems); in the other case the synthesis of the toxin protein is
prevented by inhibition of translation by a plasmid-specified antisense RNA. Several
identified ORFs of pLG1 seem to be involved in plasmid maintenance. A putative
TA module was identified, which shows the characteristic size and overlapping or-
ganization observed in proteic TA modules found in Gram-negative bacteria [45]
and in the E. faecium plasmid pRUM [45]. TA systems have been described in a
variety of enterococcal plasmids [187, 153].
Bacteria have developed homeostatic mechanisms to ensure adequate levels of
copper within the cell. However increased concentrations of copper are toxic, in re-
sponse to which plasmid-borne copper resistance mechanisms, such as the tcrYAZB
operon of E. faecalis and E. faecium, are often employed [51]. The finding of a com-
plete tcrYAZB copper resistance operon in pLG1, among other putative heavy metal
resistance genes, corroborates previous studies describing the presence of copper res-
istance, glycopeptide and macrolide resistance gene clusters on the same conjugative
plasmid [52]. The identified complete vanA operon of pLG1 constitutes a subtype of
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Tn1546 -like elements which often bear ISEf1 , IS1678 , IS1216V , ISEfa5 , IS19 -like
between vanX and vanY [190, 72, 13, 87].
Several putative genes of pLG1 seem to be involved in carbohydrate metabol-
ism. Several PTS components were identified, always in the vicinity of metabolic
genes. PTS constitute the major carbohydrate transport system in bacteria by
active translocation across the cell membrane. PTSs catalyze the transfer of the
phosphoryl group from phosphoenolpyruvate to incoming sugar substrates concom-
itant with their translocation across the cell membrane. In addition to catalyzing
sugar transport, the PTS is involved in regulation of non-PTS transport, carbon
and nitrogen metabolism, chemotaxis and other processes [116, 125]
5.3 Intra and inter species transfer of the E. faecalis
pathogenicity island (PAI)
The results presented in this work demonstrate for the first time that the entire
E. faecalis pathogenicity island (PAI) is capable of precise excision, circulariza-
tion and horizontal intra- and interspecies transfer. Chromosome-to-chromosome
transfer and site-specific integration of the E. faecalis PAI into the chromosome
of E. faecalis and E. faecium were demonstrated. The E. faecalis PAI is flanked
by 10 bp direct repeats (DR) and the first two genes encoded within the PAI are
a putative phage-related integrase and an excisionase [141] suggesting that it can
excise from and integrate into the chromosome by homologous recombination and
can be transferred as a single entity [22]. The E. faecalis strain that was used
as donor (UW3114) had been successfully used by Oancea et al. to demonstrate
the intra-species transfer of the esp gene into E. faecalis [111]; in that study, the
transfer of further fragments of the PAI could not be investigated in detail because
the recipient strain E. faecalis JH2-2 already possesses parts of the PAI. Coburn
et al. have described excision of a 27,744 bp internal fragment of the PAI, circu-
larization, integration into a pTEF1-like plasmid and transfer into an E. faecalis
recipient strain [22]. Recently Manson et al. have shown that the E. faecalis PAI
can transfer into E. faecalis , not precisely but as part of larger chromosomal frag-
ments. The horizontal transfer of such regions requires the help of either pTEF1 or
pTEF2 pheromone-responsive plasmids and is recA-dependent, while the integrase
and excisionase genes present in the PAI were not required [89]. However, a role of
the integrase and excisionase genes for the precise excision and integration of the
PAI cannot be ruled out. This is the first report of the transfer and presence of
the E. faecalis PAI into E. faecium. van Shaik et al. have recently indicated that
some hospital strains of E. faecium carry a variant of the esp gene (𝑒𝑠𝑝𝐸𝑓𝑚) in a
PAI- like structure different from the E. faecalis PAI. The 𝑒𝑠𝑝𝐸𝑓𝑚 PAI is comprised
along E. faecium U0317 Contig 00248 (𝑔𝑏|𝐴𝐵𝑆𝑊01000226.1|) and contains a 10 kb
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fragment identical to a gene cluster in the E. faecalis PAI that suggests a recent
intra-genus transfer or acquisition of the PAIs from a third source [179]. van Schaik
et al. state that the 𝑒𝑠𝑝𝐸𝑓𝑚 PAI can be transferred horizontally among E. faecium
[179]. Given the species-specific distribution of these two elements it is possible that
the in vitro inter-species transfer of the E. faecalis PAI is a less frequent event in
vivo.
The analysis of the PAI structure in the donor and the transconjugants revealed
that it did not undergo any changes during transfer. Compared to the originally
described PAI of strain MMH594, the transferred PAI structure contained some
deletions and insertions (Figure 4.12). The differences observed along the transferred
PAI compared to the prototype PAI of strain MMH594 agrees with the previous
observation that the gene content of the E. faecalis PAI is highly variable and PAI
subtypes are widely spread among different sequence types, clonal types and strains
of various clinical and non-clinical origin [90, 143, 91]. The cluster-like variability
in gene composition and presence of sequences related to mobile genetic elements
within the PAI suggest that it has evolved by initial spread of some core elements
and later recombination, acquisition and loss of gene clusters [90, 91].
The E. faecalis PAI is integrated into a non-coding region flanked by an ORF
specifying a hypothetical protein with no predictable function and a putative ox-
idoreductase [141]. The E. faecalis PAI of the E. faecalis donor strain UW3114 was
located into the same region and it also integrated into this region in the recipient
strain OG1RF, suggesting a highly site-specific integration. The E. faecium recip-
ient strain 64/3 lacks the 𝑒𝑠𝑝𝐸𝑓𝑚 PAI. In the transconjugant strain 64/3xUW3114
T-10 the E. faecalis PAI integrated into a tRNAlys gene. Besides, the integration
site of the E. faecalis PAI in E. faecium is distinct from the region where the 𝑒𝑠𝑝𝐸𝑓𝑚
PAI is located. The homology between the integration site of the E. faecalis PAI
in E. faecalis and E. faecium presents the possibility that larger regions act as the
recognition sequences for PAI integration, although the 10 bp sequence (attP -like)
should be the effective site for homologous recombination, since it resulted in DR
(attL- and attR-like) at both ends after PAI chromosomal integration.
It is known that due to the short stretches of DNA sequence similarity neces-
sary to initiate recombination events, circular DNA molecules are more likely to be
transferred and acquired, making them the most promiscuous recombinogenic states
of all DNA [167]. On the other hand circularized intermediates of other PAIs have
been seen and associated with their transfer [84, 99, 118, 177]. These observations
prompted us to test for the excision of the PAI from the chromosome and for the
formation of circular intermediates. Besides confirming that the PAI can precisely
excise and circularize (only observed in the donor strain UW3114), imprecise ex-
cision and circularization were also detected (Fig. 3.2) apparently due to homology
between internal regions of the PAI and flanking chromosomal regions. The circular
intermediates of the PAI lacking the integrase and excisionase genes might be unable
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to integrate/excise in a recipient strain. The fact that precise excision and circular-
ization could only be detected in the donor strains but not in the reference strain
MMH594 might explain why previous attempts to transfer the entire PAI element
from this strain have not been successful [22]. It seems evident that the horizontal
transfer event reported here resembles that of ICEs.
Esp protein was detected on the surface of all PAI-positive strains. Although
FACS analysis revealed a lower esp expression in the E. faecium transconjugant than
in E. faecalis (Figure 4.16), it is likely that the expression of genes encoded within
the PAI are affected by regulatory factors inherent to the cell or species-specific. esp
expression was diminished when cells were grown at 21, as previously described
for 𝑒𝑠𝑝𝐸𝑓𝑚 in E. faecium [180]. Temperature-dependent regulation of expression is
an ecological feature for regulation of pathogenicity factors also observed in other
pathogens that alternate between an environmental reservoir and a mammalian
host [180]. These results show that the temperature-dependent expression of esp
is also a feature of E. faecalis (Figure 4.16). The acquisition of the E. faecalis
PAI increased in vitro biofilm formation in E. faecalis . However, the acquisition of
E. faecalis PAI was not sufficient to develop a biofilm forming phenotype in E. fae-
cium. The nearly absent biofilm formation of the recipient strain, together with the
low Esp on the cell surface, might explain the low biofilm formation in the E. fae-
cium PAI-positive strain. Additionally, it is well-known that E. faecium has low
biofilm forming capacity compared to E. faecalis [94, 133] and it has been demon-
strated that although Esp can increase the biofilm forming capacity in E. faecium
and E. faecalis [161, 170, 180, 56], it is neither sufficient nor absolutely necessary
for biofilm formation [77, 124].
The cytolysin/haemolysin cyl operon encodes a bacterial toxin expressed by some
strains of E. faecalis which in addition to mediating lysis of erythrocytes, also pos-
sesses antibacterial activity toward a broad range of Gram-positive bacteria [42].
The cyl operon is either encoded within large, pheromone-responsive plasmids or
on the chromosome within the E. faecalis PAI [reviewed in 41]. The PCR res-
ults showed that the complete and intact cyl operon was present in the transferred
E. faecalis PAI element. However, a strong (beta-) haemolytic activity could only
be detected in E. faecalis strains. This is the first description of transfer of the
cyl operon and cyl genes to E. faecium. Previous studies have reported complete
absence of cyl genes (n=271) among E. faecium [183] as well as absence of both cyl
genes and haemolytic activity (n=21) [48]. Vancanneyt et al have reported beta-
haemolytic activity in 5 E. faecium isolates (n=78) but no link could be established
between haemolytic activity and gene presence [181]. Several bacteriocins have been
described in E. faecium: enterocin A, enterocin I, enterocin P, enterocin L50A/L50B
and enterocin B [30]; however, none of these bacteriocines and/or the strains produ-
cing them possessed haemolytic activity [6, 36, 18, 19, 14]. It remains unclear what
prevents the expression or activity of the E. faecalis cytolysin/haemolysin in E. fae-
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cium, but at least it is clear that haemolytic activity has yet been rarely observed in
E. faecium. The transfer of the PAI and the expression of pathogenicity-associated
factors encoded within it raised the question of whether the pathogenicity of the
E. faecalis isogenic strains carrying and lacking the PAI would be different. The bac-
teraemia and peritonitis mouse models used in this study have been demonstrated
to be suitable in similar settings to evaluate the role of biofilm associated factors in
enterococcal pathogenesis [66, 166]. However no significant difference between iso-
genic PAI-positive and PAI-negative E. faecalis strains was observed (Figure 4.20).
The supposed increase in pathogenicity in PAI-positive transconjugants could have
been compensated by the impaired growth observed in the E. faecalis PAI-positive
transconjugant (Fig. 4.21). It has been suggested that larger bacterial genome sizes
reduce the bacterial growth rate [174] and delayed growth or diminished fitness can
compensate the expression of virulence factors of the transconjugant strains dur-
ing infection. The recipient and transconjugant strains have a different genomic
content, consisting of an additional ca. 66 kb plasmid and a ca. 200 kb PAI. This
corresponds to almost 10% of the genome size (the chromosome size of OG1RF is
ca. 2.74 Mb). However, enterococci exhibit virulence through mechanisms such
as adhesion and biofilm formation, translocation through eukaryotic cell layers, or
release of proinflammatory molecules and the absence of an observable effect in the
models used does not exclude the possibility of an increased pathogenic potential of
the PAI-positive transconjugants.
5.4 pLG2 Plasmid sequencing
pLG2, the erm(B)-plasmid transferred along with the PAI, carries all the elements
necessary for replication including repR-pLG2 and oriR and segregation locus (PrgP-
PrgO). Although a replicase and an origin of replication homologous to pEF1 are
present in pLG2, no relaxase could be identified, as has also been described in other
pheromone-responsive plasmids (i.e. pAD1, pCF10 and pAM373). Ruiz-Barba et
al. suggest that pEF1 replicates using the oriR and repR using the 𝜃-type replic-
ation mechanism [127], which could also be true for pLG2 given the homology of
its replicase to that of pEF1. However, the mechanism of replication of pheromone-
responsive plasmids is still unknown [186]. The PrgP-PrgO partition system of
pLG2 (segE locus) constitutes a putative ParAB-like partition system [86] and is
putatively involved in replication as it has been observed in pCF10 and pRE25
[62, 140]. The two genes are upstream and inverted with respect to repR-pLG2
and constitute another characteristic of pheromone-responsive plasmids. A sim-
ilar organization of these partition protein genes, normally known as repBC, has
been previously described in pCF10, pAD1, pPD1, pAM373 and pRE25 [62]. The
conjugative transfer of Gram-positive plasmids requires elements that provide con-
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tact between the mating cells, the formation of a canal to cross the cell wall and
the transfer of the plasmid DNA. Homologs to all these elements were found in
the DNA sequence of pLG2. One of the mobilization-related regions of pLG2 is
homologous to that of bacteriocin-encoding plasmid pEF1 and the other to that
of the RepA_N- family plasmid pAD1. Meanwhile, the replicase gene identified
was a RepR, which is unrelated to the RepA_N- plasmid family. This suggests a
modular composition of pLG2, which is a common trait of enterococcal and other
plasmids [185, 78]. Phylogenetic analyses have shown that the repA replication gene
and repBC loci are separable modules that do not need to be closely associated
[186]. A recent report of Manson et al. describes that pTEF1 and pTEF2 plasmid
transfer functions (i.e. oriT, relaxase and TraG) were essential for the transfer of
chromosomal DNA among E. faecalis and its integration into the recipient’s chro-
mosome was recA dependent. BLAST comparisons revealed that pLG2 is different
from pTEF1 and pTEF2. However, the mobilization region bearing the oriT in
pLG2, as well as that of pTEF1 is homologous to the oriT region of pAD1. Despite
this congruence, they contain different replication regions and neither a relaxase
nor TraG were detected in pLG2 sequences. Although not formally proven in the
present study by functional knockout experiments, it seems that the pLG2 plasmid
resembling conjugative E. faecalis pheromone plasmids can support horizontal PAI
transfer by providing the conjugative modules necessary for cell-to-cell transfer.
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6. Conclusions
The horizontal transferability of enterococcal virulence associated factors might be
responsible for an increased pathogenicity and spreading capacity of some entero-
coccal strains and clonal types.
The ℎ𝑦𝑙𝐸𝑓𝑚 gene is part of a highly conserved genetic structure that was mostly
plasmid located among a wide set of clinical Enterococcus faecium isolates. ℎ𝑦𝑙𝐸𝑓𝑚
megaplasmids are widely distributed among clinical associated E. faecium and seem
to be restricted to this species. Co-localization of ℎ𝑦𝑙𝐸𝑓𝑚 with metabolic and res-
istance genes (e.g. antibiotic, metal) on the same conjugative plasmid suggested
co-selection of potential pathogenicity factors under the selective conditions im-
posed within the clinical environment, which might explain the rapid adaptation
and increased success of hospital associated subpopulations of E. faecium.
The E. faecalis PAI can precisely excise, form circular intermediates and trans-
fer intra- and interspecies into the chromosome of E. faecalis and E. faecium, in-
tegrating site specifically. The pheromone-responsive conjugative plasmid pLG2,
transferred along with the PAI could have provided the mobilization machinery ne-
cessary for the horizontal transfer of this element. Acquisition of the E. faecalis PAI
caused the expression of several pathogenicity-associated factors in the transcon-
jugants such as Esp on the surface of E. faecium and E. faecalis . In E. faecalis
PAI-positive transconjugants, cytolytic activity and biofilm forming capacity were
enhanced. However, results of mouse bacteraemia and peritonitis models did not
reveal significant differences in pathogenicity and survival in vivo of the PAI-positive
E. faecalis strains.
The horizontal transfer of mobile elements in vitro might differ from the in vivo
situation as observed in two scenarios thaare not observed in natural isolates: a. The
presence of the E. faecalis PAI into E. faecium and b. The spread of ℎ𝑦𝑙𝐸𝑓𝑚 plasmids
among non clinical strains. Antibiotic usage, can induce the horizontal transfer of
pathogenicity traits triggering recombination or imposing a selective pressure for
antibiotic resistance resulting either in the direct transfer of elements co-localized on
the same element (ℎ𝑦𝑙𝐸𝑓𝑚 plasmids) or in the mobilization in trans (pLG2- E. faecalis
PAI).
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A. Appendix
Primer name Sequence Reference Sequence Reference
Enterococcus faecalis pathogenicity island (PAI) investigation
esp-TIM1 CTTTGATTCTTGGTTGTCGGATAC 𝑔𝑏|𝐴𝐹454824.1| [183]
esp-TIM2 TCCAACTACCACGGTTTGTTTATC 𝑔𝑏|𝐴𝐹454824.1| 183
ermB1 AGCCATGCGTCTGACATCTAT 𝑔𝑏|𝑀11180.2| 145
ermB2 TGCTCATAAGTAACGGTACT 𝑔𝑏|𝑀11180.2| 145
PAI164 ATGCCATGTTCAGCGAAGTTGCCAATTATC 𝑔𝑏|𝐴𝐸016830.1| 141
PAI167 GCTGATTTATTATGGTTCTCAGCAATCGCC 𝑔𝑏|𝐴𝐸016830.1| 141
PAI164Efm GGCTAAGCCTTCTTGTCTTTTATCGTTAAG 𝑔𝑏|𝐴𝐵𝑆𝑊01000168.1| This study
PAI167Efm TAGTCAATCTAAGCGGGAATGTTGTTTT 𝑔𝑏|𝐴𝐵𝑆𝑊01000168.1| This study
EF2 CCAAAAAGCAACTTTCAACC 𝑔𝑏|𝐴𝐹454824.1| 111
ER1 ATTCAAGAATGGCTGGGAC 𝑔𝑏|𝐴𝐹454824.1| 111
PAI164nested TTATACAACGGGGGCATAGC 𝑔𝑏|𝐴𝐸016830.1| This study
PAI167 UW3114 AAACGTCCTAAGACGCCGACAGAATAC 𝑔𝑏|𝐴𝐸016830.1| This study
PAI167nested GATTCGAACCCTAGACCCTCT 𝑔𝑏|𝐴𝐸016830.1| This study
Genomic walking outwards of Enterococcus faecalis PAI
TSP1 5’ GAAGATGGACGGTTGATGAAGCCTC 𝑔𝑏|𝐴𝐹454824.1| This study
TSP2 5’ GGCTGGGACATGCATCGTATTCG 𝑔𝑏|𝐴𝐹454824.1| This study
TSP3 5’ CGTGCAGCAGAAGCATTAGAAAACGC 𝑔𝑏|𝐴𝐹454824.1| This study
TSP1 3’ GCGGAATTCTGGTATTGAGC 𝑔𝑏|𝐴𝐹454824.1| This study
TSP2 3’ TGAACTTGCCAAATCAGTGG 𝑔𝑏|𝐴𝐹454824.1| This study
TSP3 3’ CCTACCAATTGCCAAGGAAAT 𝑔𝑏|𝐴𝐹454824.1| This study
Enterococcus faecium ℎ𝑦𝑙𝐸𝑓𝑚 genomic island (GI) investigation
hyl1 GAGTAGAGGAATATCTTAGC AAAK03000042.1 120
hyl2 AGGCTCCAATTCTGT AAAK03000042.1 120
hylGI1-F CATTTAGAAGGCGAGATGTCTTCAGATAA HM565216 This study
hylGI1-R TCTCAATGATCGAGGTTTCTTCAATGTAT HM565216 This study
hylGI2-F TGCCTTCCACGTTTTTTAGCTCAAGGAGGAGAG HM565216 This study
hylGI2-R GGCCGTTGATAGACAGAAGCCATTTCCTGC HM565216 This study
hylGI3a-F ACAGTTAGAAGAAGTCTGGAAACCGGTAA HM565216 This study
hylGI3a-R GGCCGTTGATAGACAGAAGCCATTTCCTGC HM565216 This study
hylGI3b-F CAATTACCGTTCTTTTGGACTG HM565216 This study
hylGI3b-F ATCGTTTCAACAGAGCTTGC HM565216 This study
hylGI3c-F ACGGTTGCTAATACTCTTCCAC HM565216 This study
hylGI3c-R ATTGGAGATGCTGGATACGG HM565216 This study
hylGI3d-F TGTGCGACTTCATTTACGATACGGAC HM565216 This study
hylGI3d-R AAGGTCAAGTACCTAGTGATGGACATGAA HM565216 This study
Hyl PAI-4F TCCGCATTTGGAAAGACCGTTTTAAGCAACTGAC AAAK03000042.1 This study
Hyl PAI-4R TTCGACAAGAATTGACGCAGCTTTATAACCCGC AAAK03000042.1 This study
vanA1 TCTGCAATAGAGATAGCCGC M97297.1 74
vanA2 GGAGTAGCTATCCCAGCATT M97297.1 74
vanB1 CATCGCCGTCCCCGAATTTCAAA AY665551.1 74
vanB2 GATGCGGAAGATACCGTGGCT AY665551.1 74
Genomic walking outwards of ℎ𝑦𝑙𝐸𝑓𝑚 genomic island (GI)
TSP1hylGI 3’ GAAAACACCGAACTCACGAATACGGC AAAK03000114.1 This study
TSP2hylGI 3’ GTGGCTCCCATGTCGTGGAATC AAAK03000114.1 This study
TSP3hylGI 3’ TCCGCATTTGGAAAGACCGTTTTAAGCAACTGAC AAAK03000114.1 This study
TSP1hylGI 5’ CCCGCTTATTTAGGACGGGCCTTC AAAK03000042.1 This study
TSP2hylGI 5’ TATTCAGCCCCTCAGTGACGCCGTTTG AAAK03000042.1 This study
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TSP3hylGI 5’ CCCCCGCTGAGGTTGAGGAATATGG AAAK03000042.1 This study
Sequencing primers ℎ𝑦𝑙𝐸𝑓𝑚 genomic island (GI)
HylPAI3 seq1 F CAATTACCGTTCTTTTGGACTG This study
HylPAI3 seq2 R TGCGTAAAGGTGAAGCAGAAC This study
HylPAI3 seq1 F CAATTACCGTTCTTTTGGACTG This study
HylPAI3 seq2 F ACGGTTGCTAATACTCTTCCAC This study
HylPAI3 seq2 R TGCGTAAAGGTGAAGCAGAAC This study
HylPAI3 seq 3 F AGTGCCCGACCAGAAACATTGC This study
HylPAI3 seq2 R TGCGTAAAGGTGAAGCAGAAC This study
HylPAI3 seq2 R TGCGTAAAGGTGAAGCAGAAC This study
HylPAI3 seq 3 F AGTGCCCGACCAGAAACATTGC This study
HylPAI3 seq1 R ACTTTTATAACTTTCGGGCACG This study
HylPAI3 seq 3 F AGTGCCCGACCAGAAACATTGC This study
ctg 625DO del F ACACCTTGATAGGTGGGCTG AAAK03000042.1 This study
ctg 625DO del R ATTGCCACTCTTGCAAATCC AAAK03000042.1 This study
Hyl PAI gap F TGGCGAAACTTATGGATTGCCAG AAAK03000042.1 This study
Hyl PAI gap R TCCATGTCCCGCTAGAGCTTC AAAK03000042.1 This study
Backbone pLG1
res-p-hylF CGTTTAATGGGGTAACTGACCCTGC HM565168 This study
res-p-hylR ACGGTTTTTCTTGTAACTCCTGCGT HM565169 This study
rep-pUW2774F AGTCGAAAATATCCAGAACCTG HM565183 This study
rep-pUW2774R AACCAGTCTTTCGTAATAGTGC HM565184 This study
mobC-pUW2774F ATCAATCGTATACTCTGAATACCCCTCA HM565181 This study
mobC-pUW2774R AAGGGGAATTTTCGTTTTGCCCCAT HM565182 This study
rel-pUW2774F GTGGACTGGAAAAAATGCAAG HM565192 This study
rel-pUW2774R TTTTATCGTTCTCAGGAAGTGG HM565193 This study
repB-pUW2774F GTTTGAATCAGCAGTTAATGAAGG HM565222 This study
repB-pUW2774R CCAATCATCATACATTTCAAAGGAC HM565223 This study
MazE-pUW2774F GGGAAAAGAACTAAAGGTTAGAAAG HM565183 This study
MazE-pUW2774R CCATTCTTCTATTATCGTTTCAAGG HM565184 This study
Table A. 1: Primers used in this study for investigation of the Enterococcus faecalis PAI
and E. faecium genomic island (GI). 𝑔𝑏|𝐴𝐹454824.1| is E. faecalis pathogenicity island (PAI),
𝑔𝑏|𝐴𝐸016830.1| is E. faecalis V583, 𝑔𝑏|𝐴𝐵𝑆𝑊01000168.1| is from E. faecium strain U0317,
𝐴𝐴𝐴𝐾03000042.1 is E. faecium contig 625, 𝐻𝑀565216 is plasmid pLG1 contig 65 and 𝐴𝑌 665551.1
is E. faecalis vanB gene.
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Primer name Primer sequence Amplicon Location
long template PCR (bp)
PAI164 ATGCCATGTTCAGCGAAGTTGCCAATTATC 1548 C:
1 PAI R GGAAGATGGACGGTTGATGAAGCCTCAATATG 427
2a PAI F CAGTTGTCGAATACGATGCATGTCCCAGCC 9674 240
2a PAI R AAACCAAAGGAACCGAAACGGAAAAACTTAGCATGG 9913
2b PAI F TTTAACCAGCCATGCTAAGTTTTTCCGTTTCGGTTC 6066 9869:
2b PAI R TTTGAAATAATCTCCAACTTTTCCCCCGTTCCACAC 15934
2c PAI F AACCATAAAAAGGAACGGAGGGAGCACAACAAAAGG 7697 14033:
2c PAI R ACTTGCAGTGTGACTGTCTGTCGTAACTTCACC 21999
3a PAI F CTCGTCCGTAACGATCTGTTTTATCGCCCTTATC 11645 21566:
3a PAI R TCAAGTCCGTACAACAGGCACTTTCTTTATCAAGC 32079
3b PAI F GAAGGCCGTTGCCAATTTTGCATTAGCTTGC 11411 31320:
3b PAI R TCCTAAGCCTATGGTAAAACATGCTGGAGTTGTCTC 42730
4a PAI F CAAGGTAGTGGAGATGTTCAGGCTGAGACAACAC 11079 42395:
4a PAI R CGGATGTTACTTCTGCTGGACTTAAAACAATCCC 53473
4b PAI F GGGATTGTTTTAAGTCCAGCAGAAGTAACATCCG 11561 53440:
4b PAI R ACGCCAAGCACAAGGGATAAAGATTGCGAAAG 65000
5a PAI F GGACGACCTTTATAGACGCCGTTTGCTTTCG 10629 64944:
5a PAI R AGTCCCCTTTTTCTGCCATGACACCAGTTAAAATC 75572
5b PAI F GCTGTGGTCAAGATAGATGGGAAAGAGATTGAGCG 11431 74158:
5b PAI R GGATCTGAACCGTCTTGTGTCATAGTGTGCCAG 85588
6a PAI F TGTAGCATACTGGCACACTATGACACAAGACGG 9115 85547:
6a PAI R CGTGCCCCTAATTACCATAGAGATAGTCGCGTTG 94661
6b PAI F TGGTAAACGCTGCTCCTGAAATGAAGAGTTTGAC 8432 93984:
6b PAI R AGGTTTGATACGCAACTACCTTTCCCAACTGACG 102421
7a PAI F TTTTGGGACAGGAACGCTATCAGTTAACGATTGC 10821 101954:
7a PAI R CCTGCGGTCAAGCACAGTTGCCTTATCTTAG 113046
7b PAI F ATTAAAGTCAAAAGAGACTGTTACTTGTGCGCCCTG 13858 113008:
7b PAI R TCAGCAAACTAAGATAAGGCAACTGTGCTTGACC 126865
8a PAI F TGCTTTAGTGGGTCGTACTAACGGAACAATAG 11008 125344:
8a PAI R CAAACAACACGTCGTCGATCTTTACCTTG 136351
8b PAI F CACCAATGCACATAATCAAACAATTCTAGGCGTAG 11048 135337:
8b PAI R GTGGACAAGCACAGTCACAATTAGAAGCAATG 146384
9 PAI F CATCATTTCTTCAGCAAATTGGTTGGCACGC 8298 146272:
PAI167R ATGTTGGTTGAAAGTTGCTTTTTGGCAAAC C
Regular PCR
PAIefs-11F AGAATTGTCTTTGGGCTTCTC 378
PAIefs-11R GCCGAATGTTGCTAAAGTTAC
PAIefs-12F GGAAAATGTTTAAAAGCCCCC 486
PAIefs-12R GGCAACGTGAGAGTAACAG
PAIefs-21F GCCATTAAAAAGTAAAGAGCCG 500
PAIefs-21R CTTGATATGCGCGATAAAGTTG
PAIefs-55F AGGATTGCTTACGGTTGATGG 357
PAIefs-55R TTTGCTTTCTCTGTTTGCTCAC
PAIefs-58F GGTGTTGTTCCTGTGGTTAG 536
PAIefs-58R TTAGGAGTCGTCCCTGTTATC
PAIefs-65F TTTTCCAGCTAAAGAACCACC 446
PAIefs-65R GTAAATACCACGATGAAGTTGC
PAIefs-70F CTTGGGATAGTGAACAAGATGG 377
PAIefs-70R CAAGGACTGCGCTATGAAG
PAIefs-84F GCCGATCCTACATATACAAACG 417
PAIefs-84R TCCAATAGTTGATCATACTGCG
PAIefs-87F GTTATTGGCAGTGCCGTTAG 433
PAIefs-87R GACTTGTGAAAGTCCTCGAAG
PAIefs-89F AAGTATTCTAGGCAGTTTGCG 403
PAIefs-89R GCCACGTTCTTTAGAAATTCG
PAIefs-91F TTGGGACAGGAACGCTATC 487
PAIefs-91R GGCCCCATACTTTTGTCATC
PAIefs-92F GAAACAGGTAGACGCTAACG 521
PAIefs-92R AACGTACTTCTTTTCCCGC
100
PAIefs-95F GGAAACTGGAGGAAATGCTTG 508
PAIefs-95R CGGTCTATCGTCCACACTAC
PAIefs-99F AATTTGGACTTCCAAGCGAC 530
PAIefs-99R ACTATTTCATTCCCCAGGGC
PAIefs-102F GCGCATTTAAGAGTGCAAATTG 582
PAIefs-102R TGCGGCTAGTAAGTAACCAAC
PAIefs-108F AATGCAAACCAGCTCTTAGAC 409
PAIefs-108R GGTCGATGGTCAATTCATCAG
PAIefs-111F GTGACGACAGAAGAACAACTAC 585
PAIefs-111R TCTCTTGAAAGGAACTGCCC
PAIefs-115F CCACCAATGCACATAATCAAAC 471
PAIefs-115R GTAATGAAGCGGAGACAACG
PAIefs-122F TGTTTCAGGTTCAAGTTCAGC 505
PAIefs-122R TCAACCTCAATGGAAAATGTGG
PAIefs-128F ACCAGAAAAACTGAAAGAGACG 548
PAIefs-128R GACTGGAAGCATTTTGGGC
PAIefs-13F AAAGAGCAGCAAGTCCTAAAG 293
PAIefs-13R TGAGAAACGGTCACAACAC
PAIefs-14F AAGGCAATGCTCAATCAGG 251
PAIefs-14R CCTACGTATCTTCTTTTCGGTG
PAIefs-15F TATGAACGCCCAGCGATTC 202
PAIefs-15R GGGGGACTTTACTTTCTACGAC
PAIefs-16F TTTAGCTGCTGGATTGCG 229
PAIefs-16R CGTTGGTCTATCAAGCAACTTC
PAIefs-17F GGTGATTTTAGGACTGGTATCC 199
PAIefs-17R TCGCCAACCTTTTATTGGG
PAIefs-18F TTTGCGCCAAACGGCATTC 181
PAIefs-18R AAGAAAAGAGCGTCCACACAAG
PAIefs-19F AGATTACACCGAGGATGTAGC 174
PAIefs-19R TCTTCGCTCTCACAATCAAAAG
PAIefs-20F TCAACTGTGTTATTTGGCGG 218
PAIefs-20R CGTAGCTTTACCTGTAGCCTG
PAIefs-57F ACGTCAAACCGTATCCAAAG 179
PAIefs-57R AGCCGTCCGTAATAAAAAGC
PAIefs-59F GCAGAAAAAGGGAAGAAATTACAAC 289
PAIefs-59R CTGGAAAAATACCGAATCTTAGTTG
PAIefs-60F GCTTGACCAGATGACTAATGC 180
PAIefs-60R GCAACGAACTCATCAACAAATG
PAIefs-61F GGATTTCCGATTGCTTCAGC 198
PAIefs-61R AGCGACTATTACTCATCGACC
PAIefs-62F GAAGCCATTGACCGATTAGG 185
PAIefs-62R TGTTCCGCAATCATTGCC
PAIefs-66F TCAAGCTGGTGTGGATTTTG 198
PAIefs-66R CCACCAACGACAATTCCTG
PAIefs-67F GCAACTAGCTGATCCAAACC 181
PAIefs-67R AAATGAAGTCAAGCCACCAC
PAIefs-68F TTGACTGGACGAATTGAAGC 222
PAIefs-68R GACAGATGGATCTTTTCCTGC
PAIefs-69F GCCATACTTCCGTCAATAACG 163
PAIefs-69R TGTCACTACCATTAATCACTGC
PAIefs-72F TGAAAATGGCACTCCAACAG 226
PAIefs-72R CCGTACATCATAGGCACAATC
PAIefs-73F GAGTACTGGATTATTCAGGCG 212
PAIefs-73R TTGAATGGCTTCTTCACCG
PAIefs-74F GGGATAAGCAGACGATTATCGG 155
PAIefs-74R TCTTGTGCGTGGTGCTAAC
PAIefs-76F TGCCATAATGGGTATGAGGAC 212
PAIefs-76R CATGCTGACCTTTAACGGTAG
PAIefs-78F GGTTCACAAAGCTGAAGCAG 198
PAIefs-78R CCTCCAGCAACAGTTAATCC
PAIefs-79F AGAGAATGCTGACGAAAACAC 191
PAIefs-79R GCGCTACACTTACAACAATCC
101
PAIefs-80F AGAATTGATGATCGCTTGATCC 153
PAIefs-80R CGAAGAAATTCCAGCAGGAAC
PAIefs-81F CCTGTTGTTTCTATGACGCC 200
PAIefs-81R ACCATTCCCAAATTAACTCCAG
PAIefs-82F ACGATTTCGATGCTGCAAC 202
PAIefs-82R TCATCTGTATCCCAGCCAAG
PAIefs-83F GGAGCTGATAATGCTTGTGC 202
PAIefs-83R AAGAATTACCTGCTGCCAAC
PAIefs-92F GCTTTAGTTTCACTACAATCCCC 194
PAIefs-92R GCGTCTACCTGCTTCTTAATTAC
PAIefs-93F GGGAACATATGCCGGAATG 293
PAIefs-93R CATGATGCACAATTAGCACTG
PAIefs-94F GGCGATGCTATTTCTCATGC 223
PAIefs-94R CGGTTGAGCTATTTGCAACAC
PAIefs-119F TCATCTCCTTCTTTCCCTGC 193
PAIefs-119R AACGACTGATTACGCTTGAC
PAIefs-123F CCACCGAAGTTGAGTGTATC 198
PAIefs-123R TCGATCTTCTGCTTCTTGTTC
PAIefs-126F CCAAACACGACTTCTTGCTC 198
PAIefs-126R CACGGATTCACTGCTAAAGG
PAIefs-129F AGCCAATGAAACGACAGAAG 214
PAIefs-129R CGGCTCAATACCAGAATTCC
PAIefs-128-129 F ATCAGGTCAAACGGATCAAA 197
PAIefs-128-129 R CTGACAGAATGGCTCGTCTT
PAIefs-125-F CTAGGAATACAGCGACCAATAC 597
PAIefs-125-R CCGACTTTGCTATCGGAAC
PAIefs-126-F TTTTGTCCAAGTGACATCGG 628
PAIefs-126-R TTCAGAGATGGAAACAAGAGTG
PAIefs-128F AGGGACAGGGTTTTCGATTT 477
PAIefs-128R ATTTGGTTCGCCTTCCTCTT
oxiRed-F AACTGGTTTGAACCGTGAGG 385
oxiRed-R TTGCATCAATGGTGACCAAG
Table A. 2: Primers used for investigation of Enterococcus faecalis pathogenicity island (PAI)
presence by regular PCR. Location given as in 𝑔𝑏𝐴𝐹454824.1 E. faecalisPAI.
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Primer name Primer sequence contig location
pTEF3 like F TTGTTCGCTAAATGCACCGT 1 1533:2182
pTEF3 like R GCACGTACAATTCCTGCGTT
pili F TCCGTGCTTTCTTGTCTGTCTGCAAACGTC 21 34386:34688
pili R ATGTACGCCTAAGGGGATCAACACACACCG
ctg2 F GGAACAGGTAAAGGGCATTTAACGAC 2 713:1268
ctg2 R TGTTTACTTTGGCGTGTTTCATTGC
ctg6 F TGCTCGTATTATTGCTCGTTTACCG 6 1002:1658
ctg6 R TGCCAAGTGACTGTCGTACATAAAG
ABC-like F TCCAGAAGTTGGTTCATCGG 4 11085:11513
ABC-like R GAAAAGGGTGAATTTGTTGGTC
mano F TGGTTGCCGGACGTTTTTGGCTATTCTTGG 12 30944:31299
mano R AACATATCACGATTAACGCCGCCTCCGC
bleo F CGATGCCGGAAACCGAAAATAGTCGC 12 33451:33943
bleo R TGGCCGATATCACTACCAAACCAGACG
ctg16 F AAGATGCTAAAGTAGTTAGCGGAGAAC 16 451:1017
ctg16 R CACTCACTGACTCTAAAGACTCTTCAAAC
ctg17 F GATCATCAATCGTATACTCTGAATACCCC 17 399:970
ctg17 R CAATCAAATAGCTCTTGCGAAGGC
ctg17cr F TGAGTAATTAGTGCCGCAAAAACAGG 17 2818:3511
ctg17cr R ATTTGGGTGAAACGGGTGTTTACG
ctg18 F TTTCCATGATCGATGAGCAGGAAC 18 4051:4708
ctg18 R CGAAAAAAGGCTCTTCGACATTTAGTG
ctg20 F TTGCCCAACAAATGCGATCACATC 12 5278:5928
ctg20 R ATAGCTTCATCTCCACGTAAGCCG
ctg21 F GGCTGATGGGGTTTTTTTTACGTTTC 21 43160:43710
ctg21 R ACTCTATACACGGTGACCGCATAC
ctg24 F TCGTTCTCTGTGATGAAATTGCCTAC 12 9056:9739
ctg24 R ACACGAGTTTTGCTACTTAACACGAG
ctg26 F GCGCTACAATTACTCATCGACCTG 26 366:1008
ctg26 R ACGACAATTGATTATGAAGCCAGAGAG
ctg29 F GAAACTCAGGAGCACATTGTTCTAGATTC 29 801:1494
ctg29 R GCTGAAGCAATTGGCAATCCTCTC
ctg32 F TTGGCATCCCTCCACAACAAAAAC 32 562:1173
ctg32 R CATCACTTATTTTTGCAACCGCTGAAG
ctg34 F GCAGCTTGATTTATCTCATCTTGAACAGC 34 507:1158
ctg34 R TACCAGAGCCAAATCCATTGCCTG
ctg35 F TCCAGCTACTGGAATATACTGCTGTAATC 35 996:1628
ctg35 R ACGAAAATTTCCACTGTGTGACCG
ctg40 F CACTCTAACCAGTCTTTCGTAATAGTGC 21 40770:41361
ctg40 R TACCCACCCTCGACGAAAAATCAG
ctg67 F AAAACCCCTAAAATGACGGCCTTG 12 28068:28714
ctg67 R GCAACCATTGCCTTAGCAACTTTG
ctg69 F CTCCAGTTGATACACATCTAGCTGC 4 6705:7382
ctg69 R GAGCTTATTTTGGAGAAAAGGATGCAC
ctg70 F ATTCTGATGGCAATAAGGGGCAG 70 3005:3681
ctg70 R CCACTGATGACGGTGATAACATTTTTC
ctg71 F GGGGAGGGAGAAGTTAAAGAAAATTCAG 3 1457:2017
ctg71 R ATTATGGCAAGGGGAGGAGGTTG
ctg75 F TTTTACGTCCACTAGCCAACTGTC 3 11232:11902
ctg75 R CAGGATTTTACCACCAGCTTTTGC
ctg76 F ACCACGAATCCTATTATAGAGACATGGAC 76 4367:4960
ctg76 R GGACCAAGCCCTCTGATTTTCTTTTC
ctg78n F TGCGGGCACAACATATAGAGTAGCTTACG 78 621:1220
ctg78n R TCACCTTCTCCGCCTCCTTCTTCGTTAG
ctg87 F CTTAGGTTCGGGAAGTTTAGGCG 87 3567:4161
ctg87 R AGCCGACATCATTTTCTTCAGCG
ctg91 F TCTTGCTCAATGCTTTACGGTTAAGAC 91 3711:4378
ctg91 R GCCATGATCCATTTCACTGTGATCC
ctg92 F CTGTTGGCAAACCACAAGTGACC 92 134:708
ctg92 R ATCACCTACAAAGGCGACTGCTC
103
vanA1 TCTGCAATAGAGATAGCCGC 6 6309:6685
vanA2 GGAGTAGCTATCCCAGCATT
hyl1 GAGTAGAGGAATATCTTAGC 65 12765:13426
hyl2 AGGCTCCAATTCTGT
Table A. 3: Primers used for synthesis of 31 probes to confirm plasmid location of pLG1 contigs
by Southern hybridization. The putative function of the ORF covered by the probe is indicated,
some probes cover more than one putative ORF. All probes hybridized to the plasmid pLG1 band
resolved by S1 nuclease Pulse field gel electrophoresis (PFGE) treatment.
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Primer name Primer sequence Product
size (bp)
Result
lysteria gap F GGAGATTTTGTGTTGATTCCCCCAC 1736 3000
lysteria gap R AATTGTATCCTCAGGCAATGCCG
DO658 gap1F CATACTTCTCCCTGGATAACTTCCC 978 +
DO658 gap1R CAAACAAGATTTGCATCATATCCATT
DO658 gap2F CTTCATTAAAAGGAGCTTGACCGAT 357 +
DO658 gap2R TTGTCCTTGTTGTCCAACTTCAAAT
DO658 gap3F AGTTTTAGTTTTGGGGCTGTTTTCA 1909 +
DO658 gap3R CAATCCCCTCTGATAATTCGGATAC
DO625 gap1F ACTATCGTTTTGCAACGAGGACC 300 -
DO625 gap1R AGTGTCCGTATCGTAAATGAAGTCG
hylPAI3c-ISF CGAGGACCAACTGGACCGTAGGAGC 2576 +
hylPAI3c-ISR ACCACCTGCAACAGTGGAGTGGGAA
DO614 gap1F CCGTCAACTCATATGCGAGTATTTC 643 2000
DO614 gap1R TCTCTTTTGCCTACTGTTGATCGTC
DO590 gap1F GAGACTTTATCGGAAGAAGCGAATC 790 -
DO590 gap1R CATGTTTTATTGTGCTGGTTCATCA
DO590 gap2F GCATTTTCCCAATACACTCAGTTTG 880 +
DO590 gap2R ATAGGAGGCTTGGTTCCTAGTGTTG
DO590 gap3F TTGTAACCGGTCAATTTCATAATGG 826 +
DO590 gap3R CAAGGAACTGACATTGGCATAAAAG
DO590 gap4F GCAAAGTACCGTTTCCAGACATCTA 853 +
DO590 gap4R CGTCTTTTTCTTCTGAAAGGTCTCG
DO590 gap5F AGAACTTCCCGAAACGTTAGATGAC 465 -
DO590 gap5R ACGTAAATGGAAAGTTTTGTCTCGC
DO632 gap1F CTACACGTGGCTTTCCAGCTAAGTA 373 +
DO632 gap1R CACGGTGTCGATTTTTATGACTTTC
DO632 gap2F CCACTTTCGTGAAGTTTAACAATGG 848 +
DO632 gap2R AAGTCCCAAATGGAGCAACTGTATT
DO632 gap3F GACCTAAGGTTGTTTTTGTCGATGA 1448 +
DO632 gap3R CAATCAAAAGAAAATTGCGAATCAC
DO649 gap1F CAATTGTCCAAATTTATCGTCCAAA 814 +
DO649 gap1R TGAGACAATTATGACAAACGACAGC
DO649 gap2F TTGTAGATCCTCTACTTTCACGTTGTTTT 866 +
DO649 gap2R GCAACTCATTAGCTAGACAAACTACAAGC
pVEF2 gap F ATAGCCGCGGCAGTGCCATTGATCT 949 -
pVEF2 gap R ACTTCACACTTTCTTGGCGAACAGGA
Table A. 4: Primers used for gap closure of plasmid contigs during pLG1 sequencing. 17 PCR
reactions were done, of which 12 were positive and allowed linking of 15 gaps (primerDO632gap3
linked 3 contigs).
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